Quality of care in head and neck oncology  Development of a nationwide instrument by Overveld, L.F.J. van
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/182825
 
 
 
Please be advised that this information was generated on 2019-06-02 and may be subject to
change.

Quality of care in head and neck oncology 
Development of a nationwide instrument 
Lydia F.J. van Overveld 
The research presented in this thesis was conducted at IQ healthcare. This department is part of 
the Radboud Institute for Health Sciences (RIHS), one of the approved research institutes of the 
Radboud university medical center, Nijmegen, the Netherlands. 
Financial support by the Radboud University for the publication of this thesis is gratefully 
acknowledged. The study was financially supported by the Dutch Association of University 
Medical Centers (NFU) in the project ‘kwaliteitsregistratie in de keten’ (2013-2016) in tight 
cooperation with CZ health insurer. 
ISBN: 978-94-6332-303-1 
Cover design:  GVO drukkers & vormgevers B.V. 
Lay out : Lydia van Overveld 
Print:  GVO drukkers & vormgevers B.V. 
©2018, Lydia van Overveld, Nijmegen 
All rights reserved. No parts of this thesis may be reproduced without prior permission of the 
author. 
Quality of care in head and neck oncology 
Development of a nationwide instrument 
Proefschrift 
ter verkrijging van de graad van doctor 
aan de Radboud Universiteit Nijmegen 
op gezag van de rector magnificus prof. dr. J.H.J.M. van Krieken, 
volgens besluit van het college van decanen 
in het openbaar te verdedigen op woensdag 28 februari 2018 
om 14.30 uur precies 
door 
Lydia Francisca Jacoba van Overveld 
geboren op 4 januari 1988 
te Bergen op Zoom
4 
Promotoren: Prof. dr. M.A.W. Merkx 
Prof. dr. L.E. Smeele (UvA) 
Copromotoren: Dr. R.P.M.G. Hermens 
Dr. R.P. Takes 
Manuscriptcommissie: Prof. dr. J.H.A.M. Kaanders 
Prof. dr. A.L.M. Verbeek 
Dr. M.W.J.M. Wouters (Antoni van 
Leeuwenhoek ziekenhuis, Amsterdam) 
 Contents 
 
 
  Page 
Chapter 1 General introduction 
 
7 
Chapter 2 Quality indicators of integrated care for patients with head and neck cancer 
Clinical Otolaryngology 2017; 42(2): 322-329 
 
19 
Chapter 3 Needs and preferences of patients with head and neck cancer in integrated 
care 
Clinical Otolaryngology 2017; [Epub ahead of print] 
 
33 
Chapter 4 Variation in integrated head and neck cancer care: impact of patient and 
hospital characteristics 
Submitted  
 
51 
Chapter 5 PROs and PREs in Dutch integrated head and neck cancer care 
Submitted  
 
67 
Chapter 6 Feedback preferences of patients, professionals and health insurers in 
integrated head and neck cancer care  
Health Expectations 2017; 20(6): 1275-1288 
 
83 
Chapter 7 General discussion 
Submitted  
 
107 
Chapter 8 Main findings 121 
 Summary 125 
 Samenvatting 129 
  
 
Indicator sets 
 
 
135 
 Dankwoord 145 
 Curriculum Vitae 149 
 Bibliography 153 
  
 
  
 
CHAPTER 1 
 
General introduction 
 
 
 Chapter 1 
8 
 
BACKGROUND 
This thesis describes studies on the development of a multidisciplinary quality registration for 
patients with head and neck cancer (HNC) in the Netherlands; the Dutch Head and Neck Audit 
(DHNA). It also describes the first results of the DHNA, the evaluation of the indicators and 
preferences for audit and feedback.  
 
HEAD AND NECK CANCER 
Incidence and survival 
Head and neck cancer (HNC) represents a heterogeneous group of predominantly epithelial 
malignancies that arise in the paranasal sinuses, nasal cavity and nasopharynx, oral cavity, 
oropharynx, hypopharynx, larynx, and salivary glands (Figure 1)1. Histologically, squamous cell 
carcinoma is the most important subtype2,3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overall, HNC accounts for more than 500,000 cases annually worldwide4,5. In the Netherlands, 
approximately 3000 patients are yearly diagnosed (Figure 2)6. It was the 9th most common cancer 
in women and the 7th in men in 20166. When incidence rates are subdivided for different sites, 
especially oral cavity and oropharynx have shown an increase in incidence (Figure 3)6. A 
worldwide increase in incidence of oropharyngeal cancer also has been noted in a large study 
from a database of five continents7, especially in young adults in the USA and European 
countries2,7.  
 
 
Figure 1. Head and neck cancer sites. Reprinted from 
National Cancer Institute (NCI) website, by NCI, 
20121. 
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Figure 2. Number of new patients with head and neck cancer between 1990 and 2015 in the Netherlands. Data 
retrieved from Figures on cancer (Cijfers over kanker) website, by the Netherlands Comprehensive Cancer 
Organisation (IKNL), 20176. 
 
 
Figure 3. Number of new patients with one of four subsites of head and neck cancer between 1990 and 2015 in the 
Netherlands. Data retrieved from Figures on cancer (Cijfers over kanker) website, by the Netherlands Comprehensive 
Cancer Organisation (IKNL), 20176. 
 
 
Figure 4 shows that the 5-year survival of patients diagnosed with HNC in the oral cavity, nasal 
cavity and nasopharynx, increased over time in the Netherlands. In addition, a Dutch study with 
13,106 patients showed that 5 year survival for patients with oral cavity cancer improved from 
57% in 1991-1995 to 62% in 2006-20108.  
.  
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Figure 4. Survival of patients diagnosed with HNC in the oral cavity and nasal cavity and nasopharynx between 1989-
1993 and 2008-2012 in the Netherlands. Data retrieved from Figures on cancer (Cijfers over kanker) website, by the 
Netherlands Comprehensive Cancer Organisation (IKNL), 20176. 
 
Symptoms, risk factors and treatment 
HNC has significant impact on a patient’s well being as HNCs grow relatively aggressive in an 
anatomically and functionally important area2,9,10. During and after treatment, patients often 
experience problems with speech, swallowing, and physical disfiguration due to toxicity and side 
effects11-15. In addition, they often suffer from psychological disorders, such as depression and 
anxiety, and social problems, such as relationship difficulties with their partner and family 
members, and loss of work16-18. The median age for diagnosis is in a patient’s early 60s, with a 
male predominance2,19,20. 
 The most important risk factors are tobacco and alcohol consumption2,21-23. Wyss et al. 
reported that among never cigarette smokers, the HNC risk increased in ever cigar smokers (Odds 
Ratio (OR): 2.54 (95% confidence interval (CI): 1.93, 3.34)) and ever pipe smokers (OR: 2.08 (95% 
CI: 1.55-2.81)). These ORs increased with increasing frequency and duration of smoking (Ptrend ≤ 
0.0001)24. Regarding alcohol: alcohol consumption was associated with an increased risk of HNC 
(RR: 2.74 (95% CI: 1.85-4.06) for those drinking ≥30 g ethanol/day (about three or more drinks) as 
compared with abstainers21,25,26.  
 In addition, Humaan Papillomavirus (HPV) has been reported as an important etiological 
factor, especially for oropharyngeal cancer (OPC)27. A meta-analysis which included studies that 
were published between 2002-2012 showed a prevalence of HPV of any type in patients with 
HNC in European countries of 40% (95% CI; 34.6% to 45.5%), whereas the prevalence was 41.3% 
(95% CI; 31.8% to 50.7%) for OPC28. Apparently, rates of HPV-related OPC have been rapidly 
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rising in Western countries while the incidence of alcohol- and smoking-related tumours has 
decreased and a majority of non-smokers and non-drinkers are affected by HPV-related disease 
in OPC29,30. In addition, research showed a difference in impact of HPV and smoking for both men 
and women: HPV has a greater impact on OPC incidence trends for men, in contrast to smoking 
for women27. In contrast, a Dutch study concluded that even in the subset of OPC, HPV did not 
appear to be the main contributor to a rising incidence of OPC and smoking and alcohol 
consumption continue to play a role31. 
  
Need for standard of care 
A multidisciplinary approach is required for optimal diagnostics and decision making around 
treatment, treatment planning, and post treatment response assessment. Structured 
multidisciplinary care plans which detail essential steps in the care of patients were developed32. 
A multidisciplinary approach includes the input from surgeons, medical oncologists, radiation 
oncologists, and pathologists as well as supportive care givers such as dentists, speech and 
swallowing therapists, dieticians, physiotherapists, oral hygienists and rehabilitation therapists. 
HNC is treated with surgery, systemic therapy, radiation or a combination of these. A strategy for 
better coordination of services across the entire care continuum with alignment and 
collaboration of all disciplines is required for patients with HNC33. In other words: integrated care 
is crucial34,35. Integrated care is not only crucial for HNC, but is of great value for other oncologic 
diseases as well36,37. 
 In the Netherlands, HNC care is centralized in 14 hospitals: eight Head and Neck Oncology 
Centres (HNOCs) and six affiliated centres (Figure 5)38. The affiliated centres have committed 
themselves to using the same treatment protocols as the related HNOC. The various medical 
specialists and allied health professionals involved in 
HNC care are united in two national foundations, one for 
medical specialists (NWHHT)a and one for allied health 
professionals (PWHHT)b. There is also the Dutch Patient 
Association ‘Patiëntenvereniging Hoofd-hals’39. Even 
with these specialized hospitals and foundations, 
optimal care for HNC patients remains complex. 
  
 
 
 
                                                     
 
a Dutch Head and Neck Society 
 
b Dutch Head and Neck Allied Health Professionals Group 
Figure 5. The fourteen specialized hospitals in head and neck 
cancer care in the Netherlands.  
Red = Head and Neck Oncology Centres, blue = affiliated centres. 
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QUALITY OF CARE 
Now that the survival for patients with HNC improved during the last decades, there are 
opportunities to shift focus. Besides focusing on survival, more focus could be directed towards 
quality of healthcare, including quality of life. The WHO stated already in 2006 that, even when 
healthcare systems are well developed and resourced, variation in quality of care remains a 
serious concern40. Therefore, it is important to gain insight into the care that is actually provided 
in order to monitor and effectively improve high-quality integrated care41,42. By measuring the 
quality of care in a broad spectrum, hospitals are able to identify those aspects of healthcare that 
may need improvement. Similar initiatives already show large beneficial effects of measuring 
quality of care. For example, the Dutch Surgical Colorectal Audit (DSCA) that measures the quality 
of care of patients with colon carcinomas. They show that transparency and giving feedback 
results in increased guideline compliance and a reduction of complication-, re-intervention and 
postoperative mortality rates43. 
 
Quality indicators 
To measure and monitor quality of care, a dashboard of valid and reliable Quality Indicators (QIs) 
can be used44,45. A definition of a quality indicator was already given in 1988 by Donabedian; "a 
measurable element of practice performance for which there is evidence or consensus that it can 
be used to assess the quality of care"42. QIs infer a judgement about quality of care provided44. 
They can refer to outcomes, structures, or processes of care44. Process and outcome indicators 
are measured on patient level, structure indicators are measured on hospital level. An example of 
a process indicator is if the patient is discussed in a multidisciplinary team meeting. An example 
of an outcome indicator is the survival of patients or patients quality of life and patients’ 
experiences. The latter can be assessed with questionnaires regarding Patient Reported 
Outcomes (PROMs) or Experiences (PREMs). An example of a structure indicator is the presence 
of case manager/oncology nurse for a minimum of four days a week. 
 Process and outcome indicators are calculated by dividing the numerator (the total 
number of patients who received the predefined measurable element of practice performance or 
that met the experience) by the denominator (the total number of patients who needed to 
receive the predefined measurable element of practice performance or to experience the 
outcome) (Figure 6). A structure indicator is often expressed as a percentage of hospitals that 
meet the indicator.  
 
 
Figure 6. Calculation of a process and outcome indicator. 
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The problem: measuring quality of integrated head and neck cancer care 
An often used method to improve integrated quality of care, is by measuring indicators. 
Unfortunately, there is no set of indicators that measures the quality of integrated HNC care 
along the entire pathway, from referral to follow-up. Published indicator sets to measure quality 
in HNC care only incorporate treatment aspects46. In another publication, the care delivered by 
allied health professionals is not included47. Since HNC care is classified as integrated care where 
alignment and collaboration of several disciplines is crucial, quality of care should be measured 
within the entire healthcare process. Herewith, we can assure that quality of healthcare will be 
measured and can be improved if necessary.  
 
Including patients’ need and preferences 
Nowadays, providing patient-centred care is an essential component of high quality integrated 
care48. Responding to the needs and preferences of patients is an important aspect of current 
healthcare policy worldwide49,50. It leads to positive clinical outcomes and increased patient 
satisfaction 48,49,51-53. As a result, increased patient satisfaction might result in a better adherence 
to treatment recommendations and increase quality of life54. Unfortunately, information on 
patients’ needs and preferences for integrated care is lacking.  
 To improve the quality of integrated HNC care, it is crucial to develop a comprehensive 
set of quality indicators from different perspectives to incorporate all crucial aspects of HNC care. 
Furthermore, the perspective of the patient, by taking PROMs, PREMS and patients’ needs and 
preferences into account, should be included by all means.  
 
The method: quality registration 
A quality registration is an independent data collection tool to assess the quality of care55. A 
quality registration gives insight in the quality of care and can therefore be used to monitor and 
effectively improve quality of care. Existing quality registrations already showed improvements in 
healthcare, for example decreased complication and mortality rates43,56.  
 Examples of quality registrations in the Netherlands are the Dutch Surgical Colorectal 
Audit (DSCA) or the National Registration Orthopedic Implants (LROI)57,58. Many oncological 
registries are included in the Dutch Institute for Clinical Auditing (DICA). This is a national 
organization that gives insight in the quality of care with reliable comparisons and analysis.  
 According to the website of the National Institute for Public Health and Environment 
(RIVM), there are currently 181 active quality registrations and annual costs for quality 
registrations are estimated on 80 million55. This amount is at the expense of the provision of care. 
Therefore, quoted by the director of the Dutch Hospital Association (NVZ), it is important to 
significantly reduce the registrations and to make quality registrations as comprehensive as 
possible.  
1 
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Audit and feedback 
After measuring the quality of care via a quality registration, feedback should be given on the 
results to the healthcare professionals in order to improve professional practice and outcomes in 
healthcare59,60. Audit and feedback is defined as any summary of clinical performance of 
healthcare over a specified period of time, given in a written, electronic or verbal format, offering 
professionals performance information and motivation to improve61.  
 The last decade, much effort is devoted to improve professional practice and outcomes in 
healthcare using audit and feedback, unfortunately with varying effects60. In addition, 
implementation of audit and feedback is likely to be more effective when feedback messages can 
influence barriers to change behaviour. These barriers appear to differ across individuals62. In 
addition, stakeholders have different perspectives on quality of care44. For example, patients 
often emphasize good communication skills, whereas healthcare professionals have more 
interest in oncologic outcomes, for example survival and recurrence of the cancer44. Health 
insurers, who search for quality information suitable to explore differences in quality of care as a 
basis for their contracting, are an important stakeholder as well. Therefore, in an integrated 
pathway, it seems likely to give personalized feedback to all stakeholders: to healthcare 
professionals, as well as to patients and health insurers.  
 Unfortunately, little is known about how each stakeholder prefers to receive feedback. To 
set up an effective quality registration, it is crucial to unveil these unknown preferences of 
receiving feedback. 
 
MAIN OBJECTIVES 
The main objectives of this thesis are: 
 
1. To develop a comprehensive and evidence based set of quality indicators from three 
different perspectives: medical specialists, allied health professionals and patients; 
 
2. To investigate the preferences of various stakeholders on receiving audit and feedback. 
 
THESIS OUTLINE 
In order to measure the quality of multidisciplinary integrated HNC care, a comprehensive and 
evidence based set of quality indicators from three different perspectives was developed. The 
development of indicators from the perspective of the medical specialists and the allied health 
professionals is described in Chapter 2. The development of indicators from the perspective of 
the patient, by investigating patients’ needs and preferences, is described in Chapter 3.  
 General introduction  
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 The results of the first quality measurements regarding the quality of care delivered by 
medical specialists and allied health professionals are presented in Chapter 4. The first results 
regarding patients quality of life and the patients’ experiences in HNC care are presented in 
Chapter 5. 
 In order to increase the effectiveness of feedback, we investigated the preferences of 
various stakeholders on receiving audit and feedback (Chapter 6). We hypothesize that adapting 
feedback to the preferences of these different stakeholders, will improve their response to the 
information delivered and that more improvement effects of audit and feedback could be 
observed.  
 The main findings of this thesis together with the methodological considerations, and 
implications for clinical practice, further research and policy making will be outlined in Chapter 7. 
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ABSTRACT  
Objectives: Oncological care is very complex, and delivery of integrated care with optimal 
alignment and collaboration of several disciplines is crucial. To monitor and effectively improve 
high-quality integrated oncological care, a dashboard of valid and reliable quality indicators (QIs) 
is indispensable. The aim was to develop multidisciplinary QIs to measure quality of integrated 
oncological care, specifically for head and neck cancer (HNC) patients. 
Design: The RAND-modified Delphi method was used to decide on the outcome, process, and 
structure QIs form three different perspectives. In addition, case-mix factors were determined. 
Setting: Integrated HNC care hospitals in the Netherlands. 
Participants: HNC patients, chairmen of both patient organisations, and medical specialists and 
allied health professionals involved in HNC care in the Netherlands.  
Main outcome measures: Outcome, process, and structure indicators. 
Results: Outcome indicators were assigned to healthcare status, tumour recurrence, 
complications, quality of life, and patient experiences. The process indicators focused on the 
(allied health) care aspects during the diagnostic, treatment, and follow-up phases; for example, 
regarding waiting times, multidisciplinary team meetings, and screening for the need of allied 
healthcare. 
Conclusions: This is the first set of multidisciplinary QIs for HNC care, to assess quality of 
integrated care agreed by patients and professionals. This set can be used to build other 
oncological quality dashboards for integrated care. 
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INTRODUCTION 
The delivery of high-quality oncological integrated care, with optimal alignment and collaboration 
of all disciplines involved throughout the entire healthcare process, is crucial for patients1,2. 
However, management of integrated care is very complex1,3. To monitor and effectively improve 
high-quality integrated care, a dashboard of valid and reliable quality indicators (QIs) is 
indispensable4,5.  
 Unfortunately, little is known about QIs in oncological integrated care. Many QIs are 
developed for oncological diseases, although often only for a single part of the healthcare 
process; for example, the multidisciplinary team meeting (MTM) or surgery6-8. Moreover, 
indicator sets in oncology do not incorporate the care delivered by allied health professionals 
(AHPs)9,10 who play an important role in the care delivered11,12. 
  For patients with head and neck cancer (HNC), incorporation of AHPs in the entire 
healthcare process is particularly important. HNCs are heterogeneous both biologically as well as 
in clinical behaviour, and grow relatively fast in an anatomically and functionally complex 
area13,14. Patients often have problems with speech, swallowing, and physical disfiguration due to 
treatment15,16, requiring the collaboration of both medical specialists (MSs) and AHPs. Therefore, 
high-quality integrated care for patients with this type of tumour is needed17,18. 
 We aimed to develop a set of QIs through an evidence-based method to measure the 
quality of oncological integrated care. This study can serve as an example for quality dashboards 
for other oncological diseases to monitor and improve the integrated care. 
 
MATERIALS AND METHODS 
Study design 
We used the RAND-modified Delphi method (RMDM) to develop indicators of integrated care 
from the perspective of MSs and AHPs using four steps. The Committee on Research Involving 
Human Subjects in the Arnhem–Nijmegen region of the Netherlands assessed the study and 
concluded that our study was carried out in accordance with the applicable rules concerning the 
review of research ethics committees and informed consent. 
 
Setting 
In the Netherlands, where approximately 3000 patients are newly diagnosed with HNC each year. 
HNC care is centralized in eight university hospitals and six affiliated centres (14 hospitals)19. MSs 
and AHPs involved in HNC care are united in two national foundations, one for MSs (NWHHT) and 
one for AHPs (PWHHT). In addition, there are two patient organisations: ‘Klankbord’ and ‘NSVG’ 
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(now merged into ‘Patiëntenvereniging Hoofd-Hals’). The first represents all patients with HNC, 
the latter represents laryngectomized patients.  
 
Expert panels and patients 
Members of both national foundations were asked to deliver experts with a key role in HNC care, 
to select a set of QI. The panel of MSs (n = 18), with one or two representatives from each 
hospital consisted of six otorhinolaryngologists, six oral and maxillofacial head and neck 
surgeons, three radiation oncologists, and two medical oncologists; an epidemiologist from the 
Netherlands Cancer Registry was added. The panel of AHPs (n = 11) included all board members 
of the national foundation. The board represents all kinds of AHPs related to the HNC in the 
Netherlands. The panel of AHPs consisted therefore of one physiotherapist, two speech 
therapists, three dieticians, two oral hygienists, two oncology nurses, and one radiotherapy 
technician.  
 Each hospital and the two Dutch patient organisations were asked to select one or two 
HNC patients willing to participate in the patient panel. The two chairmen of both patient 
organisations were invited to participate. In total, 12 patients and the two chairmen participated 
(mean age of 60 years; 57% male; either a tumour in the larynx (46%) or oral cavity (54%)). 
 
Step 1: Selection of key recommendations 
A comprehensive literature search was carried out on guideline recommendations, existing 
indicators regarding outcome, process, and structure of integrated HNC care, and possible case-
mix factors. CINAHL, MEDLINE, PubMed, and the Internet were searched for literature and 
national and international guidelines regarding the perspective of both the MSs and AHPs. The 
following search terms were used: quality assessment, practice guidelines, and quality indicator 
in combination with the different types of head and neck cancer. For a clear overview, 
recommendations and indicators found in the literature regarding the process and structure of 
care delivered by MSs were assigned to one of four topics, particularly diagnostics, treatment, 
aftercare and follow-up, and coordination and organization. Those of allied healthcare were 
assigned into one of six topics, particularly nutritional care, dental care, psychosocial care, 
physical care, communication and information, and coordination and organization. In addition, 
potential outcome indicators found in the literature, were added to this overview. Subsequently, 
all recommendations from the guidelines, and existing indicators from the literature were 
processed in a questionnaire for individual rating by panel members. To assess which case-mix 
factors could be important to assess possible variation between the hospitals, we performed 
another literature search and also added a list of case-mix factors to the questionnaire, asking 
both panels to verify them. 
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Step 2: Individual rating of key recommendations by the expert panels 
Both panels received an online and paper version of the questionnaire, starting with similar 
outcome indicators and case-mix factors, followed by recommendations and indicators regarding 
the process and structure of either MS care or AHP care, including the origin. Both panels were 
instructed to rate the recommendations and indicators on a nine-point scale (1 = lowest rating, 9 
= highest rating) with regard to relevance on four criteria: (1) prolonging disease-free and overall 
survival; (2) improving quality of life; (3) quality of the healthcare process; and (4) improving 
efficiency. The MS panel was instructed to rate the outcome indicators first, and AHPs were then 
asked if they agreed with the selected outcome indicators, and if other outcome indicators 
should be added. Members were invited to discuss their ratings with professionals in their own 
hospital, and encouraged to propose new indicators and give feedback on proposed case-mix 
factors.  
 The results of Step 2 were summarized in a feedback report to facilitate Step 3. The cutoff 
for a high median was set at 8 or higher20,21. Panel members were defined as being in agreement 
if at least 70% of the ratings fell in the same tertile (e.g. 1–3, 4–6, or 7–9). If less than 70% of the 
scores fell in the same tertile, this was an indication of no agreement. Disagreement was defined 
when at least 30% of the scores were in both the bottom (1–3) and top (7–9) tertiles22. Three 
different categories were assigned following the individual rating and the level of agreement: (1) 
selection, (2) discussion, and (3) no selection. 
 
Step 3: The panel consensus meetings 
Personalized summary reports provided panel members of both panels with the opportunity to 
compare their individual scores with overall distribution and means. Discussions resulted in three 
different scenarios for the recommendations and indicators in, respectively, categories 1–3: (1) 
include; (2) reformulate or omit; and (3) omit. Suggestions on the proposed case-mix factors and 
added recommendations and indicators were also discussed.  
 
Step 4: Approval of the final set 
Selected recommendations regarding the process of care were formulated into indicators by 
determining the numerator (total number of patients who received the care that was being 
measured or that met the experience) and the denominator (total number of patients who 
needed to receive the care or to experience the outcome). For selected recommendations 
regarding the structure, the percentages of characteristics that were present in the care setting 
were determined.  
 The concept version of the set of QIs from MSs and AHPs was sent to both panels by email 
for final remarks and for approval. In addition, the patient panel members were asked to give 
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their feedback and to approve the concept version during a personal meeting. Feedback from all 
three panels was incorporated and the final set was produced.  
  
RESULTS 
Step 1: Selection of key recommendations 
The selection procedure resulted in 42 and 45 recommendations and indicators from the MS6,23-33 
and AHP perspective, respectively11,12,25-27,31,34-39.  
 
Steps 2 and 3: Individual rating and panel consensus meetings 
There was a 100% response rate of both panels to the questionnaires. All outcome indicators  
(n = 5) were selected by the MSs and approved by the AHPs.  
 
Medical specialists  
A total of 19 out of 26 recommendations and indicators in the categories ‘selection’ and 
‘discussion’ were accepted (Figure 1). All panel members agreed that all 16 recommendations 
and indicators in the category ‘no selection’ should be omitted. Five new items (Step 2) were 
added during the consensus meeting: one recommended that each patient discussed in the MTM 
should have been seen in a HNOC before treatment. The other four were complications from 
treatment that were added to the outcome indicator concerning complications. One 
recommendation regarding the integrated record-keeping was defined as a structure indicator. 
 
Allied health professionals  
A total of 21 out of 39 recommendations and indicators in the category ‘selection’ were accepted 
(Figure 1). All recommendations and indicators in the categories ‘discussion’ (n = 2) and ‘no 
selection’ (n = 4) were omitted. Four selected recommendations were split into eight 
recommendations. In all, eight new recommendations were added by the panel concerning the 
possibility of referral to centres for special dental care, the availability of AHPs during treatment, 
the possibility of movement research by physiotherapists, and the availability of structured 
follow-up treatment or structured transfer by physiotherapists. Five recommendations were 
defined as structure indicators. These concerned accessibility of psychological scores, presence of 
the case manager or nurse practitioner, presence of the AHPs at the MTM, availability of the 
AHPs at the MTM, and assignment of a nurse to every 100 new patients.  
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Figure 1. Selection of indicators for both medical specialists (MSs) (a) and allied health professionals (AHPs) (b).  
1Outcome indicators were selected by the MSs and approved by the AHPs. 2After exclusion of two indicators in the 
second approval round, namely: the structure indicator about integrated record keeping and the newly added 
indicator (patient should have been seen in the Head and Neck Oncology Center). 3Two additional guidelines were 
added by the panel. 4After exclusion of six indicators (two structure indicators: presence of the AHPs at the 
multidisciplinary team meeting (MTM) and availability of the AHPs at the MTM, and four process indicators: 
measuring mouth opening, referral when mouth opening is smaller than 3.5 mm, measuring shoulder function by 
physiotherapist, assessment of patient by oral hygienist), two indicators were merged together (information about 
effects of alcohol and smoking), and one indicator was added (scattering caps for prevention of mucositis) in the 
second approval round. 
Step 4: Approval of the final set 
After approval in the first round by the panel, a second round was organized with a selection of 
panel members to minimize the set. This resulted in a final set of five outcome indicators, 10  
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case-mix factors, 13 and 19 process indicators from the MS and AHP perspective, respectively, 
and three structure indicators from the AHP perspective (Tables 1-4, Figure 1). Both concept 
versions of the MSs and AHPs were approved by all three panels. 
Content of the final set in integrated care 
Outcome indicators formed the basis of the process and structure indicators, and both panels 
agreed on the following integrated care outcome indicators: healthcare status (for example ‘no 
evidence of disease’), tumour recurrence, complications (regarding surgery, radiotherapy, and 
chemotherapy), quality of life, and patient experiences (Table 1). Case-mix factors were assigned 
to characteristics of the patient, tumour characteristics, and treatment characteristics (Table 2).  
        In order to measure the quality of integrated care for patients with HNC, the first part of 
the indicator set focused on the diagnostic phase, with attention to the pathological report, the 
treatment plan, the MTM, presence of the case manager at the MTM and at the conversation 
informing the patient of their prognosis. The second part of the indicator set focused on the 
treatment phase, with special attention to the involvement of the physiotherapist, the dental 
team (including oral hygienist), dietitian, speech therapist, and psychologist. The third part of the 
indicator set focused on the aftercare, control of the thyroid function, and involvement of the 
speech therapist and physiotherapist during follow-up. In particular, the relevance of an MTM 
and involvement of different AHPs before and after treatment were also mentioned as being 
crucial by the patient panel. 
        Indicators defined as being important for the overall integrated care process were: 
visualization of waiting times during the care process, informing patients about the effects of 
smoking and alcohol, and assuring a structured medical transfer. In particular, waiting times were 
defined as a relevant aspect of healthcare by the patient panel. Three indicators were relevant at 
the hospital level rather than at the patient level.  
Table 1. Outcome indicators from the perspective of 
both the medical specialists and the allied health 
professionals and agreed by patients. 
 Table 2. Case-mix factors from the perspective of both 
the medical specialists and the allied health 
professionals and agreed by patients. 
Outcome indicators 
Healthcare status of the patient  
(NED = no evidence of disease; AWD = alive with 
disease; DOD = dead of disease; DID = dead of 
intercurrent disease (disease at the same time); 
DTC = dead of treatment complications) 
Tumour recurrence 
Complications 
(regarding surgery, radiotherapy, and 
chemotherapy) 
Quality of life 
Patient experience  
(experience with healthcare providers, information 
and communication, shared decision-making, 
coordination of care, guidance and support, 
completion of treatment, and follow-up) 
Case-mix 
Unchangeable characteristics of the patient  
- Age 
- Sex 
- Education level 
- Ethnicity 
Changeable characteristics of the patient 
- Living situation 
- Intoxications (smoking/alcohol) 
- Co-morbidity 
- Performance status at intake 
Tumour characteristics 
- Diagnosis (i.e. TNM, site, ICD-O, and type of tumour) 
Treatment characteristics 
- Details of surgery, radiotherapy and 
chemoradiotherapy 
 Quality indicators of integrated care for patients with head and neck cancer  
27 
  
 
Table 3. Final set of process indicators from the  
perspective of the medical specialists and agreed by  
allied health professionals and patients. 
 
Process indicators medical specialists 
Diagnostics 
Pathology report  
- Pathological status of the tumour 
Multidisciplinary team meeting (MTM) 
- Presence of practitioner who is responsible for the 
patient in the MTM 
- MTM takes place before treatment of the patient 
- Presence of other disciplines in the MTM 
Treatment plan 
- Treatment plan available 
- Conditions for treatment plan 
Treatment 
Dental team 
- Involvement of dental team when treated with 
radiotherapy 
After care 
Physiotherapist 
- Involvement of physiotherapist when treatment 
consists of neck dissection 
Thyroid function 
- Control of thyroid function 
Coordination and organization 
Waiting time 
- Referral to the hospital 
- Finishing diagnostics 
- Start first treatment 
- Start second treatment (when applicable) 
Table 4. Final set of process and structure indicators 
from the perspective of the allied health professionals 
and agreed by medical specialists and patients. 
Process indicators allied health professional 
Dietitian 
- Malnutrition screening 
- Malnutrition monitoring 
- Referral to dietitian 
Psychologist 
- Psychological screening 
- Psychological screening results registered in patient 
record 
- Relevance of referral discussed with patient 
Oral hygienists  
- Fluoride caps for prevention of caries due to 
radiotherapy 
- Use of salt/soda solution by the patient 
- Scattering caps for prevention of mucositis 
Physiotherapist 
- Control of movement 
- Referral to physiotherapist by the physician 
- Structured medical transfer or follow-up treatment 
when at high risk of shoulder disability 
Speech therapist 
- Rehabilitation of swallowing, speech, and/or voice 
complaints 
- Use of swallow screening, fiberoptic endoscopic 
evaluation of swallowing, and/or video fluoroscopy 
- Follow-up on swallowing, speech, and/or voice 
complaints 
Communication and information 
- Information about effects of alcohol and smoking 
Coordination and organization 
- Presence of case manager/nurse practitioner at 
conversation to discuss prognosis 
- Structured medical transfer to external allied 
health professionals and general practitioner 
- Presence of case manager/nurse practitioner at the 
MTM 
Structure indicators  
- Accessibility of psychological screening scores in 
patient record 
- Presence of case manager/oncology nurse for 
4 days a week 
- Assignment of a nurse to every 100 new HNC 
patients 
 
 
 
2 
 Chapter 2 
28 
 
DISCUSSION 
This is one of the first studies to select a minimum set of QIs covering the entire healthcare 
process of patients with HNC in integrated care with a systematic procedure. QIs were based on 
national and international guidelines and the literature, including the MS and AHP perspectives, 
and were approved by a patient panel. The set consisted of outcome, process, and structure 
indicators, and case-mix factors. A total of five outcome indicators and 10 case-mix factors from 
both perspectives, 13 and 19 process indicators from the MS and AHP perspective, respectively, 
and three structure indicators from the AHP perspective were developed.  
 The final set of indicators focused on the care aspects during the diagnostic, treatment, 
and follow-up phases. This set highlighted that, in each phase, integrating the care provided by 
both the MSs and AHPs is essential to guarantee high-quality care. Both panels independently 
proposed similar indicators regarding the involvement of the physiotherapist and the dental 
team. However, the indicators from the MSs were more focused on the diagnostic phase and 
organizational aspects, such as waiting times, whereas the indicators from the AHPs were more 
focused on the functional and psychosocial status of the patient before, during, and after 
treatment1,18,27,28. A total of four indicators were directed towards waiting times. From the 
perspective of patient centeredness, it is crucial to reduce waiting times; this was also 
emphasized in our patient panel. In addition, some research shows that waiting time is negatively 
related to survival40. A total of five indicators were directed towards the MTM. Also in our patient 
panel, the MTM was discussed in detail and seen as an important aspect of care. This underlines 
the relevance of a MTM for high-quality care and is in line with current research indicating that 
the use of a MTM results in better clinical and process outcomes41,42.  
 Previous research towards quality indicators focused on only one type of HNC or a single 
part of the healthcare process; for example, the multidisciplinary team, physician 
performance6,7,23. Ouwens et al.’s research on the quality of integrated care for patients with 
HNC, mainly focused on process indicators. In our study, a set was established in which the 
outcome indicators were the most important, forming the basis of our process and structure 
indicators24.  
 
Strengths and weaknesses 
First, this set of indicators was based on integrated multidisciplinary HNC care. Porter showed 
that it is relevant to measure the value over the full care cycle rather than one department43. 
Second, outcome indicators formed the basis of the process and structure indicators, and were 
approved by the patient panel. Porter stated that value in healthcare should be defined by the 
consumer and measured by the outcomes achieved and less by process of care43. Lastly, the 
method used in this study, RAND-modified Delphi method, incorporates expert opinions, which 
reduces the risk of the unintentional influence of stakeholders on the results of the development 
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process5. However, the indicator set is still extensive. The expectation is that testing the set in 
practice for validity, reliability, and feasibility will reduce the number of significant QIs. 
 
As a next step, a pilot will be performed in the 14 hospitals to test the indicators empirically on 
feasibility and clinimetrics. The developed QIs of integrated care for patients with HNC can be 
used to build a quality dashboard for other oncological diseases that also need integrated care.  
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ABSTRACT 
Objectives: Incorporation of patients’ perspectives in daily practice is necessary to adapt care to 
users’ needs. However, information on patients’ needs and preferences for integrated care is 
lacking. The aim was to explore these needs and preferences, taking patients with head and neck 
cancer (HNC) as example, to adapt current integrated care to be more patient-centred. 
Design: Semi-structured interviews were held with current and former patients and chairmen of 
patient associations. Relevant needs and preferences were identified and categorized using the 
eight-dimension Picker model of patient-centred care. 
Setting: Integrated HNC care hospitals in the Netherlands. 
Participants: Patients with HNC and chairmen of two Dutch HNC-patient associations. 
Main outcome measures: Patients’ needs and preferences of integrated HNC care categorized 
according the Picker model. 
Results: A total of 34 themes of needs and preferences were identified, by 14 patients with HNC 
or their delegates, using the Picker dimensions. Themes often emerged were as follows: 
personalization of healthcare regarding patients' values; clear insight into the healthcare process 
at organizational level; use of personalized communication; education and information that 
meets patients requirements; adequate involvement of allied health professionals for physical 
support; more attention to the impact of HNC and its treatment; adequate involvement of family 
and friends; adequate general practitioner involvement in the after care; and waiting time 
reduction. 
Conclusions: Monitoring the identified themes in integrated HNC care, fitting in the Picker model, 
will enable us to respond better to the needs and preferences of patients, and patient-centred 
care in oncological care can be enhanced. 
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INTRODUCTION 
Head and Neck Cancer (HNC) is the sixth most common cause of cancer worldwide1. HNC and its 
treatment has significantly impact on a patient’s well-being as HNCs grow relatively quickly in an 
anatomically and functionally complex area2,3. Patients often experience problems with speech, 
swallowing, and physical disfiguration due to treatment4-7. In addition, they often suffer from 
psychological disorders, such as depression and anxiety, and social problems, such as relationship 
difficulties with their partner and family members, and loss of work8-10. Therefore, HNC care is 
complex, requiring medical specialists and allied health professionals to collaborate throughout 
the entire healthcare process from the diagnostic phase until the surveillance phase. A strategy 
for better coordination of services across the entire care continuum with optimal alignment and 
collaboration of all disciplines is required11. 
 Nowadays, providing patient-centred care is an essential component of high quality 
integrated care12. Responding to the needs and preferences of patients for the delivery of 
healthcare is an important aspect of current healthcare policy worldwide13,14. It leads to positive 
clinical outcomes, for example better survival13 or physical and emotional recovery15, and 
increased patient satisfaction16. Increased patient satisfaction might result in a better adherence 
to treatment recommendations and increase quality of life17.  
 Patient-centred care has been defined as “care which is responsive to consumer needs, 
values and preferences; integrated and coordinated; relieves physical discomfort; provides 
emotional support; allows for the involvement of family and friends; and supports the provision 
of information, communication and education to enable patients to understand and make 
informed decisions about their care”12. Also, this definition points out that patient-centred care is 
relevant during the entire healthcare process. However, until now, information on patients’ 
needs and preferences for integrated cancer HNC care is lacking. 
 We aimed to identify all possible needs and preferences of Dutch patients with HNC in 
integrated care to obtain tools to make current integrated HNC care more patient-centred. By 
identifying those themes of healthcare where improvement regarding patient-centeredness is 
necessary, optimizing integrated care for patients with HNC is possible. 
 
MATERIALS AND METHODS 
Study design 
In this exploratory study, semi-structured interviews were held until data saturation (the point at 
which no new information was mentioned in interviews18) was reached with current and former 
patients and the chairmen of two HNC patient associations. The aim of the interviews was to 
identify all possible needs and preferences of patients with HNC, to discuss these explored needs 
and preferences in a group meeting with all participants and to check whether new items came 
3 
 Chapter 3 
36 
 
forward. The Medical Ethical Committee (CMO) of the region Arnhem–Nijmegen assessed the 
study and declared that ethical approval was not necessary. The study is in agreement with the 
COREQ checklist. 
 
Setting 
In the Netherlands, where approximately 3000 patients are yearly diagnosed with HNC, HNC care 
is centralized in 14 hospitals: eight Head and Neck Oncology Centres (HNOCs) and six affiliated 
centres19. The affiliated centres have committed themselves to using the same treatment 
protocols as the related HNOCs. There are two Dutch patient associations: ‘Stichting Klankbord’ 
and ‘NSVG’. Currently, they collaborate in one Dutch patient association ‘Patiëntenvereniging 
Hoofd-hals’. 
 
Participants 
Research shows that 13–15 interviewees are usually sufficient to reach data saturation18. 
Therefore, each of the 14 hospitals and both Dutch patient associations were asked to select one 
or two patients using the following inclusion criteria: the patient was diagnosed with HNC, was 
treated with a curative or palliative intention, and had the capacity to overview his own 
healthcare process. In addition, the two chairmen of both patient associations were asked to 
participate (Table 1).  
 
 
 
Table 1. Characteristics of participating patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Age, years Sex (n) Type of tumour 
(n) 
Type of treatment Year of diagnosis 
Patient 1 67 Male Larynx Operation & radiotherapy 2009 
Patient 2 52 Male Larynx Operation & radiotherapy 2008 
Patient 3 56 Female Larynx Operation & chemoradiation 2004 
Patient 4 59 Male Oral cavity Operation 2013 
Patient 5 60 Male Oral cavity Operation & radiotherapy 2011 
Patient 6 66 Female Larynx Operation & radiotherapy 2004 
Patient 7 58 Female Oral cavity Operation 2011 
Patient 8 67 Female Larynx Operation & radiotherapy 2009 
Patient 9 56 Female Larynx Operation & radiotherapy 2011 
Patient 10 58 Male Oral cavity Chemoradiation 2012 
Patient 11 65 Male Oral cavity Operation & radiotherapy 2005 
Patient 12 50 Female Oral cavity Operation & radiotherapy 2009 
Chairman 1 58 Male Larynx Operation & radiotherapy 1997 
Chairman 2 69 Male x x x 
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Participants were approached either by telephone or email, depending on their ability to talk 
clearly on the phone. This was followed up by a letter or email to confirm their participation and 
a request to sign an informed consent form. A total of 12 patients and the two chairmen 
participated in the semi-structured interviews either by telephone (n = 8) or in person (n = 6). 
One of the two chairman is a former patient with HNC. Only one chairman of a patient 
organisation was part of the steering committee of a project where the study was part of. There 
was no relationship with the other interviewees. 
 
Data collection 
An expert panel developed a structured interview guide (Appendix 1). The interview guide 
contained open-ended questions and optional questions to deepen each topic. The interview 
guide contained four sections, referring to the referral, the diagnostic, treatment, and follow-up 
phases of HNC care. In each section, similar questions were asked emphasising the received 
healthcare in the specific phase. Questions focused on the needs and preferences, involvement 
of and communication among the different healthcare providers, strong and weak points of the 
received healthcare, and points for current healthcare improvement. The interview (lasting 30–
45 minutes) conducted by the first author (female, MSc Biomedical sciences, PhD student, 
experience for interviewing obtained in her master) was fixed regarding the sections, each 
interview started with the referral and ended with the follow-up phase. Within a section, the 
questions were flexible depending on the answers of the interviewee. The pilot for the interview 
was done with the first and the last author (female, senior researcher, experience with 
qualitative research). Patients did not receive questions in advance and were not informed about 
the use of the framework to analyze the data using the eight-dimensions Picker model. 
 
Analysis 
A deductive approach was used with the eight-dimensions Picker model as a basis for our 
analyzes (Table 2). This model contains dimensions regarding patient-centeredness of care and 
served as a theoretical framework for the analyzes of the interviews20,21. The model embodies 
the conviction that all patients deserve high-quality patient-centred care. The eight dimensions 
appear important and relevant in several European countries and in the USA22,23. Expressed 
needs and preferences were categorized into Picker dimensions using the following four steps; 
step 1: marking expressed needs and preferences with codes; step 2: categorizing codes dealing 
with the same subject into similar items; step 3: categorizing items dealing with the same topic 
into similar themes; and step 4: categorizing themes into the Picker dimensions. For step 1, 
interviews were recorded using an audio recording device, transcribed verbatim and qualitatively 
analyzed using ATLAS.ti (version 7). To enhance the reliability and validity, coding was done by 
two researchers: the first and third author (female, BSc Medicine, inexperienced). The first four 
interviews were coded open ended independently by both researchers24. Hereafter, codes were 
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compared and discussed until consensus was reached. One concept coding tree was made, e.g. 
axial coding, that was used to provide some support for the remaining interviews and to 
stimulate the researchers to keep the same focus24. In addition, both researchers could add, 
remove or move codes of the coding tree. Codes of the last ten independently coded interviews  
were compared and discussed until consensus was reached. Hereafter, the coding tree was  
finalized and the following steps were taken. Steps 2-4 were carried out by the same two 
researchers. Disagreement was discussed between the two researchers and if needed classified 
with the last author (female, PhD) until consensus was reached. We aimed to fit all themes into 
the Picker dimensions, new dimensions were proposed if codes would not fit. 
 
 
Table 2. Definition of the eight Picker dimensions translated to the Dutch situation. 
Picker dimensions Definition of each dimension  
1. Respect for patient-centered values An awareness of quality-of-life issues, involvement in decision-
making, dignity, and attention to patient’s needs and autonomy 
2. Coordination and integration of care Care across clinical, ancillary, and support 
  services and in the context of receiving front-line care 
3. Information, communication, and 
education 
On clinical status, progress, prognosis, and processes of care to 
facilitate autonomy, self-care, and health promotion by 
healthcare providers or patients themselves 
4. Physical comfort Pain management, help with activities of daily living, and clean 
and comfortable surroundings 
5. Emotional support and alleviation of fear 
and anxiety 
Support with issues such as clinical status, prognosis, and the 
impact of illness on patients, their families, and their finances 
6. Involvement of family and friends Involving family and friends in decision-making and awareness 
and accommodation of their needs as caregivers 
7. Transition and continuity of care Information that will help patients care for themselves away 
from a clinical setting, and coordination, planning, and support 
to ease transitions 
8. Access to care Attention to time spent waiting for admission, diagnostics, 
treatment(s) or time between appointments in the hospital and 
with allied health professionals 
 
 
RESULTS 
All invited patients and chairmen participated in the study (Table 1). A total of 34 themes of 
needs and preferences were analyzed (Table 3 and Figure 1), and all were categorized into the 
Picker dimensions. All needs and preferences were discussed and approved in a group meeting 
with all participants. For a comprehensive and clear overview of the results, beneath we give a 
summary of most often mentioned themes in each domain with an explanation. 
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Respect for patient-centred values  
The most important two themes that the interviewees mentioned regarding patient-centred 
values, were the expectation for personalized care regarding their individual values and 
assertiveness. Personalized care was expressed by the interviewees as listening to the patient, 
taking the patient seriously and incorporating the patient’s wishes into the healthcare process. 
To deliver personalized healthcare, interviewees mention that it is important that patients are 
assertive. For more assertive patients, it is easier to express their issues and questions, resulting 
in better care adapted to the needs of the patient. 
 
Coordination and integration of care 
An important aspect mentioned in this domain was the relevance of the healthcare process at 
the organizational level being clear. It was pointed out that this would increase the confidence of 
the patient in the healthcare provided, which might reduce their feeling of being ill.  
 In addition, involvement of allied health professionals, including oncology nurses, and 
peers at the right time in the healthcare process, according to the patient’s needs, was also noted 
as being valuable. For example, the first patient does not prefer the involvement of a dietician, a 
second patient prefers the involvement of a dietician right after the diagnosis to give all available 
information about nutrition specified for the health process, and a third patient prefers the 
involvement of a dietician just before start of the treatment to give the most important 
information that is relevant at that time point, and the rest of the information can follow on a 
later time point. 
 
Information, communication, and education 
Important themes mentioned by the interviewees were the requirements for communication, 
information and education, and training of healthcare providers. Requirements mentioned by the 
interviewees were clear, honest, complete and repeated information and communication. This 
can increase trust in the healthcare provided and reduce possible feelings of uncertainty and 
doubt. Interviewees also pointed out that healthcare providers should be trained very well. This 
includes sufficient knowledge about HNC, the ability to communicate, as well as the skills and 
attitudes of healthcare professional. 
 
Physical comfort 
Interviewees mentioned that the involvement of the physiotherapist and speech therapist should 
be in line with patients' preferences, as well as the amount of support during the aftercare that 
should be provided. In addition, interviewees mentioned the restrictions and disadvantages of 
devices. More high-quality devices will increase the motivation of patients to sport and go out 
again.  
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Table 3. Expressed needs and preferences categorized into the Picker dimensions. 
Domains Themes Corresponding items 
1.
 R
es
pe
ct
 fo
r p
at
ie
nt
-c
en
te
re
d 
va
lu
es
 
Personalized care regarding 
patient values 
Healthcare providers should listen to the patient, take the patient 
seriously, and incorporate the patient’s wishes into the treatment 
plan. In addition, they should give the patient the feeling that there 
is enough time and attention for the patient. 
Assertiveness relevant in 
personal healthcare 
Assertiveness of the patient is relevant to deliver personalized 
healthcare. Patients can come with their own questions towards 
healthcare professionals and can indicate better what they prefer. 
The amount of assertiveness required depends on the attitude of 
the healthcare professional. 
Emotional support towards 
inability to speak 
It is important to support the patient who has lost the ability to 
speak. For patients it is very frightening and frustrating to realize 
and to experience the lose of voice.  
Hospital facilities A clinic with a warm atmosphere results in calmness. In addition, a 
hospital room adapted to patients wishes is preferred. 
Doctor–patient relationship Integrity and mutual respect are necessary for a good doctor-
patient relation.  
Disease physically 
demanding as a single person 
More attention should be given to single persons in order to cope 
with the physical barriers, especially in the first phase of recovery. 
2.
 C
oo
rd
in
at
io
n 
an
d 
in
te
gr
at
io
n 
of
 c
ar
e 
Clarity about healthcare 
process  
The healthcare path should be clear regarding what the patient can 
expect, this means that each step that will be taken in the 
diagnostic phase will be clear. This is also expected of the treatment 
(especially regarding the operation).   
Personalized involvement of 
allied health professionals  
Involve allied healthcare professionals before or after the 
treatment, depending on patients' preferences and the advice of 
the healthcare professional. However, there should always be an 
option to meet the allied healthcare professional. 
Availability of a contact 
person 
Patients need to have one known person available in the 
multidisciplinary integrated healthcare team who can answer 
questions and address health-related issues. The contact person 
should be often available. 
Involvement of oncology 
nurse and peers as personal 
experts 
 
It is important to involve peers as personal experts, and they are 
valuable for the patient on multiple timepoints. In addition, 
involving oncology nurses might result in time saving during the 
consult with the doctor, and also it is described as a more personal 
contact. 
Personalized involvement of 
peers 
Involve peers before or after the treatment, depending on patients' 
preferences and the advice of the healthcare professional. 
Nevertheless, the healthcare professional should always offer the 
option to meet a peer. 
Personalized diagnostic 
phase 
Adjust the number of diagnostic appointments one after the other 
according to patients' preferences and combine medical 
consultations.  
Home care for both patient 
and partner 
Besides support for the patient, home care should be directed 
towards the partner as well.  
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Domains Themes Corresponding items 
3.
 In
fo
rm
at
io
n,
 c
om
m
un
ic
at
io
n,
 a
nd
 e
du
ca
tio
n 
Communication, information, 
and education meets 
requirements 
Communication, information and education should be clear, 
honest, complete, and be repeated. It is acceptable to tell 
uncertainties about the healthcare process, as long as the 
information is clear. Information on the internet should be of good 
quality. 
Training of health 
professionals 
Healthcare providers should have enough knowledge about HNC, 
the ability to communicate properly, and good skills and attitudes 
of doctors and nurses. In addition, a good preparation before the 
appointment and thoroughness of the healthcare provider is 
expected. 
Personalized communication, 
information, and education 
A patient should receive information and education in line with 
patients' preferences on how and when it is given and which 
information is most valuable. Information from peers additionally is 
preferred. However, too many information for a patient is difficult 
to understand. 
Stimulation of perseverance 
of patients  
It is important that healthcare providers stimulate the patient in 
order to motivate the patient during recovery. 
Patients want to contribute 
to improvement in 
healthcare 
Patients do not mind to contribute to improvement in healthcare, 
for example by giving information and education to healthcare 
professionals.  
Training of professionals in 
the home care 
Home care should be provided by a specialized qualified healthcare 
provider, someone who knows the impact and effects of surgery 
and someone who knows how to act in an efficient, non harmful 
and quick way. 
Transparent healthcare It should be clear to the patients which hospitals deliver good 
quality of healthcare. 
4.
 P
hy
sic
al
 
co
m
fo
rt
 
Personalized involvement of 
allied health professionals for 
physical support 
Involvement of physiotherapy or speech therapy should be in line 
with patients' preferences, also the amount of support during the 
aftercare that should be provided.  
Solutions for limitations of 
devices 
Solutions for the restrictions and disadvantages of devices, which 
emerge especially during physical exercise, will increase the 
motivation of patients to sport. 
5.
 E
m
ot
io
na
l s
up
po
rt
 a
nd
 a
lle
vi
at
io
n 
of
 
fe
ar
 a
nd
 a
nx
ie
ty
 
Personalized psychological 
support for emotional 
problems  
It is important to offer psychological care to every patient, and then 
to deliver the care as desired by the patient. In addition, some allied 
health professionals, like a physiotherapist or speech therapist, 
sometimes tend to function in such a way that they can deliver 
emotional support as well. 
Attention to the impact of 
HNC and its treatment 
More attention should be given to the major impact of HNC and its 
treatment on patients’ life, and also it is important to keep in mind 
the differences that men and women cope with the disease 
differently.  
Personalized involvement of 
peers for emotional support 
Important to involve peers as personal experts, especially for 
emotional support. 
Emotional support of GP in 
aftercare  
The GP should be very assertive to give emotional support to the 
patient during after care, at the time that care provided by the 
hospital will be less. 
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Domains Themes Corresponding items 
6.
 In
vo
lv
em
en
t o
f 
fa
m
ily
 a
nd
 fr
ie
nd
s 
Good carer makes allied 
health professionals and 
peers less relevant 
Support from family and friends is important for psychosocial 
support, rehabilitation, and reintegration. In addition, involvement 
of family and friends during the diagnosis and treatment is a major 
support. A caregiver at home makes allied health professionals and 
peers less needed. 
Personalized involvement of 
family  
There should be the option to involve family and friends, for 
example the option to bring relatives to hospital appointments and 
the extent to which children are involved in the healthcare process. 
7.
 T
ra
ns
iti
on
 a
nd
 
co
nt
in
ui
ty
 
Good transfer from health 
professionals in the hospital 
to health professionals in the 
home situation 
The hospital plays an important role in ensuring good transfer from 
the hospital to the home situation of the patient.  
Involvement of GP in 
aftercare for optimal transfer 
The GP should be included in the healthcare transfer to ensure 
better support once the patient has returned home.  
Cooperation of allied health 
professionals and hospital for 
optimal transfer 
There should be a good cooperation between healthcare 
professionals in the hospital and in the home care situation. 
8.
 A
cc
es
s t
o 
ca
re
 
Delay due to GP, dentist, 
general hospital, and the 
patient themselves 
Delays in the first phase, before diagnosis, are often caused by the 
general practitioner, the dentist or the general hospital. In addition, 
patients themselves can also cause the delay since they postpone 
the first visit.  
 Short waiting times in 
hospital and before 
operation  
Short waiting times for an appointment and for a operation are 
preferred, it will decrease the psychological burden that might 
occur during the waiting. 
Waiting time necessary for 
recovery between two 
treatments 
Waiting time between two treatments might result in a better 
recovery; physical and psychological.  
* GP = general practitioner 
 
Emotional support and alleviation of fear and anxiety 
An important aspect of care mentioned by the interviewees was the involvement of psychological 
support at patient’s preference, given by a psychologist but also by any allied health professional. 
In addition, interviewees mentioned that more attention should be given to the major impact of 
HNC and its treatment. Furthermore, emotional support from the general practitioner (GP) 
during aftercare was mentioned as being highly important as the support from the healthcare 
providers from the hospital will decrease. Less or no involvement might result in fear and feeling 
of helplessness of the patient. 
 
Involvement of family and friends 
Support from family and friends was mentioned as highly important. Even, they concluded that a 
good partner or carer makes the allied health professionals less relevant in this situation. 
Furthermore, interviewees mentioned the involvement of family as an important issue. 
Particularly regarding children: how do you involve children? 
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Figure 1. Quotations expressed by current and former HNC-patients and the chairmen of two HNC-patient 
associations for each Picker dimension. 
 
Transition and continuity of care 
An aspect that often emerged, according to the interviewees, was the ‘gap’ between the hospital 
and the home situation. The interviewees considered it important to better organize the transfer 
to reduce this void. To better organize the transfer, it is important to include the GP in the 
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healthcare transfer; particularly, the GP should be well informed about the medical condition of 
the patient to prevent that a patient needs to inform the GP him/herself. In addition, the 
cooperation of the allied health professionals and the hospital is crucial. This includes knowledge 
of each other’s discipline and reduction of repetition of care processes, which can increase trust 
in healthcare and might ensure optimal recovery.  
 
Access to care 
The most important aspect in this domain concerned the delay between the visit to the GP or the 
dentist and the first appointment at a specialized hospital. This was caused either by the GP, 
dentist, or the general hospital, or by the patients themselves. Therefore, it is important to 
increase the knowledge about HNC to decrease the first delay. Secondly, they noted that there is 
an urgent need to reduce waiting times in the hospital, particularly prior to the start of 
treatment. On the other hand, they indicated that the waiting time between two treatments 
might result in a better recovery. 
 
DISCUSSION 
This study identifies a total of 34 themes of patients’ needs and preferences, categorized 
according to the eight-dimension Picker model regarding patient-centeredness of care, for 
current integrated HNC care. The main themes emerging from the interviews were the 
personalized care regarding patient values (Respect for patient-centred values), a clear 
healthcare process at an organizational level (Coordination and integration of care), personalized 
communication and information that meets requirements (Information, communication, and 
education), involvement of allied health professionals for physical support (Physical comfort), 
more attention to the impact of HNC and its treatment (Emotional support), adequate support 
from family and friends making support from allied health professionals less necessary 
(Involvement of family and friends), adequate involvement of the GP in the after care (Transition 
and continuity), and reduction of waiting times prior to the start of the treatment (Access to 
care). 
 
Unique for this study is that it demonstrates needs and preferences of HNC-patients over the 
entire healthcare process from the diagnostic phase until the surveillance phase. In addition, it 
demonstrates the relevance of both patient-centred care and integrated care for patients with 
HNC; two important aspects of healthcare published previously12,15,25. After analyzes of the 
interviews, we identified many themes that fitted easily into the Picker dimensions of patient-
centred care, for example, the need for personalized communication, and the need for more 
attention to the impact of HNC and identified conditions to optimize transfer from the hospital to 
the home situation. In addition, needs and preferences for healthcare delivered by both medical 
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specialists and allied health professionals emerged in the interviews. For example, the expertise 
and professionalism of doctors and the doctor-patient relationship are needs and preferences 
that refer to the medical specialist. Personalized involvement of allied health professionals for 
physical and emotional problems is an example of needs and preferences that refer to the allied 
health professional. However, personal preferences of the patient should not interfere with the 
best possible healthcare as described in evidenced-based guidelines. The task of a(n allied) health 
professional is to deliver evidence-based practice by incorporating best available evidence, 
clinicians' judgement and patient values and preferences. Herewith, the healthcare can be both 
personal based and evidence-based26. 
 
Suggestions for daily practice 
Patients in our study expect an active involvement of GPs at referral, during transfer, and for 
emotional support in the aftercare. GPs’ engagement can be increased by involving them in the 
multidisciplinary team meetings before determining the treatment27 and before discharge of the 
patient28. In the last case, a patient-specific follow-up plan can be developed together with the 
GP, the specialist and the patient. Other initiatives exist to give the right support to GP's to 
develop their own role and to provide the best care for patients with cancer. Examples of these 
initiatives are the Macmillan Cancer support in the UK or Oncological Networks in the 
Netherlands29. Moreover, multimedia campaigns such as The Make Sense campaign can increase 
the awareness and knowledge of patients, health professionals (including GPs) and society 
regarding head and neck cancer symptoms and subsequently drive earlier presentation, diagnosis 
and referral30. Therefore, it is important that more people know that this campaign exists. 
 
Strengths and weaknesses 
The selection of patients from across the spectrum of Dutch hospitals, and the inclusion of 
representatives from the patient associations are strengths of this study. The aim of this 
explorative study was to identify all possible needs and preferences of patients with HNC and not 
to give a representative set of their needs and preferences. Therefore, only data saturation was 
needed, which we indeed reached with our 14 patients18. A disadvantage might be that we only 
included patients, diagnosed with an oral cavity carcinoma or laryngeal carcinoma. However, 
most cancer treatments, independent of the type of HNC cancer, follow similar healthcare 
processes. Therefore, we think that most expressed needs and preferences for HNC care are 
relevant for both the included and not included HNC cancer types. In addition, the included two 
tumour types represent 55% of the patient population in the Netherlands.  
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Conclusions 
Patients’ needs and preferences for integrated oncological care were identified to obtain tools to 
make current care more patient-centred. Knowing the patients needs and preferences helps to 
improve healthcare accordingly. The next step is to quantify the expressed needs and 
preferences among a representative population, to explore to what extent the needs and 
preferences are met in practice and which has the highest priority. 
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Appendix 1 - Interview guide 
  
General information 
Name: 
Age:  
Diagnosis: 
Year of diagnosis: 
Type of treatment: 
 
A. Received healthcare 
For each contact moment (A1 to A7) we focused on the following questions: 
x What involved this process? How did it look like?  
x How was the experience with the process? What went well, what could have been better? Why? 
x Were allied health professionals involved in the process? Was the involvement of allied health 
professionals as you preferred? If yes, why? If not, why? 
x What would be any improvement for the process? 
 
A1. before referral to specialized hospital? (GP and/or peripheral hospital) 
A2. at first appointment in the specialized hospital? 
A3. during diagnosis? 
A4. at the consultation where the treatment plan was discussed? 
A5. during preparation of the treatment? 
A6. during treatment? 
A7. during the follow-up phase? 
 
B. Specific organizational aspects in the received healthcare 
For each organizational aspect (B1 to B3) we focused, beside specific questions/topics, on the following 
questions: 
x How did you experience the process? 
x Was it as expected? 
x What could have been better? 
 
B1. Communication 
 - Was there one contact person? Did you prefer that?  
 - Was communication clear about appointments, parking, with health professionals? 
 
B2. Information 
 - Did you understand everything? 
 - Was the information enough? 
 - Was information given in the right format? 
 - Was family involved if you preferred? 
 - Were peers involved if you preferred? 
 Needs and preferences of patients with head and neck cancer in integrated care  
49 
  
 - Was information repeated? 
 
B3. Organization and coordination 
 - Clear where you were expected? 
 - Waiting times 
 - Enough time for you as a patient 
 
B4. Transfer to GP 
 
C. Overall experience 
 - What was your best experience? 
 - What was your worst experience? And what improvement would you suggest? 
 - What would you suggest for future healthcare? 
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ABSTRACT 
Objectives: Monitoring and effectively improving oncologic integrated care requires dashboard 
information based on quality registrations. The dashboard must include evidence-based quality 
indicators (QIs) that measure the quality of integrated multidisciplinary care. We aimed to assess 
the quality of current integrated head and neck cancer care with QIs, the variation between 
Dutch hospitals, and the influence of patient and hospital characteristics. 
Methods: Previously, 39 QIs were developed from the perspectives of medical specialists, allied 
health professionals, and patients. Data for calculating QI scores were collected by self-
registration of 1667 curatively treated patients in eight hospitals. Only QIs with a patient sample 
larger than 400 were included so that we could calculate reliable QI scores. We used multilevel 
analysis to explain the variation. 
Results: Current care varied from 29% for the QI about a case manager being present to discuss 
the treatment plan to 100% for the QI about the availability of a treatment plan. Variation 
between hospitals was small for the QI about the percentage of patients discussed in 
multidisciplinary team meetings (adherence: 95%, range 88–98%) and large for the QI about 
malnutrition screening (adherence: 50%, range 2–100%). At the patient level, higher QI scores 
were associated with lower performance status, an advanced tumour stage, and tumour in the 
oral cavity and oropharynx. At the hospital level, higher QI scores were associated with more 
curatively treated patients (volume). 
Conclusion: Although the quality registration was only recently launched, it already visualises 
hospital variation in current care. Four determinants were influential: tumour stage, performance 
status, tumour site, and volume. However, more data are needed to assure stable results for use 
in quality improvement. 
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INTRODUCTION 
The WHO stated in 2006 that even when healthcare systems are well developed and resourced, 
quality remains a serious concern1. Therefore, it is important to gain insight into the care that is 
actually provided in order to monitor and effectively improve high-quality care2,3. The 
management of high-quality integrated care, with optimal alignment and collaboration of all the 
disciplines involved throughout the healthcare process, is complex4-6. Hence, measuring and 
monitoring the quality of integrated care is crucial. This can be done by using a dashboard of valid 
and reliable quality indicators (QIs)7,8. A QI is defined as "a measurable element of practice 
performance for which there is evidence or consensus that it can be used to assess the quality of 
care"3. Many QIs have already been developed for oncologic diseases9,10 and non-oncologic 
diseases11. 
 Head and neck cancer (HNC) is the sixth most common cause of cancer worldwide12. HNC 
and its treatment have a significant impact on a patient’s well-being because HNCs grow 
relatively quickly in an anatomically and functionally complex location13-16. Patients often 
experience problems with speech, swallowing, and physical disfiguration due to surgery, systemic 
therapy, radiation, or a combination of such treatments17-21. It is crucial to an optimal result that 
medical specialists and allied health professionals deliver integrated care throughout the care 
process.  
 In 2014, a dashboard in the form of a quality registration, with evidence-based QIs, was 
developed for measuring the quality of integrated care for patients with HNC in eight Dutch head 
and neck oncology centres (HNOCs) and six affiliated centres, e.g. the Dutch Head and Neck Audit 
(DHNA)22. The goal of this quality registration was to give HNOCs more insight into their current 
care delivery, to compare themselves to other HNOCs, and to improve HNC care. However, the 
start-up of a quality registration takes several years before stable data can be obtained23.  
 Besides stable data, data at patient and hospital levels that might influence the quality of 
care are needed for calculating QIs in assessing current care and the variation in care between 
different HNOCs and affiliated centres. Insight into determinants that influence variation in care 
at patient and hospital levels can provide tools for explaining the QI scores and improving current 
care by medical staff learning from each other24. 
 We aimed to obtain insight into the quality of currently delivered HNC care in the 
Netherlands and some of the influencing characteristics. This is the first paper with results, in 
which we assessed the quality of current integrated HNC care on the basis of QI scores from a 
recently launched quality registration that collects data prospectively: the DHNA. We have 
determined the hospital variation in QI scores and explored this variation to see whether 
differences at patient and hospital levels explain it. We used both the current care evaluation and 
the determinants of variation in care to test the value of the QI set as an instrument for 
monitoring and improving clinical performance for this quality registration25.  
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METHODS 
Study design 
This is a prospective observational multicentre study for measuring current quality of integrated 
HNC care with a recently launched quality registration including 39 evidence-based QIs22. 
Hospital variation and determinants at patient and hospital levels were assessed. 
 
Setting 
In the Netherlands, where approximately 3000 HNC patients are diagnosed annually, HNC care is 
centralised in 14 hospitals: 8 head and neck oncology centres (HNOCs) and 6 affiliated centres26. 
The affiliated centres have committed themselves to use the same treatment protocols as the 
related HNOCs. The number of patients treated annually varies between 70 and 600 per centre. 
The various medical specialists and allied healthcare professionals involved in HNC care are 
united in two national foundations, one for medical specialists and one for allied health 
professionals. There is also one Dutch HNC patient association. Together, they developed 
evidence based QIs to initiate a quality registration: the Dutch Head and Neck Audit (DHNA). 
 
Study population 
All patients with HNC newly diagnosed in the period December 2013 to January 2017 that were 
treated with a curative intention in one of the 14 HNOCs and affiliated centres were eligible for 
registration in the DHNA.  
 
Quality indicator set 
All 39 QIs had been systematically developed and based on national and international evidence-
based guidelines. For this purpose, the two national foundations for medical specialists and allied 
health professionals, and the patient association, used the Rand modified Delphi method22. This 
resulted in five outcome indicators, 13 and 18 process indicators from the perspective of medical 
specialists and allied health professionals, respectively, and three structure indicators from the 
perspective of the allied health professionals. In addition, a total of 10 determinants at patient 
level were selected: age, gender, smoking, alcohol, marital status, nationality, performance 
status, tumour site, clinical TNM, and comorbidity13,22,27-29. The only determinant at hospital level 
was volume, e.g. the average number of patients curatively treated annually in the HNOCs and 
affiliated centres30,31. This was based on the number of curatively treated patients per year in the 
HNOCs and affiliated centres as registered by the Netherlands Comprehensive Cancer 
Organisation32. 
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Data collection 
Health professionals working in the participating hospitals used an online self-registration system 
to collect the necessary data for calculating QI scores and assessing determinants at patient and 
hospital levels. The outcome indicators focused on survival, recurrence, complication rate, and 
patient-reported outcomes and experiences. The process indicators focused on performance in 
the diagnostic, treatment, and follow-up phases, as well as aspects regarding coordination and 
communication. The structure indicators focused on the numbers of available case managers and 
nurses for each hospital. We subdivided the determinants into the following categories: age 
(continuous); gender (male versus female); smoking (never smoker versus former smoker and 
current smoker); alcohol (never drinker versus former drinker and current drinker); WHO 
performance status (0 versus 1–4); tumour site ([oral cavity and oropharynx] and [larynx and 
hypopharynx] versus [other]); tumour, nodes, and clinical TNM stage (early [I–II] versus advanced 
[III–IV]); and comorbidity (yes versus no) at patient level, and the volume of HNOCs and affiliated 
centres (<200 patients versus >200 patients) at hospital level. 
 
Sample size 
Previous research shows that the precision of a QI score depends on the number of patients 
included (numerator)33. For individual QIs, a sample of about to 400 patients is required for 
calculating a precise indicator score with a confidence limit of plus or minus 5 percentage points. 
Therefore, only QIs with a numerator of more than 400 patients were included.  
 
Data analyses  
The inclusion criteria for the analysis were: 1) the patients had to be curatively treated, 2) there 
had to be enough data for each patient (at least the age and date of the start of the first 
treatment), and 3) there had to be at least 30 patients per hospital34. The last inclusion criterion 
assured that results were not skewed unfairly because of too few data. 
 
Descriptive analyses 
For each indicator we assessed:  
1) The numerator: the total number of patients who received the care as recommended in the QI 
2) Indicator score: the quotient of the number of patients who received care as recommended in 
the QI compared to the number of patients who received the care as recommended 
3) Missing data: the percentage of missing values per indicator. Missing data for indicators may 
bias the results. A percentage exceeding 25% refers to poor data quality35.  
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Determinant analyses 
To assess determinants at patient and hospital levels, we first studied the single relationship 
between indicators (e.g. percentage of patients discussed in a multidisciplinary team meeting 
(MTM) before start of the treatment) and determinants that could influence the indicator score 
(e.g. tumour site). 
 We tested determinants that had an association with indicator scores (p<0.20) together in 
a multilevel logistic regression model to account for the nested structure of data from individual 
patients (level 1) nested within hospitals (level 2). We automatically excluded patients (list-wise 
deletion) from the analysis if indicator or determinant data were missing and the missingness 
was ignorable. Missingness was defined as the state in which data were randomly missing as was 
seen by comparing the population included for each indicator with the original population of the 
study. We needed a minimum of 10 patients for each degree of freedom in the model to develop 
a reliable multilevel model. Odds ratios with 95% confidence intervals described the association 
between indicator scores and determinants. To assess to what extent these determinants 
explained suboptimal adherence (<90%) we recalculated the indicator scores by stratification. If 
multiple determinants were associated with a single indicator, we combined the different 
determinants and calculated stratified scores for the different categories. 
 
RESULTS 
Study population  
In total, 1667 patients satisfied the inclusion criteria for this analysis. The patients originated 
from five HNOCs and three affiliated centres (Table 1 and Figure 1). The median age of the  
patients was 65 years (range 64–68 years) and most were male (69%; range 60–72%). Missing 
data for most patient characteristics varied between 0% and 32%. However, 75% of the data for 
comorbidity were missing. Regarding volume, three out of eight HNOCs and affiliated centres 
were classified as low-volume centres (<200 curatively treated patients) (Table 2). 
 
 
Figure 1. Inclusion of patients in this study. Sufficient data = at least the age and date of the start of the first 
treatment are known. 
Patients were treated curatively  
n = 2351 
Sufficient data was registered for each patient  
n = 1685 
 
Registration of at least 30 patients for each hospital  
n = 1677 
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Table 1. Characteristics of 1667 patients from eight hospitals based on the inclusion criteria 
 Results 
n           Range 
Missing data 
(%)* 
 
Median age at start of  treatment (y) 1667 65 years (64–68years) 0.0 
Gender     0.1 
  Male 1142 68.5% (60–72%)  
  Female 524 31.5% (29–40%)  
Tobacco smoking     28.7 
  Never smoker 220 18.9% (15–34%)  
  Former smoker 462 39.7% (18–43%)  
  Current smoker 483 41.5% (33–65%)  
Alcohol use    27.5 
  Never drinker 272 23.4% (11–41%)  
  Former drinker 88 7.6% (5–18%)  
  Current drinker 801 69.0% (41–76%)  
Performance status    32.0 
  No performance status  80 8.5% (1–97%)  
  Performance status registered 862 91.5% (3–100%)  
        Score      0.8 
        Score 0 (perfect health) 570  66.7% (10–92%)  
        Score > 0 285  33.3% (8–90%)  
Tumour site    0.1 
Oral cavity and oropharynx 666 47.7% (43–61%)  
Larynx and hypopharynx 437 31.3% (15–42%)  
Other 293 21.0% (16–32%)  
Clinical TNM stage    21.1 
 Early (Stage ≤ 2) 582 47.1% (39–59%)  
 Advanced (Stage >2 ) 654 52.9% (39–66%)  
Comorbidity   75.0 
 Yes 415 0%  
 No 0   
*Low percentages registered in the category ‘unknown’ are not presented. 
 
 
 
 
 
 
 
 
Hospital No. of patients 
Hospital 1 47 
Hospital 2 111 
Hospital 3 252 
Hospital 4 480 
Hospital 5 234 
Hospital 6 55 
Hospital 7 64 
Hospital 8 424 
Table 2. Number of patients diagnosed in the period December 2013 to January 2017 of which 
data was registered in the audit for each hospital. 
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Current HNC care and variation 
A total of nine process indicators had a numerator above 400 patients: 7 from the medical 
specialists perspective and 2 from allied health perspective (Table 3). The indicator for a case 
manager or nurse practitioner being present at the consultation to discuss the treatment plan  
had the lowest score and a high variation (adherence to QI9 was 29%; range 0–90%), and the 
indicator for the availability of a treatment plan had the highest score (adherence to QI2: 100%; 
no range). The scores of three process indicators for a MTM and treatment plan had an 
adherence larger than 90%, and the variation between hospitals was small: particularly a MTM 
before treatment of the patient (QI1): 95%, range 88–98%, availability of a treatment plan 
(QI2):100%, no range, and registration of whether the patient was treated according to protocols 
(QI3): 97%, range 86–99%. The scores of three indicators of lead time varied between 48% and 
83% adherence, with the lowest score for starting the first treatment within 30 calendar days 
from the first consultation (QI7: 48%, range 24–78%) and the highest score for finishing 
diagnostics within 21 calendar days (QI6: 83%, range 63–100%). The variation between hospitals 
was the largest for malnutrition screening (QI8: 50%, range 2–100%). Three indicators had more 
than 25% of missing data, particularly for involvement of a dental team before radiotherapy, start 
of the first treatment within 30 days, and malnutrition screening.  
 
Determinants 
Comorbidity, nationality, and marital status had 75% or more missing data and were therefore 
excluded from further analysis. Multilevel analyses showed that three determinants at patient 
level and one determinant at hospital level influenced the scores of six indicators significantly, 
namely: tumour stage, tumour site, performance status, and volume (Table 4). Patients with an 
advanced tumour stage or tumour in the oral cavity or oropharynx compared to larynx and 
hypopharynx were associated with larger adherence to indicator scores for involvement of the 
dental team (QI4) (exclusion of T1 larynx carcinoma), finishing diagnostics within 21 calendar 
days (QI6), malnutrition screening (QI8), and a case manager or nurse practitioner being present 
at the consultation to discuss the treatment plan (QI9). Imperfect health (high performance 
score) is associated with low indicator scores for malnutrition screening. High volume centres 
were associated with better adherence to indicator scores for registration whether the patient 
has been treated according to the protocol (QI3), for referral to the hospital within 7 calendar 
days (QI5), and for finishing diagnostics within 21 calendar days (QI6). Stratified QI scores varied 
from the original QI scores (Tables 3 and 4). The lowest increase of adherence, from 28.9% to 
30.4%, was seen for the QI about the presence of a case manager or nurse practitioner at the 
consultation to discuss the treatment plan. The greatest increase of adherence, from 49.9% to 
81.9%, was seen for the QI for malnutrition screening.  
  
 
 
 Table 3. Results of indicators from medical and allied health professional perspectives. 
 
 
No. 
 
 
Topic – Indicators (perspective) 
N
um
erator (n) 
Indicator score (%
) 
Range betw
een  
hospitals (%
) 
M
issing data (%
) 
Influencing patient  
characteristics 
1 
Multidisciplinary team meeting takes place before 
treatment of the patient (MS) 877 95.4  88–98 14.1
A X 
2 
Treatment plan available (if patient discussed in MTM 
before start of the treatment) (MS) 
836 100  0 18.1B NA 
3 Registration if patient is treated according protocol (MS) 835 97.2  86–99 17.7  Volume 
4 
Involvement of dental team before start of radiotherapy 
(MS) 
713 83.7  67–100 25.1C Tumour stage  
5 Referral to the hospital (within 7 calendar days) (MS) 975 79.6  53–100 4.5  Volume  
6 Finishing diagnostics (within 21 calendar days) (MS) 1010 82.6  63–100 1.1  
Tumour site & 
Volume  
7 
Start first treatment (within 30 calendar days) from first 
consult (MS) 
978 48.4  24–78 26.3  X 
8 
Malnutrition screening at intake or before start of 
treatment (AHP) 
619 49.9  2–100 39.4A 
Tumour stage & 
Performance 
status  
9 
Presence of case manager/nurse practitioner at 
consultation to discuss the treatment plan (AHP) 
1013 28.9   0–90 0.8A Tumour site 
 AHP = allied health professional, MS = medical specialist  
 APatients for whom at least the intention of the treatment is clear and for whom diagnostics are carried out 
 BPatients for whom at least the intention of the treatment is clear, diagnostics are carried out, and there is a treatment plan 
 CPatients for whom at least the intention of the treatment is clear, and they are treated with radiotherapy  
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 Table 4. Patient and hospital characteristics that influence scores of indicators in multilevel analyses and the corresponding stratified indicator score. 
 
No. Topic – Indicators 
 
 
Patient 
characteristic 
n OR [95% CI] Indicator score (%) 
3 Registered whether patient is 
treated according to protocol 
Volume 138 
674 
Low volume: REF 
High volume: 2.255 (1.073–4.740) 
Low volume: 93.2 
High volume: 99 
4 Involvement of dental team before 
start of radiotherapy 
Tumour stage  204 
411 
Early: REF 
Advanced: 3.066 (1.901–4.946) 
Early: 72.5 
Advanced: 90.3 
5 Referral to the hospital (within 7 
calendar days) 
Volume  1096 
67 
Low volume: REF 
High volume: 3.521 (1.722–7.196) 
Low volume: 57.1 
High volume: 85.1 
6 Finishing diagnostics (MTM; within 
21 calendar days) 
Tumour site 
 
 
 
Volume 
220 
485 
304 
 
135 
699 
Other: REF 
*(1) 1.710 (1.102–2.652) 
(2) 0.889 (0.564–1.399) 
 
Low volume: REF 
High volume: 3.692 (1.342–10.162) 
Other & low volume: 55.8  
(1) & low volume: 70.3 
(2) & low volume: 62.3 
 
Other & high volume: 86.4  
(1) & high volume: 90.6 
(2) & high volume: 82.1 
8 Malnutrition screening at intake or 
before start of treatment 
Tumour stage 
 
 
Performance 
status  
220 
309 
 
270 
199 
Early: REF 
Advanced: 4.110 (2.466–6.849) 
 
PS = 0: REF 
PS >0: 0.595 (0.356–0.995) 
Early & PS = 0: 56.6 
Early & PS >0: 23.6 
 
Advanced & PS = 0:81.9 
Advanced & PS >0: 38.1 
9 Presence of case manager or nurse 
practitioner at consultation to 
discuss the treatment plan 
Tumour site* 204 
426 
280 
Other: REF 
(1) 0.627 (0.403–0.974) 
(2) 0.487 (0.303–0.781) 
Other: 37.7  
(1) 30.8 
(2) 30.4 
 *(1) = Oral cavity and oropharynx , (2) = Larynx and hypopharynx 
 MTM = multidisciplinary team meeting, PS = Performance status
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DISCUSSION AND CONCLUSION 
We aimed to assess the variation of current head and neck cancer (HNC) care between Dutch 
hospitals and the influence of patient and hospital characteristics. The quality of current care was 
low for the QI on the presence of a case manager at the consultation to discuss the treatment: 
the case manager was present in nearly one-third of all hospitals. There was hardly any variation 
between hospitals for the QI about the percentage of patients discussed in the MTM. However, 
almost all hospitals scored differently, with a variation from 2% to 100%, for the malnutrition 
screening QI. Four characteristics at patient and hospital levels had a large influence on indicator 
scores: tumour stage, performance status, tumour site, and volume of HNC patients.  
 Previous research shows that care, despite national guidelines, is not always delivered in 
the same way in different hospitals36,37. We also found a large variation between care delivery 
from the perspectives of medical specialists and allied health professionals. The largest variation 
was for QIs from the perspective of allied health professionals – perhaps because there are 
hardly any evidence-based guidelines. Regarding patient characteristics, there was a small 
increase in the stratified QI scores for the single determinants tumour stage and tumour site 
compared to the raw QI scores. However, if the QIs were calculated for both different tumour 
stages and performance status, the stratified QI score was much larger than the raw QI score. 
Both determinants are often used for case mix correction and prognosis of survival38. If indicators 
are to be used to compare the quality of care between hospitals, adjustment of the indicator 
scores might be needed. When more data is available in the future, the prognostic value of 
patient characteristics for survival could be investigated. Regarding hospital characteristics, 
previous studies show an association between varying hospital volume and survival30,39. We 
determined the influence of hospital volumes on our QI set and found a positive influence of 
hospital volume on lead time and registration if a patient is treated according to the protocols. In 
the future, the association between volume and patient outcomes, such as survival and 
recurrence percentage, can also be assessed for patients with HNC to investigate whether further 
concentration of HNC care in the Netherlands is beneficial.  
 Other countries already have databases with the aim of improving quality of care and 
patient outcomes; for example, the Head and Neck Audit (HANA) in the UK and the Danish head 
and neck cancer database40,41. A difference with our database is that the Dutch Head and Neck 
Audit (DHNA) relies on evidence-based QIs from the three different perspectives of medical 
specialists, allied health professionals, and patients. The other databases are mostly set up from 
an epidemiological perspective and form a base for clinical trials. An epidemiologic database is 
not primarily intended for quality registration. Apart from our initiative with quality of care data, 
De Ridder et al. have published a retrospective cohort evaluation study about the variation in 
HNC care in the Netherlands36. They show hospital variation in volume and treatment of 
especially oropharyngeal and oral cavity cancer. However, conclusions were drawn from 
retrospective data that were collected for a purpose other than quality registration. The set-up 
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and prospective character makes the DHNA far more suitable for measuring and monitoring the 
quality of HNC care. 
 Low indicator scores do not necessarily mean that the quality of care is poor, it is rather a 
signal to evaluate further. Possible explanations could be that care is not given according to the 
guidelines, the guideline does not fit daily practice, or the quality of the data is poor. Dentler et 
al. define good-quality data as being available, complete, and correct. Further, they show that 
data quality can influence indicator results42. Our quality registration is in the start-up phase. The 
availability of our data does not seem optimal: a total of four out of eight determinants and three 
out of nine indicators had more than 25% of missing data, which is too much. Regarding 
completeness, it is crucial to include all the existing patients before we can say anything about 
general healthcare43. At this moment, the registration is not complete, and centres with low 
inclusion must be encouraged to include more patients. Regarding correctness, data from the 
DHNA will be compared with data from the Netherlands Cancer Registry (NCR), which is managed 
by the Netherlands Comprehensive Cancer Organization (IKNL). However, in the past years, the 
online self-registration system has improved due to the optimising of registration guidelines and 
the learning curve of health professionals. Therefore, in the future we expect better data quality. 
 
Strengths and limitations 
A strong point of this study is that it makes it possible to assess evidence-based QI scores for 
nearly 1700 patients. Because only indicators with a numerator of more than 400 patients were 
taken into account for calculating a precise indicator score, insight into the total quality of care 
for patients with HNC was impossible. In addition, data quality criteria such as availability, 
completeness, and correctness need further improvement. We will achieve this by giving 
feedback about missing data and indicator scores, advising on improvement processes, and 
validating the registered data. Furthermore, more data is necessary to perform a reliable case-
mix correction. On the basis of the opinions of the caregivers involved in the registration, 
collection of data seems to be difficult and time consuming. Focus on less labour-intensive 
registration systems and more automatic data collection is needed, particularly registration at 
the source. Initiatives in the United States and the Netherlands have already started44,45. 
 
Conclusion 
Initiating a multidisciplinary quality registration based on evidence-based QI is challenging. Main 
requirements are guidelines to develop QIs, and sufficient data to evaluate the QI, to determine 
case-mix, and to assess the effects of variation on outcomes. However, our recently launched 
audit visualises already the variation in current care among hospitals that deliver HNC care. One 
of the following steps for the DHNA will be more research to explore the association of variation 
in quality of care with differences in patient outcomes and identifying targets for quality 
improvement.
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ABSTRACT 
Objectives: Monitoring how patients feel and what they experience during the integrated care 
process gives health professionals tools to improve their care. To obtain more information about 
specific improvements for different treatment methods, we aimed to measure patient-reported 
outcomes (PROs) and patient-reported experiences (PREs) in integrated care for patients with 
head and neck cancer receiving monomodality or multimodality treatment. 
Methods: We recruited patients from three hospitals participating in the Dutch Head and Neck 
Audit. Validated PRO measures (PROMs) were completed at baseline and 3, 6, and 12 months 
after the last treatment. The PRE measures (PREMs) were completed at 12 months after 
diagnosis. Descriptive analyses were used to assess trends in PROs over time, differences 
between monomodality and multimodality treatments in PROs and PREs, and differences in 
patient characteristics in PROs and PREs. 
Results: A total of 345 patients completed 571 PROMs, and 71 patients completed PREMs. In 
general, patients with multimodality treatments tend to have poorer functional scores and more 
symptoms than patients with monomodality treatment. In addition, patients receiving 
radiotherapy treatment alone have poorer functional scores and more symptoms than patients 
with surgery alone. Regarding PREs, patients receiving multimodality treatment reported slightly 
more frequently poorer experiences than patients receiving monomodality treatment. 
Conclusions: Given the greater incidence of symptoms and loss of functioning among patients 
after multimodality treatment, the follow-up phase should be more personalised and directed 
toward rehabilitation for restoring function and decreasing symptoms. 
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INTRODUCTION 
Integrated care is defined as 'the methods and type of organization that will provide the most 
cost-effective preventative and caring services to those with the greatest health needs and that 
will ensure continuity of care and co-ordination between different services'1. Management of 
high-quality integrated care is particularly complex due to the optimal alignment and 
collaboration of all the disciplines involved throughout the entire healthcare process2-5. Hence, 
measuring and monitoring the quality of integrated care is crucial; for example, by using a 
dashboard of valid and reliable quality indicators (QIs)5,6. Many QIs have already been developed 
for both oncologic diseases7-9 and non-oncologic diseases10.  
 In recent years, more attention has been paid to the use of outcome indicators in quality 
measuring and monitoring, as well as to process and structure indicators. This is particularly true 
for patient-reported outcomes (PROs) and patient-reported experiences (PREs) measured with 
patient-reported outcome measures (PROMs) and patient-reported experience measures 
(PREMs). These outcomes provide information about the patients’ feelings and experiences 
during the healthcare process. This information can be used as feedback to the hospital and 
healthcare provider as a starting point for healthcare improvement11. Such outcomes also give 
patients the opportunity of monitoring their own health during treatment and follow-up; and 
they give health professionals the opportunity to personalise the healthcare process12,13. 
Therefore, outcomes and experiences from patients’ perspectives are increasingly used to 
measure quality of care and, if necessary, to improve it. Greenhalgh and colleagues report that 
only occasionally health professionals do use PROs during treatment and follow-up to improve 
the quality of care14. However, Basch and colleagues state in a recent publication that integration 
of PROs into routine care for patients with metastatic cancer was associated with increased 
survival compared to usual care. They indicate that early responsiveness to patients symptoms 
prevents further adverse effects13. 
 A prime example of the need of high-quality oncologic integrated care is the delivery of 
care to patients with head and neck cancer (HNC). HNC and its treatment have a significant 
impact on the patient’s well-being because HNCs grow relatively quickly in an anatomically and 
functionally complex area15-17. Patients often experience problems with speech, swallowing, and 
physical disfiguration due to treatment18-20. The treatment may consist of surgery, radiation 
therapy, systemic therapy (monomodality treatment) or a combination of treatments 
(multimodality treatment). Optimal alignment and collaboration of both medical specialists and 
allied health professionals is crucial for an optimal result. In 2014, evidence-based QIs were 
developed to measure the quality of integrated care for patients with HNC at eight Dutch head 
and neck oncology centres (HNOCs) and six affiliated centres, i.e. the Dutch Head and Neck Audit 
(DHNA)21. The goal of this quality registration was to enable HNOCs to obtain insight into their 
current care delivery, to compare themselves to other HNOCs, and to improve HNC care. The 
PROs and PREs were included as outcome indicators in the DHNA. Since data at patient level 
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might influence the indicators, they were included as possible case-mix factors15,22. However, the 
questions remain whether there will be differences in outcomes and experiences between 
different types of treatments and different subgroups of patients, and how we can use the PROs 
and PREs to improve healthcare. 
 For this purpose, we measured PROs and PREs in integrated HNC care to assess how 
patients feel and how they experience integrated care. We determined the differences between 
monomodality treatment and multimodality treatment to obtain information about specific 
aspects of different treatment methods to be used for improving care. In addition, we assessed 
specific trends in both PROs and PREs of patients with differences in gender, age, and tumour 
stage to determine whether rehabilitation varies among different subgroups. 
 
MATERIALS AND METHODS 
Study design 
In a prospective, observational, multicentre study, patients receiving integrated HNC care 
measured PROs and PREs so that researchers could assess trends in PROs over time, differences 
between monomodality treatment and multimodality treatment in PROs and PREs, and 
differences between different patient characteristics in PROs and PREs. 
 
Setting 
Approximately 3000 HNC patients are diagnosed in the Netherlands annually23. HNC care is 
centralised in 14 hospitals: eight HNOCs and six affiliated centres. The affiliated centres have 
committed themselves to use the same treatment protocols as the related HNOCs. The various 
medical specialists and allied healthcare professionals involved in HNC care are united in two 
national foundations, one for medical specialists and one for allied health professionals. There is 
also one Dutch patient association for head and neck cancer. The Dutch Federation of University 
Medical Centres (NFU) and health insurer CZ jointly initiated the set-up of a quality registration 
that uses evidence-based QIs: the DHNA. The PROs and PREs are included as the main outcome 
indicators in the DHNA, along with survival, recurrence rates, and complication rates.  
 
Study population 
The DHNA inclusion criteria for HNC patients were: a diagnosis of a primary HNC tumour and 
curative treatment for it in one of the 14 Dutch participating hospitals in the period November 
2014 to February 2017. Each hospital and the two Dutch patient organisations were asked to 
select one or two HNC patients willing to participate in the patient panel. The two chairmen of 
both patient organisations were invited to participate. In total, 12 patients and the two chairmen 
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participated (mean age of 60 years; 57% male; either a tumour in the larynx (46%) or oral cavity 
(54%)). 
 
Questionnaires 
PROMs 
Two different validated PROMs were included in the DHNA. The European Organization for 
Research and Treatment of Cancer Quality-of-Life Questionnaire (EORTC QLQ-C30) comprises 30 
questions grouped in six function scales (Global health status, Physical, Role, Emotional, 
Cognitive, and Social functioning) and nine symptom scales (examples are Insomnia and Fatigue). 
This questionnaire complements the EORTC Head and Neck Cancer Module (H&N35), which 
consists of 35 questions grouped in 18 symptom scales (examples are Pain, Sticky saliva, and 
Problems with social eating)24-26. A higher score on the function scales means better functioning. 
A higher score on the symptom scales means more problems for the patient. Both questionnaires 
have been exclusively tested in several populations, as well as in several languages and cultural 
settings24. The questionnaires were digitally completed at baseline and 3, 6, and 12 months of 
follow-up after the last treatment. ‘Baseline’ was defined as the date of diagnosis during 
multidisciplinary team meetings. 
PREMs  
The consumer quality index for oncologic care (CQO) is a PREM designed to measure the 
performance of healthcare providers and patients’ experiences in healthcare27. The CQO is based 
on the international Consumer Assessment of Healthcare Providers and Systems (CAHPS). It has 
been validated in several settings and originally contained eight domains. The CQO included in 
the DHNA was expanded with needs and preferences expressed by patients in a previous study28. 
In total, one domain and 15 separate questions were added. The questionnaire was digitally 
completed at 12 months after diagnosis.  
 
Data collection 
An oncology nurse asked the patients if they were willing to complete PROMs and PREMs. Health 
professionals working in the hospitals that are included in the DHNA used an online self-
registration system to collect the necessary data for calculating QI scores and patient 
characteristics. In addition, PROMs and PREMs were sent automatically at pre-defined moments 
by a specific application in the self-registration system. In this system, all patients gave informed 
consent by clicking the button stating ‘I agree’ before completing the questionnaires. All data for 
PROMs, PREMs, indicators, and patient characteristics were collected in a pseudonimised 
database. The relevant patient characteristics for this study were age, gender, and tumour stage. 
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Data analyses 
All the domains of the PROMs were included in the analyses. Since we were specifically 
interested in aspects of integrated care, we analysed the following domains of the PREMs: 
Organisation, Attitude of health professionals, Expertise of health professionals, Information & 
Communication, Patients’ own contributions, Continuity & Coordination, and Guidance & 
Support. All variables from the PROMs were transformed to scales from 0 to 100 and divided into 
scale scores according to the EORTC QLQ-C30 rules and the H&N35 Scoring Manual29. Specific 
patterns of the various follow-up moments were analysed. In addition, we assessed whether 
these patterns differed in monomodality treatment and multimodality treatment. Monomodality 
treatments were split into surgery alone and radiotherapy alone since quality-of-life aspects 
differ depending on which treatment the patient received. Clinical relevance was set at a 
difference of 10 or more points on a scale of 0 to 100 in the EORTC symptom scores18,30. We 
descriptively analysed the PREM results with calculated domain scores according to the scoring 
manual in three different categories: Never/Sometimes, Mostly, and Always. We determined 
whether every participant had completed at least 50% of the questions for each domain. 
Participants who had not were excluded from the analysis for the domain in question. In 
addition, we analysed these patterns to see if they differed in monomodality treatment and in 
multimodality treatment. We assessed specific patterns in PROs and PREs for the following 
patient characteristics: gender (male versus female), age (<70 years versus ≥70 years), and 
tumour stage (early versus advanced). 
 
Ethics 
The Medical Ethical Committee of the region Arnhem–Nijmegen declared that ethical approval 
was not necessary. 
 
 
RESULTS 
Study population 
A total of 345 patients completed 571 questionnaires containing both the EORTC QLQ-C30 and 
EORTC QLQ-H&N35 at baseline and at three follow-up moments (Table 1). A total of 71 patients 
completed the CQI oncology at 12 months after diagnosis (Table 1). The patients were treated in 
three different HNOCs. 
 
Patient-reported outcomes 
The global health status (GHS) tended to increase from baseline to 12 months after follow-up for 
surgery, radiotherapy, and multimodality (Figure 1). However, in the surgery group, the GHS had 
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already increased at 3 months after the last treatment compared to multimodality treatment and 
radiotherapy alone. Emotional functioning tended to increase at each follow-up moment for all 
treatment types. In general, a treatment with radiotherapy alone tended to have a major impact 
on physical functioning and role functioning up to the first 3 months after the last radiation. 
Thereafter, these patients had better increases on the functional scales than for the other 
treatments. 
 
 
Table 1. Characteristics of patients who completed the PROMs and PREMs. 
*RAT = Radiotherapy; TNM = tumour nodes metastasis 
 
 
PROMs PREMs 
 
Monomodality Multimodality Monomodality Multimodality 
 
 (%)  
Surgery 
n = 82 
RAT 
n = 117 
(%) 
 
n = 146 
 (%) 
 
n = 38 
(%) 
 
n = 33 
Median age at start of treatment 67 years 66 years 66 years 68 years 59 years 
Gender                                             Male 78 78 73 84 73 
  Female 22 22 27 16 27 
Tobacco smoking            Never smoker 13 9 18 11 33 
 Former smoker 35 26 40 50 49 
  Current smoker 21 37 28 26 12 
Data missing 31 28 14 13 6 
Alcohol use                       Never drinker 18 16 16 21 24 
Former drinker 5 3 8 5 9 
Current drinker 60 60 63 63 58 
Data missing 17 21 13  9 
Performance status                       None 4 4 3 5 6 
 Performance status  registered 55 48 62 76 64 
 Score 0 (perfect health) 40 40 53 61 55 
 Score > 0  15 8 8 16 9 
Data missing 45 52 38 24 36 
Data missing 35 48 35 18 6 
Tumour site                                    Other 15 13 27 11 27 
Oral cavity and oropharynx 44 27 47 45 55 
Larynx and hypopharynx 37 58 21 37 12 
           Data missing 5 6 4 8 6 
Clinical TNM stage      Early (Stage ≤ 2) 63 42 18 61 21 
        Advanced (Stage >2) 12 38 64 24 61 
Data missing 24 21 18 16 18 
Comorbidity                                Score 0 31 37 21   
   Score 2 
 
1 
 
3  
Score 3 9 11 23 11 15 
Data missing 61 51 57 87 85 
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Figure 1. Global health status and functioning scales from the EORTC-C30 for patients with head and neck cancer 
Red, surgery; green, radiotherapy; blue, multimodality treatment. X axis: 1, baseline; 2, 3 months after last 
treatment; 3, 6 months after last treatment; 4, 12 months after last treatment. Y axis: EORTC-C30 score (0 to 100). 
 
Figure 2A-C. Examples of trends in EORTC-C30 and EORTC-H&N35 of patients with head and neck cancer 
Red, surgery; green, radiotherapy; blue, multimodality treatment. X axis: 1, baseline; 2, 3 months after last 
treatment; 3, 6 months after last treatment; 4, 12 months after last treatment. Y axis: EORTC-C30 and EORTC-H&N35 
(0-100). 
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We distinguished three types of trends: an increasing or decreasing trend, a peak at 3 months 
after the last treatment, and varying trends (Figure 2A-C). The domain of Emotional functioning 
and Pain appeared to increase or decrease for all types of treatment (Figure 2A). The domain 
Nausea - vomiting showed hardly any variation for either monomodality treatment or 
multimodality treatment. The domains Sticky saliva, Speech problems, and Problems of the 
senses each showed a clear peak at 3 months after the last treatment (Figure 2B). For these three 
domains, a multimodality treatment appeared to give rise to the most problems, followed by 
radiotherapy alone. The domains Physical functioning, Less sexuality, and Insomnia showed no 
clear pattern that was similar for all three types of treatment (Figure 2C).  
 In the domains Dry mouth, Problems with social eating, Problems of the senses, Fatigue, 
and Speech problems, patients younger than 70 years who received radiotherapy treatment had 
more problems at 3 months after the last radiation therapy than patients older than 70 years 
(results not shown). For the next follow-up moments, the problems decreased for patients 
younger than 70 years and increased for patients older than 70 years. However, the domain 
Physical functioning showed the opposite; most problems occurred at 3 months after the last 
treatment for patients older than 70 years. 
 Patients with an advanced tumour stage had more problems than patients with an early 
stage for radiotherapy alone and for multimodality treatment (results not shown). This was 
especially the case for Sticky saliva, Pain, Swallowing, and Problems of the senses after 
multimodality treatment at baseline and 3 months follow-up. The symptoms and functional 
scales Dry mouth, Problems with social eating, Global health status, Physical functioning, and 
Role functioning led to more problems or worse functioning for patients with an advanced 
tumour stage after multimodality or radiotherapy treatment at 3 and 6 months of follow-up.  
 Differences between male and female patients appeared mainly in the functional scales 
and less in the symptom scores (results not shown). Men had better scores for role functioning 
and emotional functioning regarding surgery and radiotherapy alone. Men had better scores 
after surgery than women in the domain Pain. There were hardly any clinical differences for 
multimodality treatment. 
 
Patient-reported experiences 
Figure 3 shows the experiences of patients with monomodality treatment and multimodality 
treatment. In general, patients receiving multimodality treatment mentioned poorer experiences 
slightly more frequently than patients receiving monomodality treatment did, particularly in the 
domains Organisation, Attitude of health professionals, Expertise of health professionals, and 
Continuity & Coordination. For example, the domain Continuity & Coordination scored up to 75% 
for three questions in the categories Never/Sometimes and Mostly; namely, if care was arranged 
by one health professional (question 15), if the patient had one contact person in the hospital for 
scheduling and matching consultations (question 17), and if the patient saw the same health  
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professionals as much as possible during investigations and treatments (question 13). These 
questions scored only 55%, 38%, and 52% in the categories Never/Sometimes and Mostly for 
patients receiving monomodality treatment.   
 
 
 
Figure 3. Experiences of patients with head and neck cancer receiving monomodality treatment or multimodality 
treatment. Red, Never/Sometimes; yellow, Mostly; green, Always. 
 
 
In the remaining domains Information & Communication, Patients’ own contributions, and 
Guidance & Support, most questions showed similar experiences or, more frequently, poorer 
experiences for patients receiving multimodality treatment than patients receiving 
monomodality treatment. This was more often true if health professionals informed the patient 
about patient organisations (question 1), if a consultation with an oncology nurse was arranged 
to discuss the definitive treatment plan (question 20), if the right information was given at the 
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right time (question 31), and if information about advantages and disadvantages was given 
(question 24). However, three questions in the domain Guidance & Support had better scores for 
patients receiving multimodality treatment, namely, if information about help and guidance in 
dealing with emotions and practical problems with cancer was given (question 3), if attentionwas 
given to fatigue problems in the follow-up phase (question 5), and if attention was given to 
fatigue problems in the diagnosis phase (question 7). Scores for Never/Sometimes and Mostly 
were 48%, 30%, and 52% for monomodality treatment, respectively, and 36%, 26%, and 37% for 
multimodality treatment, respectively. It is interesting that the question whether caregivers took 
pain seriously (question 12) had a score above 96% in the category Never/Sometimes and Mostly 
for both treatments. 
 Regarding patient characteristics, patients 70 years or older had better experiences with 
healthcare compared to patients younger than 70 years, except for the domain Guidance & 
Support and the domain Organisation (results not shown). In each domain, patients with an 
advanced tumour stage had poorer scores for experience with healthcare than patients with an 
early tumour stage. Women did better in the domains Guidance & Support, Information & 
Communication, Attitude of health professionals, and Expertise of health professionals than men 
did. 
 
 
DISCUSSION 
We aimed to measure PROs and PREs in integrated HNC care to assess how patients feel and how 
patients experience integrated care. In addition, we assessed differences between monomodality 
treatment and multimodality treatment to obtain information about specific aspects of different 
treatment methods to be used for improving care. The PROs showed that functioning and 
symptoms differ between follow-up moments and type of treatment. In general, patients who 
received radiotherapy alone had better functioning and fewer symptoms than patients who 
received multimodality treatment. Patients who underwent surgery tended to have better 
functional outcomes and fewer symptoms than patients who received radiotherapy. Regarding 
PREs, patients receiving multimodality treatment mentioned poorer experiences more frequently 
than those receiving monomodality treatment. This was especially the case in the domains 
Organisation, and Attitude of health professionals, and Expertise of health professionals. In 
addition, we assessed different trends for the different patient characteristics of gender, age, and 
tumour stage. 
 As expected, our study shows that the type of treatment influences how patients feel and 
what they experience during the integrated care process. Certain symptoms are specific to the 
type of treatment and will therefore always come forward; for example, a dry mouth after 
radiotherapy. However, for non-specific functions, symptoms and experiences, we also expected 
that multimodality treatment would give poorer results than monomodality treatment since 
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more alignment, collaboration, and co-ordination is necessary in the healthcare process. 
Ramaekers and colleagues studied the negative association of complications with lower utility 
and Visual Analog Scale (VAS) score and shows that adding surgery to radiotherapy 
(multimodality) decreases the quality of life of HNC patients31. In more detail, there are studies 
that even show that different techniques for radiotherapy or surgery result in different HNC-
related symptoms32,33. Villaret shows that the quality of life of patients who underwent a surgical 
reconstruction after being diagnosed with oral cavity cancer decreases dramatically during the 
first 3 months. Hereafter, it increases. Similar patterns were seen in the functioning scales in this 
study, but not for symptoms. The explanation is that 48% of the patients also received post-
operative radiotherapy or chemo-radiotherapy. In addition, patients completed the 
questionnaires at follow-up moments after the operation (even though radiotherapy and 
chemoradiation were given). In our study, patients completed the questionnaires after the last 
treatment. Probably the patients in Villaret’s study had not recovered optimally due to the 
additional treatments, which adds another dimension to their results.  
 Previous studies show an association between patient characteristics and quality of 
life24,34. Taher et al. show a negative effect on quality of life for females above the age of 60 years 
old with a clinical stage of III and IV compared to males under the age of 60 years old with a 
clinical stage of I and II34. Kucuk and colleagues show that symptoms of the EORTC H&N35 were 
significantly higher in patients with an advanced stage than in patients with an early stage. 
Although we only analysed frequencies for these characteristics, both studies show results similar 
to those of our study. In the future, more data will be available for studying the association of 
PROs and PREs versus patient characteristics.  
 Regarding outcomes, previous literature shows that integration of PROs into the routine 
care increases survival significantly for patients with cancer compared to usual care13. This 
increases the importance of monitoring PROs in clinical practice. In the DHNA, the online system 
can be expanded for health professionals so that they can use the PROs and PREs in their 
consultations. 
 
Strengths and limitations 
Strengths of this study were the possibility to analyse PROs and PREs in different subgroups of 
patients and targets for quality improvement on specific parts of the healthcare process where 
problems were encountered. We performed an observational study with 345 patients who 
completed the PROMs and 71 patients who completed the PREMs. The number of patients who 
completed the PREM is equal to only 20% of the patients who completed the PROMs. One 
explanation for this is that a patient needs to be further in the follow-up phase to complete a 
PREM than for the times when the PROMs have to be completed. In addition, for the PROMs, we 
see a decrease in the response rate when the period of treatment becomes longer. This might be 
another explanation for a low response rate for the PREMs. Since the patient populations for 
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both PROMs and PREMs seem similar (Table 1), we do not expect bias. Apart from frequencies, 
no statistical analyses were done because the number of patients for each treatment group at 
each follow-up moment was sometimes less than 20. There were three reasons: non-response of 
patients after the first questionnaire, not all patients were able to complete a PRO at each follow-
up moment, and not all patients had reached the time of 1 year of follow-up after the last 
treatment. When more data become available in the future, possible differences can be tested 
for various follow-up moments and different treatments using statistics. Further, associations 
between PROs and PREs can be studied by analysing the data of patients who completed both 
PROMs and PREMs. Patients were included from three different specialised hospitals. When 
more data is available, differences between these hospitals and the influence of patient 
characteristics can be analysed. We generalised different treatment methods by categorising 
them as monomodality or multimodality.  
 
Conclusion 
In conclusion, a patient who undergoes multimodality treatment tends to experience a 
healthcare process that is less well-organised, achieves poorer functional scores, and has more 
symptoms than patients who undergo monomodality treatment. Given the greater incidence of 
symptoms and greater loss of function in patients after multimodality treatment, the follow-up 
phase should be directed to rehabilitation by restoring function and decreasing symptoms. For 
both monomodality and multimodality treatments, monitoring PROs and PREs should become 
easier and results should be more visible for health professionals to act on. 
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ABSTRACT 
Background: Audit and feedback on professional practice and healthcare outcomes are the most 
often used interventions to change behaviour of professionals and improve quality of healthcare. 
However, limited information is available regarding preferred feedback for patients, professionals 
and health insurers.  
Objective: Investigate the (differences in) preferences of receiving feedback between 
stakeholders, using the Dutch Head and Neck Audit as an example. 
Methods: A total of 37 patients, medical specialists, allied health professionals and health 
insurers were interviewed using semi-structured interviews. Questions focussed on: ‘Why’, ‘On 
what aspects’ and ‘How’ do you prefer to receive feedback on professional practice and 
healthcare outcomes?  
Results: All stakeholders mentioned that feedback can improve healthcare by creating 
awareness, enabling self-reflection and reflection on peers or colleagues, and by benchmarking 
to others. Patients prefer feedback on the actual professional practice that matches the 
healthcare received, whereas medical specialists and health insurers are interested mainly in 
healthcare outcomes. All stakeholders largely prefer a bar graph. Patients prefer a pie chart for 
patient-reported outcomes and experiences, while Kaplan–Meier survival curves are preferred by 
medical specialists. Feedback should be simple with firstly an overview, and 1–4 times a year sent 
by e-mail. Finally, patients and health professionals are cautious with regard to transparency of 
audit data.  
Conclusions: This exploratory study shows how feedback preferences differ between 
stakeholders. Therefore, tailored reports are recommended. Using this information, effects of 
audit and feedback can be improved by adapting the feedback format and contents to the 
preferences of stakeholders. 
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INTRODUCTION 
Much effort has been devoted to improve professional practice and outcomes in healthcare 
during the past decades, unfortunately with varying effects. A widely used strategy to improve 
healthcare is 'audit and feedback'1,2, defined as any summary of clinical performance of 
healthcare over a specified period of time, given in a written, electronic or verbal format, offering 
professionals performance information and motivation to improve3.  
 One of the methods to derive the information for audit and feedback is using quality 
indicators4,5. Quality indicators are aimed at detecting suboptimal care either in structure or 
process (e.g. the percentage of patients discussed in multidisciplinary team meetings), or 
outcomes (e.g. patient-reported outcomes [PROs] and experiences [PREs]). They can be used as a 
tool to guide the process of quality improvement in healthcare6.  
 Although positive effects of audit and feedback have been reported, namely decreased 
duration of hospital stay7 and decreased mortality rates8, this improvement strategy has not 
been found to be consistently effective2,9-12. So far, research has focussed on increasing the 
effectiveness of feedback, for example by including a worksheet in the feedback to facilitate goal 
setting13 and timing of audit and feedback3,14,15. Audit and feedback researchers have 
recommended a shift towards comparative effectiveness studies, evaluating how and when audit 
and feedback components will work, rather than its overall effectiveness16. 
 The format of feedback may significantly affect the interpretation of data17-19. However, 
there is only limited information available regarding formats of feedback, for example on how to 
summarize and display results of outcome measures in the best way20-22. Furthermore, 
implementation of audit and feedback is likely to be more effective when feedback messages can 
influence barriers to change behaviour. These barriers appear to differ across individuals23. In 
addition, most audit and feedback interventions use written or graphical feedback in one uniform 
format for all recipients7. This will surely not meet the preferences of all recipients, and effects 
will be low if recipients do not understand the feedback. In developing feedback formats, it is 
therefore necessary to involve all stakeholders receiving feedback, so as to guarantee that the 
presentation of feedback meets their preferences20,24. 
 In healthcare systems worldwide, various stakeholders use feedback on quality indicators 
for different purposes, such as: (1) patients, who are the recipients of healthcare and for whom 
feedback on PROs and PREs can be used to improve and monitor their own or others’ health and 
healthcare pathways; (2) medical specialists, who deliver healthcare and for whom the feedback 
on their own delivered care may improve healthcare; (3) allied health professionals, including 
nurses, who have a similar role as medical specialists, although restricted to allied healthcare; 
and (4) health insurers, who search for quality information suitable to create differences in 
quality of care levels as a basis for their contracting. We hypothesize that by adapting feedback 
to the preferences of these different stakeholders, they will better respond to the information 
delivered, and more improvement in effects of audit and feedback could be possible. 
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In this exploratory study, we aim to investigate the preferences of various stakeholders on 
receiving feedback, with the Dutch Head and Neck Audit (DHNA) as an example. Head and neck 
cancers (HNCs) are heterogeneous both biologically as well as in clinical behaviour, and they 
grow relatively fast in an anatomically and functionally complex area25,26. Patients often have 
problems with speech, swallowing and physical disfiguration due to treatment27,28, requiring the 
collaboration of both medical specialists and allied health professionals. Therefore, high-quality 
integrated care for patients with this type of tumour is needed29,30. The DHNA uses quality 
indicators to measure the quality of integrated care for patients with HNC within 14 Dutch 
hospitals31. By investigating the preferences on feedback of all four stakeholders in the DHNA 
(medical specialists, allied health professionals, patients and health insurers), including ‘Why’, 
‘On what aspects’ and ‘How’ do you prefer to receive feedback on professional practice and 
healthcare outcomes, this study can provide useful tools to potentially improve quality of care by 
adapting the feedback format and contents to stakeholders’ preferences. This can serve as an 
example for other integrated oncologic care pathways where audit and feedback will be used or, 
unfortunately, is still less effective. 
 
 
METHODS 
Study design 
The first author conducted semi-structured interviews with four stakeholders to investigate 
preferences on feedback using the ‘consolidated criteria for reporting qualitative research’ 
checklist (COREQ)32. Interviews were transcribed verbatim and qualitatively analysed by the first 
and third author. 
 
Setting 
Approximately 3,000 patients are diagnosed yearly with HNC in the Netherlands33. HNC care is 
centralized in 14 hospitals: eight Head and Neck Oncology Centres (HNOCs) and six affiliated 
centres. The affiliated centres have committed themselves to using the same treatment protocols 
as the related HNOC. The various medical specialists and allied healthcare professionals involved 
in HNC care are united in two national foundations: one for medical specialists (NWHHT) and one 
for allied health professionals (PWHHT). Previously, there were two Dutch patient associations: 
‘Stichting Klankbord’ and ‘NSVG’. The former represented all patients with HNC, the latter only 
laryngectomised patients. Currently, they collaborate in one Dutch patient association called 
‘patiëntenvereniging Hoofd-hals’. In the Netherlands, there are four major health insurers as well 
as several smaller companies. In 2014, a quality registration was set up to measure the quality of 
integrated HNC care, using quality indicators selected by the four stakeholders 31. 
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Participants 
Four different groups of stakeholders were interviewed about their preferences. Research shows 
that 13–15 interviewees are usually sufficient to reach data saturation (the point at which no 
new information is mentioned in interviews)34. Therefore, at least 13 persons were invited for 
each stakeholder group. However, only the four major health insurers were invited. A patient 
panel (including the chairmen of both patient associations) that participated in a previous study 
was asked by e-mail to participate again35. A letter with additional information about the 
research methods and an informed consent form were handed over to the patients at a meeting 
prior to the interview. The location for the personal appointment was either at their home, their 
work or at the hospital. Medical specialists and allied health professionals and nurses, belonging 
to the national foundations, were invited to participate in an interview, either by telephone or in 
person. We aimed to interview at least one professional of each profession (radiation oncologist, 
medical oncologist, oral and maxillofacial surgeon, otorhinolaryngologist, speech therapist, 
physiotherapist, dietician, oral hygienist and nursing consultant) involved in HNC care. We 
contacted the four major health insurers by e-mail, to ask whether they would be willing to 
participate in an interview, either by telephone or in person. Persons approached were 
specialised in healthcare purchasing policy, innovation and advice or innovation and quality. Prior 
to an interview by telephone or a meeting, the professionals, patients and health insurers 
received a document with examples of the type of graphs to be discussed (see Result section 
Table 6, first column). In this article, the term 'professionals' will be used when referring to 
medical specialists together with allied health professionals, and 'allied health professionals' 
refers to both allied health professionals and nurses. 
 
Data collection 
Each interview took approximately 20–30 minutes and was audio-recorded. Moreover, all 
patients signed informed consent forms, while each interviewee received the same questions. 
Questions focussed on three topics: (1) ‘Why do you prefer to receive feedback on professional 
practice and healthcare outcomes?’, e.g. reasons for feedback at an individual level, hospital level 
and national level for indicators on outcome, process and structure; (2) ‘On what aspects would 
you prefer to receive feedback regarding professional practice and healthcare outcomes?’, e.g. 
interest in specific indicators; (3) ‘How do you prefer to receive feedback on professional practice 
and healthcare outcomes?’, e.g. frequency, timing, report form, type of graph preferred and 
transparency, e.g. whether patients prefer to receive national average scores on PROs and PREs 
and whether results of quality of care in hospitals can become public. In addition, the interviews 
with patients were focussed particularly on the PROs and PREs with regard to questioning 
healthcare outcomes, since patients had a better understanding of the feedback on these 
questions compared with feedback on, for example, survival. Questions for the health insurers 
focussed merely on the goal of feedback, since they will use feedback in a different way 
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compared with patients and health professionals. Different graph types were selected from 
feedback reports used in other research or found on the Internet, for example a bar graph, pie 
chart, line graph, point graph, area graph, box plot, Kaplan–Meier graph or a funnel plot. 
Moreover, a distinction was made between graphs for outcome indicators such as survival and 
PROs and PREs, since, in general, different graphs are used for both types of data.  
 
Analysis of interviews 
Interviews were transcribed verbatim and qualitatively analysed using ATLAS.ti (version 7)36. The 
first two interviews of each stakeholder group were coded independently by the first and third 
author (LO and TV) (female, MSc, first author; male MSc, third author; both working in the same 
research institute). All identified items were compared and discussed until consensus was 
reached. The remaining interviews were coded by the first author and checked by the third 
author to enhance the reliability and validity of the results. The same two researchers then 
categorised all identified items into the interview topics. Subcategories of all codes dealing with 
the same subject were made by the two researchers within each category, resulting in a code 
tree. For example, a division into three subcategories was made within the category ‘Why do you 
prefer to receive feedback?’: individual level, hospital level and national level. Or, in the category 
‘How do you prefer to receive feedback’, all codes regarding distribution of the report were 
compiled, thereby forming a subcategory. Disagreement was discussed between the two 
researchers and if necessary with the last author (RH) (female, PhD, last author) until consensus 
was reached.  
  
 
RESULTS 
Study population 
For the patients as stakeholders, a response rate of 76% was reached, since three patients did 
not participate due to time constraints or did not respond to the e-mail or reminder. A total of 
eight patients and the chairmen of both patient associations participated in the semi-structured 
interviews, all in person (Table 1). 
 The medical specialists and allied health professionals had a response rate of 94% and 
69%, respectively. Reasons for not participating were time constraints, the person did not belong 
to the board of the national foundation for allied health professionals anymore or the person did 
not respond to the e-mail or the reminder. A total of 15 medical specialists (n = 15) and nine 
allied health professionals participated in an interview (n = 9), either by telephone (n = 18) or in 
person (n = 6) (Table 2).  
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Table 1. Characteristics of ten participating patients*. 
Variable   n 
Age, years Mean 59.4 
Sex, n Female 4 
  Male 6 
Education level, n* Medium and lower 4 
 High 5 
Type of tumour, n* Larynx 4 
  Oral cavity 5 
Type of treatment, n* Operation 2 
  Chemoradiation 1 
  Operation & radiotherapy 5 
  Operation & chemoradiation 1 
Year of diagnosis*   1997–2013 
* Exclusion of the chairman of a patient association, who was not a patient. 
 
 
Table 2: Characteristics of 24 participating professionals. 
Variable n 
Dutch Head and Neck Society 15 
Head and Neck Oncology Centres  10 
Affiliated centres 5 
Dutch Head and Neck Allied Health Professionals Group 9 
Head and Neck Oncology Centres 7 
Affiliated centres 2 
 
 
The professions of these members included three radiation oncologists, two medical oncologists, 
five oral and maxillofacial head and neck surgeons, five otorhinolaryngologist head and neck 
surgeons, one speech therapist, two physiotherapists, two dieticians, two oral hygienists and two 
nursing consultants. Furthermore, the health insurers had a response rate of 75%, since one 
health insurer was not willing to participate. In total, three health insurers participated in an 
interview, either by telephone (n = 1) or in person (n = 2). 
 
Preferences 
Tables 3, 4, 5 and 6 present an overview of the preferences of patients, professionals, and health 
insurers regarding the three topics. In the following paragraphs, the preferences have been 
summarised. In addition, Figure 1 presents quotes from different stakeholders on the main 
research questions. 
6 
  
 
 
Table 3. Why do you prefer to receive feedback?
Subject Patient Medical specialist Allied health professional Health insurer 
Feedback on indicators*  At an individual level – Patients: 
 Patients are curious 
 Feedback is useful for future 
patients  
 To give patients more 
information about the 
healthcare process 
 To give patients the opportunity 
to choose the best hospital 
(although some patients state 
that there is no option to 
choose, due to distance and 
other factors and the fact that 
patients prefer a treatment 
first) 
 Patients may not be interested 
 Feedback is not of any value to 
the patient 
 Patients might regret their 
decision for their treatment in 
that specific hospital if data 
become transparent/public 
 
At an individual level – Professionals: 
 To give doctors more insight 
into the healthcare process; an 
eye-opener 
 A way to improve healthcare 
instead of a threat to the 
professional 
 
At a hospital level: 
 To motivate professionals to 
perform better 
 To monitor healthcare in 
hospitals 
 
At an individual level – Patients: 
 Feedback can result in wrong 
interpretations by patients  
 Patients are possibly not 
interested in indicators  
 
At an individual level – Professionals: 
 To become better aware of the 
outcomes 
 Feedback can result in wrong 
interpretations by professionals 
 
At a hospital level: 
 To see how other professionals 
in your hospital function; to 
keep everyone focussed 
 Feedback as a stimulating factor 
to improve performance 
 To know where the weak points 
are in your hospital  
 To better organise the 
healthcare process 
 Important to develop 
improvement plans: first let the 
hospitals change within their 
hospital and improve 
healthcare 
 Important to put quality on the 
agenda in your hospital in order 
to pay more attention to 
feedback 
 
At a national level: 
 To compare all hospitals with 
each other 
 To increase national healthcare 
 To improve outcomes 
At an individual level – Patients: 
 Patient can engage in the 
conversation with professionals 
if the delivered care does not 
meet the conditions  
 Feedback can result in wrong 
interpretations by patients 
 
At an individual level – Professionals: 
 To see how your colleagues are 
working 
 To create more awareness in 
order to deliver good 
healthcare as a professional 
 To pay attention to indicators, 
since these are easily forgotten 
 Feedback can result in wrong 
interpretations by professionals 
 No interest in results of 
indicators  
 
At a hospital level: 
 To see how well your hospital is 
functioning and from which 
hospital you can learn 
 To see which processes work in 
other hospitals 
 Feedback gives tools to engage 
conversations with colleagues 
 To put pressure on the board of 
directors 
 Important to create a structure 
where improvement is possible 
and to develop improvement 
plans  
 Put quality on the agenda in 
your hospital 
At an individual level – Patients: 
 To represent patients’ interests 
 To inform patients where best 
care is delivered. 
 
At an individual level – Professionals: 
 To engage in conversation 
between professional and 
health insurer 
 
At a hospital level: 
 To improve quality of care 
 To purchase by value 
 To engage in conversations with 
hospitals and to take actions if 
the care delivered is of inferior 
quality, not to punish hospitals  
 To measure quality of 
integrated healthcare instead of 
measuring quality of separate 
parts of the healthcare pathway 
 Put quality on the shared 
agenda of healthcare providers 
and health insurers 
 
At a national level: 
 To develop demands to 
improve quality of care 
 To compare hospitals for care 
procurement 
 To set up best practices 
 To ensure that hospitals do not 
see the health insurance 
company as the enemy 
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At a national level: 
 To compare hospitals with each 
other and visualise the 
differences, although some 
patients consider this to be a 
difficult task 
 Important to act upon the 
feedback reports 
nationwide  
 
 
 Feedback is just a small part of 
healthcare; healthcare itself is 
about the whole figure 
 
At a national level: 
 To compare and to improve 
together 
 To improve or develop (new) 
options for treatment 
Feedback on PROs and 
PREs  
At an individual level – Patients: 
 Patients are curious 
 To reflect and create awareness 
for the patient 
 To engage in the conversation 
with relatives, peers and 
professionals 
 Patients may not be interested 
 Feedback might be hard to deal 
with  
 Feedback about your own 
experiences and quality of life 
makes it less useful 
 
At an individual level – Professionals: 
 To create more empathy in 
professionals towards patients 
 Feedback might be more 
relevant and convenient for the 
nurse instead of the doctor 
 Feedback can influence the 
patient–professional relation 
 
At hospital level: 
 To improve quality of 
healthcare according PROs and 
PREs 
 
At national level: 
 To give insight into which 
hospital performs best on PROs 
and PREs 
At an individual level – Patients: 
 Important to give all results 
back to the patient, also your 
own PROs and PREs 
 
At an individual level – Professionals: 
 Interesting to see results of 
PROs through time  
 
At a hospital level: 
 Use PROs and PREs for research 
on prognostic factors  
 To improve by knowing how 
your hospitals scores on PROs 
and PREs 
 
At a national level: 
 To benchmark with other 
hospitals  
 
At an individual level – Patients: 
 To compare scores of patients 
on PROs and PREs 
 
At an individual level – Professionals: 
 It is also about ‘how’ the patient 
lives instead of ‘if’ the patient 
lives 
 
At a hospital level: 
 To improve by knowing how 
your hospitals scores on PROs 
and PREs 
 
At a national level: 
 To compare scores of patients 
on PROs and PREs within a 
healthy population 
 
At an individual level – Patients: 
 To send patients to the best 
performing hospital 
 
At an individual level – Professionals: 
 To better know what the 
patient wants 
 
At a hospital level: 
 To use patient experiences to 
improve quality of care in 
hospitals 
 
At an national level: 
 PROs and PREs are part of the 
healthcare delivered  
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Why do you prefer to receive feedback? 
Feedback on professional practice & healthcare outcomes 
In general, all stakeholders prefer feedback on professional practice and healthcare outcomes 
(Table 3). The main reason mentioned was that feedback can improve healthcare, either at an 
individual level, hospital level or national level. Feedback can create awareness. It can also be a 
method for reflection on yourself and on peers or colleagues.  
 Feedback can also be used to benchmark and improve healthcare with all healthcare 
providers together. Stakeholders agree that it is important to act upon feedback, either by 
developing improvement plans or by putting the feedback on the agenda as a start. Both actions 
will result in more attention to the use of feedback in the hospital. Additionally, feedback can 
engage quality of care discussions among and with professionals, patients and health insurers 
about the care delivered and the experiences of all parties involved. All four stakeholders agree 
that patients might not be interested in or might not understand the feedback on professional 
practice. In addition, healthcare professionals themselves mentioned that not all healthcare 
professionals would be able to understand the feedback properly. 
 Health insurers specifically stated that it is not their aim to judge hospitals for the good 
work they deliver, but to apply feedback as a discussion tool in their interactions with care 
providers. Health insurers consider feedback to be a necessary tool to improve care for the 
patient (e.g. by informing the patient and representing their interest based on the feedback). In 
comparison, professionals consider feedback to be a method to improve care together with the 
patient.  
 
Feedback on PROs and PREs 
The main reason for patients to want to receive feedback on PROs and PREs is to be able to 
engage in the discussions with peers or professionals regarding their quality of life, experiences 
and received care.  
Medical specialists see the PROs and PREs as another way of benchmarking and improving 
healthcare. Allied health professionals mention that feedback on PROs and PREs are of particular 
interest, since they are about ‘how’ the patient lives instead of ‘whether’ the patient lives for a 
longer period. For health insurers, PROs and PREs form a part of the outcome indicators and are 
necessary to measure quality; patient experiences are necessary to improve healthcare. 
 
On what aspects do you prefer to receive feedback? 
Patients would prefer to receive feedback on the professional practice that matches their 
healthcare pathway; for example, the patient does not want to receive feedback on the 
professional practice of the physiotherapist if the patient did not receive any physiotherapy at all 
(Table 4). Medical specialists and health insurers alike mention that healthcare outcomes are  
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most relevant when they can be compared with the aspects of professional practice, because 
they deal with the effect of the treatment.  
 In contrast with medical specialists, allied health professionals mention more frequently 
that they are more interested in feedback on the professional practice of their own discipline. 
However, both groups agree that feedback on all health outcomes and aspects of professional 
practice is needed, since they also form part of the healthcare pathway of the patient.  
 
 
Table 4. On what aspects do you prefer to receive feedback? 
 
 
How do you prefer to receive feedback? 
Frequency and timing 
Patients prefer to receive feedback when the specific health outcomes and aspects of 
professional practice have become relevant in their disease process. They prefer to receive this 
feedback by e-mail or through a patient portal. In terms of frequency, patients mentioned that, 
for all indicators (including PROs and PREs), feedback once a year would be sufficient (Table 5). 
Patients would prefer to receive feedback for the first time after the diagnostic phase, because 
then their stress level will be lower compared with during the diagnostic phase.  
Both medical specialists and allied health professionals agree that feedback should be given more 
often in the start-up phase of a quality registration. In this way, users will get used to receiving 
feedback and will act on it.  
 Medical specialists and allied health professionals differ on the frequency of feedback: 
medical specialists prefer to receive feedback on process indicators (1–4 times a year) more often 
compared with outcome indicators (1–2 times a year). However, for allied health professionals, 
this is exactly the opposite.  
 
Subject  Patient Medical specialist Allied health 
professional 
Health insurer 
Interest in specific 
indicators 
x Interest in 
healthcare 
indicators that 
match the care 
received by the 
patient 
x Interest in 
indicators that are 
considered to be 
relevant for the 
patient  
x Feedback on all 
indicators to find 
out whether you 
missed specific 
care 
x No consensus on 
content of 
indicators: 
interested in all 
indicators on one 
hand, or only 
interested in 
specific outcome 
indicators on the 
other hand 
 
x Interested in 
indicators of allied 
health 
professionals; the 
remaining 
indicators are 
mainly for 
information (they 
also mentioned the 
relevance of 
receiving feedback 
on all indicators 
since they are part 
of one patient-care 
pathway) 
x Mainly interested 
in outcome 
indicators. 
Process indicators 
are necessary to 
monitor the 
processes that 
underlie the 
outcome 
indicators 
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Figure 1 Quotes from different stakeholders on the main research questions. 
 
Report form  
Patients mentioned that feedback should be well balanced and an explanation of the figure or 
graph should be given. Furthermore, patients mention that average scores of how all hospitals 
perform on professional practice might be of more interest for professionals and patient 
associations. With regard to average scores of PROs and PREs, patients mention that it gives 
them an insight where they stand, as well as possibly giving a boost. On the other hand, 
information about the average quality of life of other patients might result in insecure or 
discouraging feelings of patients regarding their own care status.  
 Professionals agree that the report should be simple as well as giving an overview of the 
indicators, followed by more in-depth information. In addition, they are all in doubt about 
displaying average scores or specific scores of hospitals in public. They fear that it could result in 
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reputational damage when the hospital is pictured as a lesser-performing hospital. Professionals 
agree that feedback should preferably be given by e-mail. 
 In contrast to medical specialists, allied health professionals prefer to receive the 
indicators of their own discipline first, followed by the remaining indicators. In addition, allied 
health professionals would prefer a meeting around the feedback with more background 
information. Medical specialists prefer to discuss feedback within their hospital before asking for 
more background information. 
 Furthermore, prior to giving feedback on PROs and PREs to patients, medical specialists 
feel that professionals should question the preferences of the patient regarding receiving their 
own results or the results of the general population. Professionals should also ask patients 
whether results on PROs and PREs might be consulted by professionals. 
 
Transparency 
Patients and professionals alike are cautious about transparency of data. They are worried about 
the quality of data and the risk of misinterpretation. Medical specialists suggest organising a 
committee to decide on issues concerning transparency. In contrast, allied health professionals 
are in favour of making data public and have less stringent requirements for making data public 
compared with medical specialists. Health insurers mention that they feel a duty to take 
responsibility to the population. In order to improve care, it is important to visualise delivered 
care.  
 
Type of graph for feedback on indicators 
Patients mentioned that feedback figures for professional practice are difficult to read for 
patients in general (Table 6). In contrast, figures for health outcomes are easier to read for 
patients. Professionals also confirm that patients might not be able to read the feedback on 
health outcomes and professional practice.  
 For both health outcomes and professional practice, patients as well as professionals 
prefer bar graphs since they are easy to read. Other preferred graphs for medical specialists are 
Kaplan–Meier graphs and box plots for survival indicators and process indicators, respectively. 
Allied health professionals mention that box plots, Kaplan–Meier graphs and funnel plots give a 
less clear overview and are more difficult to interpret.  
 
Type of graph for feedback on PROs and PREs 
Patients mention that figures for this kind of feedback are easier to read compared with figures 
for process and structure indicators (Table 6). Patients prefer both a pie chart and a bar graph. In 
general, patients prefer a figure over plain text. Professionals have a slight preference for a pie 
chart compared with a bar graph. 
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Table 5. How do you prefer to receive feedback? 
Subject Patient Medical specialist Allied health professional Health insurer* 
Frequency and 
timing 
General:  
x Do not give feedback on PROs and 
PREs too often 
 
Frequency: 
x Indicators: once a year 
x PROs/PREs: once a year  
 
Timing: 
x Either before treatment or after the 
diagnostic phase (there is more 
stress during the diagnostic phase)  
x When the indicators are relevant in 
the healthcare process 
General:  
x Preference for receiving more 
feedback at the beginning 
x Preference for receiving feedback 
more often when severe deviations in 
the data appear 
 
Frequency: 
x Process indicators: 1–4 times a year 
(depending on the possibility of 
improving in the meantime) 
x Outcome indicators: 1–2 times a year 
General:  
x In the beginning, feedback could 
be given more often 
 
Frequency: 
x Process indicators: 1–2 times a 
year  
x Outcome indicators: 2–4 times a 
year 
 
 
Report method General: 
x Figures with an explanation of the 
content and 'how to read' 
x Dosing of the amount of 
information in smaller parts 
x Keep the target audience in mind 
(e.g. colour blind, use of medical 
terms, level of degree) 
 
Use of average scores: 
x Give feedback with average national 
scores on the PROs and PREs, but be 
aware of consequences: 
Positive: give insight into where you 
stand, give a boost and lean on 
results of other patients 
Negative: insecure or discouraging 
feelings 
x National average scores on 
indicators of more interest for 
patient organisations and 
professionals 
General: 
x Find a balance between giving 
feedback and giving too much 
information 
x Give an overview of the results first, 
followed by the details 
x Present it in such a way that one can 
easily understand without 
explanation 
 
Use of average scores: 
x Give feedback on own scores 
compared with the average score, 
the best hospital and the worst 
hospital when data will be presented 
anonymously 
x Give the scores of all hospitals 
including national average scores, the 
best and the worst performing 
hospital 
 
Distribution of feedback: 
x Feedback by e-mail 
x First, the hospitals can try to work it 
out on their own, then they can ask 
General: 
x Keep it simple 
x Give an overview of own 
indicators first, followed by the 
remaining indicators 
 
Use of average scores: 
x Give feedback with the scores of 
each hospital; use of average 
scores depends on the goal of 
the feedback 
x Give feedback on own scores 
compared with the national 
average scores to see how your 
hospital is functioning, since one 
prefers not to be presented as a 
‘bad’ hospital 
 
Distribution of feedback: 
x Feedback by e-mail 
x A meeting in the hospital 
organised by the investigator is 
preferred for more background 
information and explanation of 
the results  
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Distribution of feedback: 
x Feedback by e-mail or a patient 
portal 
x A conference is a good idea for 
paying more attention to head and 
neck cancer 
 
 
 
for more background information or 
explanation of the investigator 
x Organise a committee to monitor the 
content and format of the feedback 
report  
x Take case mix into account 
x Give feedback on the quality of data  
x Use specific themes each year when 
data will be compared on a national 
level  
x National feedback in the form of a 
conference is a useful idea; however, 
feedback in your own organisation 
will be useful as well 
x National feedback in the form of 
a conference is a useful idea; 
however, it is better to discuss 
feedback in your own hospital 
first 
 
Transparency General: 
 Transparent for patients 
 Be careful that feedback is not 
interpreted carelessly  
 Be aware that results can change in 
a short time span 
 
Method: 
x Ask permission of the patient to 
receive their own results or the 
results of the general population 
x Make sure that you can trust the 
data: if a doctor gathers the data 
they could be less reliable 
 
 
General: 
 The only way to improve is to make 
data public/transparent 
 To feel a sense of responsibility 
towards the population 
 Be careful with transparency; it is 
about vulnerable data 
 
Method: 
x Set up a committee to decide on 
issues related to transparency  
x Be critical in what a patient is able to 
understand 
x Make sure the specific hospital 
cannot be derived from the data 
presented  
x Only give feedback using scores of all 
hospitals when data will be 
presented anonymously  
x Investigate whether there are specific 
conditions to make the data public.  
x Make sure data are correct  
General: 
 Being transparent is good  
 The only way to improve is to 
make data public/transparent 
 You cannot influence the 
indicators 
 
Method: 
x No anonymous feedback, only in 
the start-up phase 
x Be critical in what a patient can 
understand 
x Make sure that professionals are 
able to influence the indicators 
General: 
 To feel a sense of responsibility 
towards the population 
 Visualise in order to improve 
healthcare 
 
Method: 
¾ Visualise as transparently as 
possible what type of care is 
delivered  
* There is no information available on how the health insurer prefers to receive feedback since they prefer to receive raw data to develop their own figures. 
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Table 6. Preferences on the various figures. 
Figures General perspective Patient Medical specialist Allied health professional 
Kaplan Meier graph 
 
 Gives a clear overview 
 A classical way of presenting data, 
often used in science 
 A good way of presenting, mainly for 
outcome indicators 
 Most useful when there are big 
differences 
 Might be difficult for patients (and for 
some professionals too) to interpret 
 
 For outcome indicators: 
too difficult to 
understand  
 
 For outcome indicators: 
gives a clear overview, 
seen as the classical way 
to present outcomes 
 
¾ Preference for this 
figure and a bar graph to 
present outcome 
indicators  
¾  
 For outcome indicators: 
too difficult to read 
 
Box plot 
 
                         
 Gives a clear overview at a glance 
 A clear overview of how your hospital 
scores compared with the rest 
 Difficult to read for patients, and for 
some professionals as well 
 
 
 For outcome indicators 
and process indicators: 
too difficult to 
understand  
 For outcome indicators 
and process indicators: 
gives a clear overview at 
a glance  
 
+/-  For outcome indicators:   
       for some people it could  
       give a very clear  
       overview, for others it is  
       difficult to read 
 For process indicators: 
gives a less clear 
overview and is more 
difficult to interpret 
  
Point diagram 
 
 
 Does not give a clear overview 
whether all information is added into 
the same figure;  
 Visualise all the information you want  
  For outcome indicators: 
gives an unclear 
overview 
 For outcome indicators: 
gives an unclear 
overview 
  
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Figures General perspective Patient Medical specialist Allied health professional 
Bar graph 
A.  
 
 
B. 
 
 
 For a clear presentation of data  
 For patients, the bar graph is visually 
attractive and more clear to see 
compared with a pie chart, especially 
for elderly people 
+/-   Can be used for the first overview, but  
        afterwards you would prefer more  
         detail 
+/-   Insightful, although it might be  
        difficult to read if more categories are   
        used in one chart 
 Can become a very muddled and 
unclear figure 
 
 For outcome indicators 
(A): gives a clear 
overview  
 For PROs and PREs: gives 
a more clear overview 
 For process indicators 
(B): too difficult to 
understand 
 
¾ Preferences for this 
figure and a pie chart to 
present PROs and PREs 
 For process indicators 
(B): insightful 
 For PROs and PREs: is 
easier to read compared 
with a pie chart 
+/-   For outcome indicators  
        (A): can be difficult to  
        read when several   
        categories are used in  
        the outcome indicators 
 
¾ Preferences for this 
figure to present 
outcome indicators and 
process indicators. A 
Kaplan–Meier graph is 
also preferred for 
outcomes 
 For process indicators 
(B): gives a clear 
overview 
+/-   For outcome indicators  
        (A): can be difficult to   
       read when several  
       categories are used 
 
¾ Preferences for this 
figure to present 
outcome indicators and 
process indicators 
 
¾ Not a specific 
preference for a pie 
chart or a bar graph to 
present PROs and PREs 
Pie chart 
 
x Gives a clear overview, especially 
when there are big differences 
x Mainly for younger patients 
x For PROs and PREs: gives 
a more clear overview 
 
¾ Preferences for this 
figure and a bar graph to 
present PROs and PREs 
x For PROs and PREs: gives 
a clear overview 
 
¾ Slight preferences for 
this figure to present 
PROs and PREs 
compared with a bar 
chart 
 
x For PROs and PREs: gives 
a more clear overview 
and is easier to read 
 
¾ Not a specific 
preference for a pie 
chart or a bar graph to 
present PROs and PREs 
Funnel plot 
 
+/-   Gives a good overview but also  
         contains a lot of information 
 Can be a complicated and unclear 
figure 
 For process indicators: 
too difficult to 
understand  
 For process indicators: 
gives a clear overview 
 Difficult to read at a 
glance 
 
 For process indicators: 
gives a less clear 
overview and is more 
difficult to interpret 
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Figures General perspective Patient Medical specialist Allied health professional 
Area graph 
 
 Advantage is that all information is in 
one figure 
 Not clear; the figure will probably be 
easier to understand with an 
explanation  
 Difficult figure to understand directly 
 Difficult for a patient to read; they 
never see this figure in daily life 
 For PROs and PREs: too 
difficult to understand 
+/-   For PROs and PREs: more 
clear when a 
explanation is given, 
although it remains 
difficult as well: patients 
have probably never 
seen area graphs before 
+/-   For PROs and PREs: more 
clear when an 
explanation is given, at a 
glance it is a difficult 
figure to understand 
 
Line graph 
 
 
 Both insightful and unclear  +/-   For outcome indicators: 
it gives a lot of 
information but it is also 
confusing 
+/-   For outcome indicators: 
it gives a large amount 
of information but it is 
also confusing 
100 
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DISCUSSION  
This exploratory study investigated the preferences of receiving feedback on outcome, process 
and structure indicators in the DHNA from four different stakeholder perspectives: patients, 
medical specialists, allied health professionals including nurses, and health insurers. It shows that 
stakeholders agree that use of feedback can improve healthcare by creating awareness, by 
enabling reflection on oneself and colleagues, by benchmarking to others and by engaging quality 
of care discussions between parties involved. Patients prefer to receive feedback on quality 
indicators that match their healthcare pathway, whereas medical specialists and health insurers 
are interested mainly in outcome indicators. Furthermore, all stakeholders prefer a bar graph for 
feedback on most health outcomes and professional practice. In addition, patients prefer a pie 
chart for PRO experiences, while a Kaplan–Meier graph is preferred specifically for survival curves 
by medical specialists. Feedback should be simple and intended to give an overview firstly. 
Moreover, it should be sent by e-mail with a frequency of 1–4 times a year. 
 Other literature is focussed mainly on preferences of patients or clinicians, but this study 
includes preferences of four different stakeholders22,37,38. It is also directed towards different 
types of indicators, namely process, structure and outcome indicators. Furthermore, it gives a 
clear overview of why, what and how patients, professionals and health insurers prefer to receive 
feedback.  
 Our study confirms that feedback is a method for reflection and for creating awareness, 
resulting in a change in behaviour1,22. Also, patients and professionals mention that knowing the 
hospital’s scores on PROs and PREs can improve the quality of care. Greenhalgh showed already 
that the use of PROs in clinical practice is valuable in improving the discussion and detection of 
health-related quality of life problems39. 
 In line with previous literature and irrespective of the stakeholder, simple formats, such 
as bar graphs, were generally preferred to more complex graphical information20,40,41. Regarding 
PROs and PREs, our study shows that both a pie chart and a bar graph are preferred by patients. 
Professionals have a slight preference for a pie chart over a bar graph. Hildon et al. described that 
patients often prefer a bar graph, since it is a clearer graph visually42. Moreover, patients’ 
preferences for a bar graph are in line with Kuijpers et al20. In addition, Hildon et al. described 
that a funnel plot was difficult to read for patients, which our study confirms as well42.  
 Although our patient population prefers a figure over plain text, they would also prefer an 
explanation to go with the figure. This is in line with Brundage et al., who stated that patients did 
not wish to receive HRQL information out of context or without explanation40, and also with 
Tufte, who gave an overview of the characteristics that a well-readable graph should have43.  
 
6 
 Chapter 6  
102 
 
Strengths and limitations 
The fact that only three health insurers participated in the study could be considered a limitation. 
This is probably too small to reach saturation (the point at which no new information was 
mentioned in the interviews)34. However, the health insurers shared the same thoughts on the 
topics discussed. Bias may have occurred when selecting the patients, since it is possible that 
patients with a higher social status and adequate communication skills were selected by each 
hospital, resulting in a less representative patient population. HNC is associated with poor 
socioeconomic circumstances44. In the interviews, it became clear that it was difficult for patients 
to understand the feedback regarding health outcomes, such as recurrence rates. Therefore, the 
interviews with patients were directed mainly towards the use of feedback on PROs and PREs, 
when we spoke about ‘health outcomes’. Questions for the health insurers merely focussed on 
the goal of feedback, because the insurers mentioned that they prefer raw data instead of 
receiving a complete report. 
 Lastly, there might be an overvalue of positive preferences for feedback. This study shows 
that all stakeholders are positive about receiving feedback on professional practice and 
healthcare outcomes. However, if this view would manifest itself in action, you would expect that 
the literature on implementation of audit and feedback would show much larger and more 
consistent effect sizes. This is similar to the situation in which adherence to clinical guidelines is 
still low and clinicians often overstate their adherence to the guidelines45-47. Knowing how 
stakeholders prefer to receive audit and feedback does not assure that they will actually respond 
to it. Therefore, it is necessary to test the response in practice. 
 
Conclusion 
This exploratory study shows that preferences for receiving feedback between patients, 
professionals and health insurers differ regarding content but not regarding layout. Therefore, 
reports tailored to these preferences are recommended. Using this information, the effect of 
audit and feedback can be improved by adapting the feedback format and contents to 
preferences of stakeholders. As a result, this could potentially improve quality of care. A next 
step is to test in practice to what extent professionals actually respond if audit and feedback suit 
their preferences. 
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THE DUTCH HEAD AND NECK AUDIT: THE FIRST STEPS 
The treatment of Head and Neck Cancer (HNC) is an excellent example of low volume, highly 
complex, multidisciplinary integrated care. HNCs are heterogeneous (both biologically and in 
clinical behaviour) fast-growing tumours in an anatomically and functionally complex area, with 
multiple invasive treatment opportunities. Several health professionals, such as medical 
specialists (head and neck surgeons with expertise in Ear Nose & Throat (ENT) and Oral 
Maxillofacial (OMF) surgery, radiotherapists, medical oncologists, pathologists and radiologists) 
and allied health professionals (dieticians, speech pathologists, physical therapists, oral hygienists 
and oncology nurses) are involved in delivering high quality care to individual patients. To 
increase the quality of care, coordination is crucial1, resulting in less fragmentation and 
unnecessary replication.  
 To monitor and effectively improve high quality integrated care, a clinical audit can be set 
up. A clinical audit is defined as "a quality improvement process that seeks to improve patient 
care and outcomes through systematic review of care against explicit criteria and the 
implementation of change"2. The Dutch Head and Neck Audit (DHNA) was set up in 2014 to 
monitor the quality of integrated HNC care (with quality indicators as a basis), to benchmark and 
to find areas for improvement. Quality indicators were developed from three different 
perspectives: medical specialists, allied health professionals and patients. Following one year of 
inventory and building an online quality registration system3,4, the first data were collected to fill 
the indicators in 2015-20165. The preferences of health professionals and patients in receiving 
feedback on results were investigated as well6. In this chapter, the main findings of the project 
from the perspective of the current status of HNC care in the Netherlands will be addressed. Also, 
the methodological considerations and the implications for clinical practice, future research and 
policymaking will be described.  
 
CHARACTERISTICS OF THE DHNA 
One of a kind 
The DHNA is the first quality of healthcare registration system in the Netherlands involving both 
medical specialists and allied health professionals, with all indicators agreed upon by patients. In 
other words, the DHNA is a truly multidisciplinary registration. Most quality registrations are 
currently monodisciplinary or only involve process indicators from the medical specialists’ 
perspective7. A monodisciplinary audit focuses on process performance and patient outcomes 
from the perspective of one discipline with the aim of improving quality of care. However, 
multidisciplinary care is nowadays more common, as several disciplines contribute to patient 
outcomes. A good example of this is the ‘swallow function’ after a curative treatment for an HNC: 
this can be influenced by both medical treatment and supportive care of the speech therapist or 
dietician8. Quality is often a result of both.  
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 The DHNA is also one of the first HNC quality registrations on an international level. Other 
countries already have databases with the aim of improving quality of care and patient 
outcomes, for example, the Head And Neck Audit (HANA)9 in the UK, or the Danish Head and 
Neck Cancer database (DAHANCA)10. These databases, however, were built from an 
epidemiological perspective for clinical trials and did not use predefined evidence-based quality 
indicators from the start. An epidemiological database is not primarily intended for quality 
registration from the perspective of process indicators, PROs and PREs11. 
 
Selection method based on both process and outcome indicators  
The basic assumption for the quality indicator development procedure used for the DHNA was 
that outcome indicators formed the basis of process and structural indicators. The DHNA 
outcome indicators followed the three-tiered hierarchy for value-based healthcare, as developed 
by Porter12. The first level, e.g. survival, is generally the most important, and lower-tier 
outcomes, e.g. sustainability of health, follow the success of higher tiers. We therefore followed 
the current trend to focus on outcomes13, such as disease-specific mortality and survival or PROs. 
Previous research shows that the preference for an outcome indicator comes from the fact that it 
is a measure of something that is important in its own right, whereas the process indicator is only 
of value when it is assumed to have a link to outcomes14.  
 There are three reasons not to focus solely on outcome indicators. Firstly, process 
indicators are more sensitive in measuring differences in quality of care14. Secondly, a process 
indicator is easier to interpret, whereas an outcome indicator, for example mortality, is a rather 
more indirect measure14. Thirdly, by only measuring outcome performance, there is no 
information on how to begin addressing problems.  
 When a hospital discovers poor performance for one particular outcome, the first step is 
to dissect the outcome into its different components, and to ensure adherence to all best 
practice recommendations at process level13. For these reasons, outcome indicators seem to be a 
measure of quality of care to a lesser extent15 and some researchers push the pendulum back 
towards process measures13. This sets the development of an extensive set that contains both 
process and outcome indicators, as necessary tools to improve quality of care. 
 Incorporating the indicators on outcome, process and structure, a broad view is 
presented on patient-related outcomes, patient-related processes and hospital-related 
processes. However, the link between process and outcome indicators is often unclear. This is 
mainly since many data and sufficient follow-up years are necessary to analyze this association. 
With the DHNA, the link between process and outcome indicators can be analyzed when more 
data are available in the future. Furthermore, incorporating the indicators on outcome, process 
and structure might easily result in an extensive set of quality indicators. This is especially the 
case when both medical specialists and allied health professionals provide indicators.  
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Privacy and juridical challenges for collecting patient data 
To analyze the data on a national level in order to measure the quality of healthcare, an online 
registration system was developed. The PROs and PREs are requested via online patient 
questionnaires, the remaining data are recorded by healthcare providers themselves in the 
DHNA. All collected data are stored in a database. This database forms the basis for the 
automatic feedback system. To ensure that data will be saved correctly and that data will be 
analyzed according to current rights and privacy regulations, it was necessary to set up contracts 
between the HNC centers and the data processors. However, hospitals and their HNC centers 
appeared to have their own interpretation of legal regulations. Therefore, setting up contracts to 
exchange data from the hospital to the data processor was difficult. The contract was prepared 
with the utmost care, taking aspects as exchange of encrypted data and ownership into account. 
However, the lawyers of several hospitals demanded changes in the contract. Apart from this 
being a time-consuming process, lawyers could not reach consensus. This strikes the need for a 
uniform regulation about privacy aspects. 
 
CURRENT QUALITY OF HEAD AND NECK CANCER CARE IN THE NETHERLANDS  
Using the perspectives of both medical specialists and allied health professionals, evidence-based 
quality indicators and case mix variables were developed which were agreed upon by patients3. 
The final set of indicators consisted of five outcome indicators (survival, recurrence, 
complications, patient reported outcomes (PROs) and patient reported experiences (PREs)), 13 
and 18 process indicators from the medical specialist perspective and the allied health 
professional perspective respectively, while three structure indicators from the allied health 
professional perspective were developed within the DHNA. From the patients’ perspective, a 
total of 34 relevant themes of needs and preferences were identified to obtain tools to make 
current integrated HNC care more patient-centered4. The results and usefulness of three 
indicators will be discussed in this paragraph. The first indicator discussed is survival, since this is 
one of the most important outcomes relevant for both patients and professionals. Hereafter time 
to treatment interval is discussed since patients noted that there is an urgent need to reduce 
waiting times in the hospital. Finally, the patient reported outcomes are discussed since these are 
increasingly used to measure quality of care and provide us with information about how the 
patient feels. 
 
Survival 
Previous (European) studies showed that the survival of HNC patients in the Netherlands is 
relatively high16,17. Compared to other countries in Europe, the Netherlands is one of the best 
performers on survival. In a EUROCARE-5 population-based study for head and neck cancers 
diagnosed in the early 2000s for example, five-year survival for patients with laryngeal cancer is 
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68.9% in the Netherlands as compared to 58.9% in Europe. For patients with oral cancer the 
difference is similar, namely 56.1% in the Netherlands compared to 45.4% in Europe17. This 
shows that HNC care in the Netherlands is relatively superior with regard to survival, which could 
be indicative for quality of care. This might be due to the concentration and centralization of HNC 
care since 1984 under the umbrella of the Dutch Head Neck Society (DHNS)18. Monitoring of the 
quality of integrated HNC care using the DHNA provides opportunities to further explore the 
association between survival and quality of care. 
 
Time to treatment interval 
In the Netherlands, all professional associations related to HNC care agreed that 80% of all new 
patients should receive their primary treatment within 30 calendar days from the first 
consultation at an HNC center. However, nationwide, only 48% of the patients start with their 
treatment within 30 calendar days, with a variation of 20-72% in different HNC centers5. A 
previous study in the Netherlands (2007) shows an average ‘time to treatment interval’ of 28 
days with a variation of 5-95 days between diagnostic and radiotherapy planning scans19. So, 
results have not changed that much in ten years and further improvement is still possible. By 
visualizing ‘time to treatment interval’ using the DHNA, and providing active feedback to health 
professionals, this can be improved in the future.  
 
Patient Reported Outcomes (PRO) 
The Netherlands is one of the countries that seem to be most advanced in implementing PROs, 
and it also appears to be leading in the way of inclusion of PROs in national registries20. 
Internationally, there is a policy shift towards value-based healthcare and health outcome 
evaluations, such as in the UK, USA, Sweden and the Netherlands. The first DHNA results 
concerning the PROs showed that function and symptoms differ between type of treatment, 
follow-up moments, age and tumour staging6. Results and methods used were comparable to 
other studies21,22. Many studies focus on differences in patient-reported outcomes and on what 
can be done by hospitals and health professionals to increase the effectiveness of using PROs23. 
However, a crucial step in value-based healthcare is the effectiveness of measuring PROs on 
patient outcomes such as survival. A good example of this is given by Basch et al., who recently 
stated that survival increases significantly in patients who monitored symptoms with PROs 
compared to patients who received standard care24. So far, this is studied to a lesser extent and 
will be one of the aims of the DHNA for the future.  
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CURRENT TOOLS FOR IMPROVING QUALITY OF HEALTHCARE  
Variation in delivered HNC care already visible 
Does this set really facilitate monitoring and improvement of the quality of healthcare? In 
general, an audit registration such as the DHNA needs a couple of years of data to provide stable 
results25. As the first data were collected in December 2014, it is too early yet to present results 
on all indicators. Preliminary results of the DHNA show that, even in a recently launched quality 
registration, with 2,400 new HNC patients included, variations in the delivery of current 
processes of care among HNC centers is already visible. Feedback on indicators in the DHNA is 
given via an automatic online system, which is only accessible by staff at individual HNC centers, 
who are able to view the score of other HNC centers anonymously along with the average 
score7,26. This system allows health professionals to easily compare the performance of their own 
HNC center with a nationwide benchmark, upon which they can start acting on their own results. 
For example, the first results of the quality registration showed a variation between hospitals on 
the indicator of delay from the first consult to finishing the diagnostics and to the start of the 
curative therapy. Subsequently, the first hospital site visits were planned to share practice 
experience towards decreasing lead-time or delay. Besides transparency within and between 
hospitals, the first results of the DHNA can also be shown to the public in the upcoming years, in 
other words: public transparency.  
 
Results already visible for patients  
For most outcome indicators, such as recurrence rates and survival, it takes several years before 
stable and reliable data are complete enough to be interpreted. However, currently some results 
of the DHNA are already visible for patients, namely PROs and PREs. PROs and PREs are collected 
with questionnaires at several follow-up moments using an automatic online system. Currently, 
patients can directly see how their results differ from the last time. In addition, they can bring 
along the results to the medical consult and discuss their concerns or ask for possible solutions. 
In the future, the health professional can also check for outliers or relevant differences compared 
to a previous consult in his own electronic system, prior to the consult. Together with the patient, 
they can start acting on the results at an earlier stage, thus improving rehabilitation. Therefore, 
an automatic feedback loop toward the patient and the health professional and introducing the 
relevance of PROs in a medical consult can improve quality of care in small steps and earlier on, 
compared to quality improvements depending on aspects such as recurrence rates and survival.  
 
Feedback 
Although positive effects of audit and feedback in general have been reported, e.g. decreased 
duration of hospital stay27 and decreased mortality rates28, this method of improving quality of 
care has not been found to be consistently effective29-32. Previous research shows that the format 
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of feedback may significantly affect the interpretation of data33-35. The DHNA showed that 
tailored reports of feedback on professional practice and healthcare outcomes are 
recommended, since feedback preferences differ between patients, medical specialists, allied 
health professionals, and health insurers26. In general, the preferences for receiving feedback 
differ regarding content but not regarding lay-out. This knowledge gives us tools to improve the 
effects of audit and feedback by adapting the feedback format and contents to the preferences 
of stakeholders. In the start-up phase of the DHNA, the first feedback is given in a uniform lay-
out. Now steps can be undertaken to individualize feedback.  
 
METHODOLOGICAL CONSIDERATIONS 
Challenges in developing indicators 
Developing evidence-based indicators for the DHNA from the perspective of allied health 
professionals proved to be rather a challenge, as there are hardly any (inter)national guidelines 
that provide evidence-based recommendations for daily healthcare delivery3. The indicators 
were developed in collaboration with the Dutch national foundation for allied health 
professionals in this specialist sector – the Paramedische Werkgroep Hoofdhalstumoren 
(PWHHT). Panel members were instructed to discuss the potential indicators with the allied 
health professionals of their own discipline, in their own center, and in other Dutch HNC centers 
as well. For some disciplines, variation in delivery of care between the different centers became 
visible. Therefore, the development of indicators was more of a starting point for debate about 
how HNC care should be delivered. As a consequence, development of indicators from the allied 
health perspective took more time to reach agreement compared to medical indicators. 
Discussion remained for the indicators developed from the perspective of speech therapists. 
Therefore, new indicators were developed after one year. Overall, to develop evidence-based 
indicators, evidence-based guidelines or literature are important requirements. However, 
evidence-based guidelines are not always available for rare diseases. A well-performed consensus 
procedure is then necessary to develop useful indicators.  
 
Interpreting results 
When interpreting quality indicator scores, it may be difficult to distinguish between a lack of 
documentation and actual insufficient adherence to guidelines. For example, if the indicator 
‘Presence of a case manager or nurse practitioner at the consultation to discuss the treatment 
plan’ does not have a positive score, it could mean that the case manager was not present, or 
that this was not documented, as such. In addition, to reliably benchmark the performance of 
one hospital compared to average national performance, it is crucial that all hospitals include all 
their patients. Otherwise, with only a proportion of patients, it is impossible to calculate a stable 
indicator, as 1) it is unknown which patients are missing, and 2) variations in patient numbers can 
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influence the adherence percentage. If this happens for outcome indicators, it might set both the 
hospital and the national performance at a disadvantage. Therefore, during the first year most 
registrations merely focus on developing indicators and quality registration; the second year on 
ensuring that all data will be collected; while in the third year the first results are anonymously 
presented. 
 
FUTURE PERSPECTIVES 
By the end of 2016, the DHNA was able to include approximately one third of all new curatively 
treated patients from November 2014, with complete datasets onwards. This could be 
interpreted as a rather low input. However, one must take into account that this project, with 
indicators from the perspectives of medical specialists, allied health professionals, and patients, 
and from referral to follow-up, has prompted a lot of effort from individual therapists, ICT 
systems and work processes. A couple of wise lessons were learned from this project, and will be 
explained in this section. 
 
Implications for clinical practice 
Increase support of health professionals 
Setting up a multidisciplinary quality registration is quite challenging and time-consuming. For a 
successful quality registration, it is important that it is set up for and through health 
professionals25. Considering examples seen in other countries, we know that a government-
administered head and neck cancer registration has nearly failed, because the support of health 
professionals was missing (British HANA)13. With a ‘saving’ plan, many resources are spent on 
improving the support and inclusion of the registration. The DHNA is an example of a quality 
registration in which the health insurer was involved as a partner, next to the health 
professionals, when developing the quality registration. This is also called 'tripartite'. Besides 
health professionals, involving the hospital Board of Directors could be a large opportunity to 
improve care from a policy level. The importance of involving the Board of Directors is also seen 
by the Netherlands Federation of University Medical Centres (NFU). The DHNA participates in one 
of its first pilots in the project ‘Sturen op kwaliteit’36. 
 
Registering at the source 
The website of the National Institute for Public Health and Environment – the ‘Rijksinstituut voor 
Volksgezondheid en Milieu’ (RIVM), in the Netherlands states that there are currently 181 active 
registrations, while annual costs for quality registrations are estimated at 80 million euros37,38. 
These costs are currently spent on registrations and not directly on the patient. One way to 
decrease the registration burden and the associated costs is to reduce the number of 
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registrations and to make the quality registrations as comprehensive as possible. Another 
method to decrease the registration burden is to automate data subtraction from hospital 
electronic patient records. To build an IT-reliable automatic subtraction system is, of course, 
initially expensive, but not in the long run. Furthermore, Govaerts et al. show that improved 
outcomes due to auditing can also reduce costs39.  
 The first steps to lower the registration burden for health professionals that register in the 
DHNA have already been taken by engaging the Netherlands Cancer Registry (NCR) in a close 
cooperation. The NCR has 30 years’ experience in data registration on incidence and survival. 
However, these empolyees are paid from another source, namely the government. Furthermore, 
the DHNA participated in two projects of ‘Registering at the source’. This program has been 
developed in cooperation with the NFU and aims to automatically subtract variables for the 
DHNA from the patient electronic record. In a couple of years the registration burden of the 
DHNA can be significantly decreased. 
Transparency 
In general, some health professionals might have a less positive attitude towards public 
transparency, because they fear that they may be judged and that (social) media might 
misinterpret the indicators. However, besides public transparency, the key to achieving 
improvement collaboratively is to share results within a hospital or between hospitals. Therefore, 
it is crucial to present the results in such a way that they support collaborative improvement, but 
also represent a safe platform to share results. Moreover, the method of communication about 
this kind of non-public transparency is important and should not be neglected. 
 
Implications for future research 
Improve quality of care 
Previously, oncologic care was only evaluated by a few standards from the Dutch Federation of 
Oncologic Specialties (SONCOS)40 and the Healthcare Inspectorate as an independent supervisor 
in Dutch healthcare (IGZ)41. These data were collected for accountability and were not used to 
improve quality of care. The data from the DHNA provides the first opportunity to visualize 
differences in outcomes and practice performance at a national level. With this information, 
more research can be directed towards variation in current practice between different centers. 
Best practices can be framed, and ultimately, data can be used to improve quality of care. In 
addition, from the first results of the DHNA, we know that variation between centers is present, 
and that four determinants on patient and hospital level influenced the indicator scores5. When 
more data are available, research can be directed towards all indicators to explore the variance 
and possible patient and hospital determinants. 
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Patient reported outcomes and experiences 
The DHNA shows that patients with multimodality treatments experience a less well-organized 
healthcare process, suffer from lower functional scores and more symptoms compared to 
patients with a monomodality treatment6. In the future, more data should be collected to obtain 
more insight into long-term quality of life and patients’ experiences. Apart from carrying out 
research on the outcomes, studies towards the effectiveness of measuring PROs should be 
undertaken to increase patient outcomes such as survival. 
Evaluation of quality indicators of the DHNA 
The first quality indicators for the DHNA were developed in the start-up phase of the quality 
registration. After three years, more data will be obtained, enabling more reliable feedback on a 
national level and a hospital level. This gives us tools to evaluate the indicators. However, before 
making a decision on the indicator, it is important to evaluate why an indicator is performing well 
or poorly. For example, if care is delivered, but not registered as such, it is crucial to improve the 
registration processes in the patient records instead of continuing the quality registration in the 
same way.  
Go global 
Besides comparing quality of care between different HNC centers in the Netherlands, it would be 
interesting to compare the quality of HNC care to other countries in Europe17. In addition, 
international research projects can be initiated to investigate international variations in 
performance of HNC care, to learn from each other and to improve current HNC care. An already 
existing consortium is the ‘International Consortium for Health Outcomes Measurement’ 
(ICHOM), which measures international patient outcomes. At this moment, no international HNC 
indicator set exists under the umbrella of ICHOM. The DHNS with its DHNA can provide input for 
the development and its implementation.  
 
Implications for policy making 
Development of good quality indicators for future registrations 
Besides a clear definition of the concept to be measured and the target population, the origin of 
the indicator is important42. It was difficult to develop evidence-based indicators from the 
perspective of allied health professionals in the DHNA, mainly because there were no national 
guidelines3. Campbell et al. have previously described that evidence-based quality indicators 
form the foundation for a good quality registration, preferably developed by an evidence-based 
method3,43,44. However, the results from the quality registration could start a dialogue between 
disciplines working in different HNC centers. It could provide the first tools to discuss where and 
why HNC care is delivered differently in order to reach consensus about best practice. Quality 
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indicators themselves can therefore be the evidence to improve clinical practice and, therefore, 
reframe national guidelines.  
Monodisciplinary versus multidisciplinary 
A monodisciplinary quality registration will depend to a lesser extent on the support of different 
health professionals, compared with a multidisciplinary quality registration. This is most notably 
the case when the multidisciplinary registration involves both medical specialists and allied 
health professionals. This will make the implementation of the quality registration more complex. 
However, with a multidisciplinary registration, the quality of care provided by all disciplines can 
be measured. In that case, a multidisciplinary healthcare process benefits from a multidisciplinary 
quality registration. Therefore, a clear decision on the aim should be made, while weighing the 
advantages and disadvantages of a multidisciplinary registration and a monodisciplinary 
registration for each (oncologic) disease.  
Privacy and juridical restrictions 
This project was not the first to encounter privacy and juridical problems, and will also not be the 
last. We tried to expand the discussion to a national level with various relevant parties. 
Unfortunately, the importance of making these processes less bureaucratic was not shared by 
national organizations. However, such problems are encountered on a local level, yet require a 
solution on a national level, while hopefully a uniform regulation on a national level will follow in 
the future. It is crucial that research projects continue to indicate the problems to make directors 
more aware of the problem. 
 
FINAL CONCLUSION 
The DHNA is the first quality of healthcare registration system in the Netherlands that involves 
both medical specialists, allied health professionals and patients. In addition, it is also one of the 
first HNC quality registrations on an international level. Therefore, this project shows that the 
development of a multidisciplinary quality registration for patients with HNC from three different 
perspectives, namely patients, medical specialists, and allied health professionals, is feasible. 
Outcome indicators formed the basis of process and structural indicators, while all indicators are 
evidence-based. A key element to implement an efficient HNC registration was to keep the 
health professionals involved. 
We know that current HNC care in the Netherlands is well organized and it seems effective with 
regard to survival results16,17. However, preliminary results from the DHNA show that care can be 
improved and that it varies among different hospitals at certain points. In the future, more data is 
needed to better explain the variation and possible patient and hospital determinants, to obtain 
more insight into long-term quality of life and patients' experiences, and to define the relation 
between PROs and PREs and patient outcomes such as survival. Hereafter, results can be shared 
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within a hospital or between hospitals to support collaborative improvement. When hospitals 
give permission, data can become transparent to the public as well. In addition, it would be 
interesting to compare the quality of HNC care with other countries in Europe.   
 Efforts should be made on a national level to solve privacy and juridical restrictions for 
quality registrations. In addition, the registration load should be decreased with the use of IT-
reliable automatic subtraction systems. With more data and a reduction of the registration load, 
the focus of the DHNA will move from registration of data to improving quality of HNC care. So 
far, the first steps to improve quality of care have already been taken. Examples of existing 
quality improvement steps are the visibility of indicator scores with corresponding benchmarks in 
a hospital specific online feedback report, hospital site visits to share practice experiences toward 
decreasing time to treatment interval, and the visibility of patients’ own results regarding PROs 
and PREs. In the upcoming years, more such steps will be taken to improve quality of healthcare 
for patients with HNC in the Netherlands. 
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MAIN FINDINGS 
Development of quality indicators for integrated head and neck care 
1) A comprehensive set of evidence-based quality indicators from three different 
perspectives (medical specialists, allied health professionals and patients) over the 
entire HNC pathway was developed (Chapters 2 & 3). 
2) The perspective of the patient, the medical specialist and the allied health professional 
are essential in each phase of care: the diagnostic, treatment and follow-up phases 
(Chapter 2). 
3) Similar outcome indicators were developed from the perspective of medical 
specialists, allied health professionals and patients, focusing on survival, recurrence 
and complication rate, as well as patient reported outcomes (PROs) and patient 
reported experiences (PREs) (Chapter 2). 
4) Process indicators from the perspective of medical specialists focused more on the 
diagnostic phase and on organizational aspects, such as high quality multidisciplinary 
team meetings and diagnostic and therapeutic delay. Process indicators from the 
perspective of allied health professionals focused more on the functional and 
psychosocial status of the patient before, during and after treatment (Chapter 2). 
5) Patients’ needs and preferences emerging from the study concerned a) the diagnostic, 
treatment, and surveillance phases, and were related to b) both medical specialists 
and allied health professionals. Patients needed a more ‘Personalized diagnostic 
phase’, and ‘Adequate involvement of the general practitioner in the aftercare for an 
optimal transfer’. They also needed ‘Personalized involvement of allied health 
professionals for physical support’, ‘Involvement of the oncology nurse for time saving 
during the consultation with the doctor and more personal contact’, and ‘Doctor–
patient relationship relies on integrity and mutual respect’ (Chapter 3). 
 
First results of the quality registration 
1) Despite the fact that registration has recently started, differences in the care provided 
were found on the basis of the jointly appointed indicators; the indicator for the 
availability of a treatment plan had the highest score and variation between hospitals 
was small, while the indicator for a case manager or nurse practitioner being present at 
the consultation to discuss the treatment plan had the lowest score and a high 
variation (Chapter 4). 
2) Three determinants at patient level and one determinant at hospital level influenced 
the scores of different indicators (tumour stage, performance status, tumour site and 
number of new patients per year) (Chapter 4). 
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3) Patients with multimodality treatments (combination of treatments) tended to 
experience a lesser well-organized healthcare process, while also having worse 
functional scores and more symptoms compared to patients with a monomodality 
treatment (Chapter 5). 
 
Audit and feedback 
1) According to the different stakeholders (patients, medical specialists, allied health 
professionals and insurance companies) regular feedback can improve healthcare 
through creating awareness, benchmarking to other hospitals, engaging quality of care 
discussions between parties involved, and by providing focus for actions to improve 
the quality of care (Chapter 6). 
2) Feedback preferences differed between stakeholders on the frequency and indicator 
types, which makes tailored reports preferable (Chapter 6).  
3) Medical specialists preferred to receive feedback on outcome indicators (one to four 
times a year) more often compared to process indicators (one to two times a year) 
(Chapter 6).  
4) Allied health professionals preferred to receive more feedback on process indicators 
rather than on outcome indicators. Furthermore, allied health professionals preferred 
to receive the indicators of their own discipline first, followed by the remaining 
indicators, whereas patients preferred indicators that match the care received 
(Chapter 6). 
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SUMMARY 
In chapter 1 general information about Head and Neck Cancer (HNC) is provided, explaining more 
about the incidence, survival, symptoms, risk factors, treatment, and the need for 
standardization of care. In addition, a quality registration to measure quality of care using quality 
indicators is explained. Finally, the main objectives and outline of the thesis are described. 
 
Development of quality indicators for integrated head and neck care 
Oncological care is very complex, and delivery of integrated care with optimal alignment and 
collaboration of several disciplines is crucial. A dashboard of valid and reliable quality indicators is 
indispensable to monitor and effectively improve high quality integrated oncological care. 
Chapter 2 describes the development of quality indicators to measure quality of integrated 
oncological care, specifically for head and neck cancer (HNC) patients. For this purpose, the 
RAND-modified Delphi method was used to decide on the outcome, process, and structure 
quality indicators from three different perspectives: patients, medical specialists and allied health 
professionals involved in HNC care. In the final set, outcome indicators were assigned to 
healthcare status, tumour recurrence, complications, quality of life, and patient experiences. The 
process indicators focused on the (allied health) care aspects during the diagnostic, treatment, 
and follow-up phases; for example on waiting times, multidisciplinary team meetings, and 
screening for malnutrition. Developed case mix factors focused on patient characteristics such as 
gender, age and tumour stage. This set can be used to build other oncological quality dashboards 
for integrated care. 
  
 
Chapter 3 explores the needs and preferences of patients with head and neck cancer (HNC), to 
adapt current integrated care to a more patient-centered integrated care. Semi-structured 
interviews were held with 14 current and former patients and chairmen of two Dutch HNC 
patient associations to identify all possible needs and preferences. In addition, needs and 
preferences were categorized using the eight dimension Picker model of patient-centered care. A 
total of 34 themes of needs and preferences were identified and categorized into the eight Picker 
dimensions. Themes that often emerged were: personalization of healthcare regarding patient 
values, clear insight into the healthcare process at an organizational level, use of personalized 
communication, education and information that meets patients’ requirements, adequate 
involvement of allied health professionals for physical support, more attention to the impact of 
HNC and its treatment, adequate support from family and friends, adequate general practitioner 
involvement during aftercare, and waiting time reduction. Monitoring the identified themes in 
integrated HNC care will enable us to respond better to the needs and preferences of patients, 
while patient-centered care in oncological care can be enhanced. 
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First results of the quality registration 
Chapter 4 describes the assessment of current head and neck cancer care using quality 
indicators, particularly the variation among Dutch hospitals, and the influence of patient and 
hospital characteristics. Data for calculating quality indicator scores were collected by means of 
self-registration of 1,667 curatively treated patients in eight hospitals. A multilevel analysis was 
used to explain the variation between Dutch hospitals and to analyze the influence of patient and 
hospital characteristics. The quality of current care varied between the different hospitals: the 
indicator for the availability of a treatment plan had the highest score and variation between 
hospitals was small, while the indicator for a case manager or nurse practitioner being present at 
the consultation to discuss the treatment plan had the lowest score and a high variation. At 
patient level, higher quality indicator scores were associated with lower performance status, an 
advanced tumour stage, and the presence of tumours in the oral cavity and oropharynx in three 
indicators, namely: the indicator for involvement of a dental team before radiotherapy, for the 
start of the first treatment within 30 days, for finishing diagnostics within 21 calendar days, and 
for malnutrition screening. At hospital level, higher quality indicator scores were associated with 
more curatively treated patients (volume) in three indicators, namely: the indicator for 
registering whether the patient was treated according to the protocol, for referral to the hospital 
within 7 calendar days, and for finishing diagnostics within 21 calendar days. We conclude that 
although the quality registration had only recently been launched, it already visualizes hospital 
variation in current care. Four determinants are of influence in this respect: tumour stage, 
performance status, tumour site, and number of new patients per year. However, more data are 
needed to assure stable results for use in quality improvement. 
  
 
Monitoring how patients feel and what they experience during the integrated care process gives 
health professionals tools to improve their care. In chapter 5 we obtained more specific 
improvement aspects for different treatment methods by measuring Patient Reported Outcomes 
(PROs) and Patient Reported Experiences (PREs) in integrated HNC care for both patients with 
monomodality and multimodality treatment. Validated PRO Measures (PROMs), yielded global 
health status, functional scores, and symptom scores (EORTC-C30 & H&N35) were completed at 
baseline and 3, 6 and 12 months after the last treatment. The PRE Measure (PREM) (Dutch 
CAHPS), including domains such as organization and cooperation, was completed at 12 months 
after diagnosis. Descriptive analyses were used to assess trends in PROs over time and the 
difference between monomodality and multimodality treatment in PROs and PREs. This study 
showed that patients with multimodality treatment tend to experience a lesser well-organized 
healthcare process, have worse functional scores and more symptoms compared to patients with 
a monomodality treatment. In addition, patients with radiotherapy treatment alone suffered 
from less functional scores and more symptoms compared to patients with surgery alone. Given 
the higher incidence of symptoms and loss of functioning in patients after multimodality 
8 
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treatment in particular, the follow-up phase should be more personalized and directed to 
rehabilitation for restoring function and decreasing symptoms. 
 
Audit and feedback 
Chapter 6 explores the (differences in) preferences of receiving feedback between stakeholders 
in the DHNA. Therefore, semi-structured interviews were held with a total of 37 patients, medical 
specialists, allied health professionals, and health insurers. All stakeholders mentioned that 
feedback can improve healthcare by creating awareness, enabling self-reflection and reflection 
on peers or colleagues, and by benchmarking to others. Patients preferred feedback on the 
actual professional practice that matches the healthcare received, whereas medical specialists 
and health insurers were mainly interested in healthcare outcomes. All stakeholders largely 
preferred a bar graph. Patients preferred a pie chart for patient reported outcomes (PROs) and 
experiences (PREs), while Kaplan Meier survival curves were preferred by medical specialists. 
Providing feedback should be simple with firstly an overview, and 1-4 times a year sent by e-mail. 
Finally, patients and health professionals were cautious with regard to transparency of audit 
data. In conclusion, this exploratory study shows how feedback preferences differ between 
stakeholders.  
  
 
Finally, in chapter 7 the main findings of this thesis are discussed in the light of recent literature, 
and implications for future research, clinical practice and policy making are outlined.
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SAMENVATTING 
In hoofdstuk 1 wordt algemene informatie gegeven over hoofd-halstumoren (HHT), met name 
over het aantal nieuwe patiënten, overleving, symptomen, risicofactoren, behandeling en de 
behoefte aan standaardisering van de zorg. Daarnaast wordt het begrip kwaliteitsregistratie 
toegelicht, evenals het belang van kwaliteitsindicatoren voor zo’n registratie en het meten van de 
kwaliteit van zorg. Tenslotte worden de hoofddoelstellingen en de inhoud van het proefschrift 
beschreven. 
 
Ontwikkeling van kwaliteitsindicatoren voor geïntegreerde hoofd-hals 
oncologische zorg 
Het leveren van geïntegreerde zorg met optimale samenwerking tussen verschillende disciplines 
is van cruciaal belang. Een kwaliteitsregistratie met valide en betrouwbare kwaliteitsindicatoren 
is onmisbaar om de geïntegreerde oncologische zorg te monitoren en effectief te verbeteren. 
Hoofdstuk 2 beschrijft de selectie van kwaliteitsindicatoren om de kwaliteit van geïntegreerde 
oncologische zorg te meten voor patiënten met hoofd-halstumoren: de Dutch Head and Neck 
Audit (DHNA). De RAND-gemodificeerde Delphi methode is gebruikt om kwaliteitsindicatoren op 
uitkomst-, proces- en structuurniveau te selecteren vanuit drie verschillende perspectieven: 
patiënten, medische specialisten en paramedici betrokken bij HHT-zorg. In de uiteindelijke set 
zijn uitkomstindicatoren geselecteerd op het gebied van overleving, recidief, complicaties, 
kwaliteit van leven en patiëntervaringen. De geselecteerde procesindicatoren zijn gericht op 
handelingen van medisch specialisten en paramedici in de diagnostische, behandelings- en 
nazorgfasen, bijvoorbeeld wachttijden, kwaliteit van het multidisciplinair overleg en screening 
voor ondervoeding. Patiënteigenschappen die vanuit de verschillende perspectieven ook van 
belang worden geacht om mee te nemen in de kwaliteitsregistratie zijn geslacht, leeftijd en 
tumor stadium. Deze set van kwaliteitsindicatoren kan een basis vormen voor andere 
oncologische kwaliteitsregistraties. 
 
Hoofdstuk 3 beschrijft onderzoek naar behoeften en voorkeuren van patiënten met hoofd-
halstumoren, met name om de huidige geïntegreerde zorg aan te passen aan een meer 
patiëntgericht zorg. Semi-gestructureerde interviews zijn gehouden met 14 huidige en 
voormalige patiënten en voorzitters van twee Nederlandse hoofd-halstumor 
patiëntenverenigingen om alle mogelijke behoeften en voorkeuren te identificeren. De gevonden 
behoeften en voorkeuren zijn vervolgens gecategoriseerd met behulp van het acht-dimensionale 
Picker-model voor patiëntgerichte zorg. In totaal zijn 34 thema's en voorkeuren geïdentificeerd 
en gecategoriseerd in het Picker-model. Thema's die vaker voorkwamen zijn: 1) behoefte aan 
gepersonaliseerde zorg met aandacht voor de waarden van de patiënt; 2) duidelijk inzicht in het 
zorgproces op organisatorisch niveau; 3) gebruik van gepersonaliseerde communicatie, onderwijs 
en informatie die voldoet aan de behoeften van patiënten; 4) adequate betrokkenheid van 
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paramedici voor lichamelijke ondersteuning; 5) het vergroten van de aandacht voor de impact 
van hoofd-halstumoren en de behandeling ervan in de maatschappij; 6) adequate ondersteuning 
voor familie en vrienden; 7) adequate betrokkenheid van de huisarts bij de nazorg; en 8) 
vermindering van de wachttijd. Het monitoren van de geïdentificeerde thema's in geïntegreerde 
hoofd-halstumor zorg stelt ons in staat om beter te reageren op de behoeften en voorkeuren van 
patiënten waardoor de patiëntgerichtheid van de oncologische zorg kan worden verbeterd. 
 
Eerste resultaten van de kwaliteitsregistratie 
Hoofdstuk 4 beschrijft de huidige zorg voor patiënten met een hoofd-halstumor aan de hand van 
de geselecteerde kwaliteitsindicatoren (zie hoofdstuk 2). Met name de variatie tussen 
Nederlandse ziekenhuizen en de invloed van patiënt- en ziekenhuiskenmerken hierop zijn 
beschreven. Benodigde data voor het berekenen van scores van de kwaliteitsindicatoren zijn 
verkregen door zelfregistratie van 1.667 curatief behandelde patiënten in acht ziekenhuizen. Een 
multilevelanalyse is gebruikt om de variatie tussen Nederlandse ziekenhuizen te verklaren en de 
invloed van patiënt- en ziekenhuiskenmerken te analyseren. De kwaliteit van de huidige zorg 
varieerde tussen de verschillende ziekenhuizen. De indicator voor de aanwezigheid van een 
behandelplan had bijvoorbeeld de hoogste score (bij gemiddeld 95% van de patiënten is aan de 
indicator voldaan) en de variatie tussen ziekenhuizen was klein, namelijk 88-98%. Aan de andere 
kant, de indicator voor de aanwezigheid van een case manager of verpleegkundige bij het overleg 
om het behandelplan met de patiënt te bespreken had de laagste score (29%) en een grote 
variatie tussen ziekenhuizen, namelijk 0-90%. Op patiëntniveau zijn hogere indicator scores 
geassocieerd met een betere performance status, een verder gevorderd tumor stadium en de 
aanwezigheid van tumoren in de mondholte en orofarynx. Dit betrof met name de indicatoren 
voor de betrokkenheid van een tandarts voorafgaand aan de radiotherapie, de doorlooptijd van 
binnenkomst in een ziekenhuis tot het afronden van diagnostiek binnen 21 kalenderdagen en de 
start van de behandeling binnen 30 kalenderdagen en voor screening op ondervoeding. Op 
ziekenhuisniveau zijn hogere indicatorscores geassocieerd met meer curatief behandelde 
patiënten (volume) voor de indicatoren over het registreren of de patiënt volgens het protocol is 
behandeld, de doorlooptijd van verwijzing naar het ziekenhuis binnen 7 kalenderdagen en het 
afronden van diagnostiek binnen 21 kalenderdagen. Hoewel de kwaliteitsregistratie pas recent is 
gestart, geeft het al variatie in de zorg weer tussen de verschillende ziekenhuizen. Echter, er zijn 
meer gegevens nodig om stabielere resultaten te verkrijgen voor het gebruik van de registratie 
bij kwaliteitsverbetering. 
 
Monitoren hoe patiënten zich voelen en wat patiënten ervaren tijdens het zorgproces, geeft 
zorgverleners mogelijkheden om de zorg te verbeteren. In hoofdstuk 5 zijn meer specifieke 
verbeteringsaspecten verkregen voor verschillende behandelingsmethoden door het meten van 
patiënt gerapporteerde uitkomsten (PRO's) en patiënt gerapporteerde ervaringen (PRE's) voor 8 
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zowel patiënten met één behandelmodaliteit (bijvoorbeeld alleen een operatie) als met 
patiënten met meerdere modaliteiten (bijvoorbeeld operatie en bestraling). Gevalideerde PRO-
vragenlijsten (PROM's), met onder andere de globale gezondheidsstatus, functionele scores en 
symptoomscores (EORTC-C30 & H & N35) zijn afgenomen voorafgaand aan en op 3, 6 en 12 
maanden na de laatste behandeling. De PRE-vragenlijst (PREM) (gebaseerd op de CQ-index), met 
vragen over bijvoorbeeld de organisatie van zorg en samenwerking van zorgverleners, is 
afgenomen op 12 maanden na de diagnose. Beschrijvende analyses zijn gebruikt om de trends in 
PRO's over de tijd te beoordelen en om het verschil tussen mono- en 
multimodaliteitsbehandeling van PRO's en PRE’s te bepalen. Uit deze studie is gebleken dat 
patiënten met multimodaliteitsbehandeling een minder goed georganiseerd zorgproces hebben 
ervaren, slechtere functionele scores hadden en ook meer symptomen hadden dan patiënten 
met een monomodaliteitsbehandeling. Daarnaast hadden patiënten met alleen radiotherapie 
lagere functionele scores en meer symptomen dan patiënten met alleen een operatie. Gezien de 
hogere incidentie van symptomen en verlies van functioneren bij patiënten na een 
multimodaliteitsbehandeling, moet de nazorgfase meer op maat georganiseerd worden en 
gericht zijn op herstel van functie en het verminderen van symptomen. 
 
Audit en feedback 
Hoofdstuk 6 beschrijft een onderzoek naar de (verschillen in) voorkeuren van belanghebbenden 
van de DHNA wat betreft het terugrapporteren van de resultaten uit de kwaliteitsregistratie. Er 
zijn semi-gestructureerde interviews gehouden met in totaal 37 patiënten, medisch specialisten, 
paramedici en zorgverzekeraars. Alle belanghebbenden gaven aan dat terugkoppeling de 
gezondheidszorg kan verbeteren door bewustwording, zelfreflectie en reflectie op lotgenoten of 
collega's en door benchmarking. Patiënten zijn geïnteresseerd in het ontvangen van 
terugkoppeling over de zorg die zij daadwerkelijk ontvangen hebben, terwijl medisch specialisten 
en zorgverzekeraars voornamelijk geïnteresseerd zijn in uitkomsten van de zorg. Alle 
geïnterviewde belanghebbenden hadden de voorkeur voor het gebruik van een staafdiagram 
voor het terugkoppelen van resultaten. Patiënten hadden de voorkeur voor een taartdiagram 
voor PRO's en PRE's; de Kaplan Meier curve had de voorkeur van medische specialisten voor 
overlevingscijfers. Geïnterviewden hebben aangegeven dat terugrapportages eenvoudig moeten 
zijn met eerst een globaal overzicht van alle cijfers en worden bij voorkeur 1-4 keer per jaar 
verzonden per e-mail. Tenslotte, patiënten en zorgverleners hebben aangegeven dat ze 
voorzichtig zijn met het naar buiten brengen van gegevens. Uit deze verkennende studie blijkt 
dat voorkeuren op het gebied van terugrapportages verschillen tussen belanghebbenden. 
 
In hoofdstuk 7 zijn de belangrijkste bevindingen van dit proefschrift besproken aan de hand van 
recente literatuur, waarna de implicaties voor toekomstig onderzoek, klinische praktijk en 
beleidsvorming zijn besproken. 
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INDICATORENSETS 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Verschillend aantallen indicatoren in voorgaande hoofdstukken 
De eerste set indicatoren bestond uit 40 kwaliteitsindicatoren; vijf uitkomstindicatoren vanuit beide 
perspectieven, 13 en 19 procesindicatoren vanuit respectievelijk de medisch specialist en de paramedicus 
en drie structuurindicatoren vanuit het perspectief van de paramedicus. Discussie bleef bestaan over de 
indicatoren vanuit het perspectief van logopedist waarna na één jaar nieuwe indicatoren zijn ontwikkeld. 
Dit resulteerde in een totaal van 18 procesindicatoren vanuit het perspectief van de paramedicus. Op dit 
moment bestaat de uiteindelijke set indicatoren uit 39 indicatoren. Om deze rede worden verschillende 
aantallen indicatoren genoemd in hoofdstuk 1, 4 en 7. 
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Indicatorenset Kwaliteitsregistratie Hoofdhalsketen - Medisch specialisten  
 
Uitkomstindicatoren  
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch 
Centrum (inclusief preferred partner) wordt het percentage patiënten bepaald….. 
1.  .. waarbij de status NED, AWD, DOD, DID, DTC of Dead 
a) 1 jaar na afronding van de behandeling is geregistreerd; 
b) 2 jaar na afronding van de behandeling is geregistreerd; 
c) 3 jaar na afronding van de behandeling is geregistreerd; 
d) 4 jaar na afronding van de behandeling is geregistreerd; 
e) 5 jaar na afronding van de behandeling is geregistreerd; 
f)     1 t/m 5 jaar na afronding van de behandeling is geregistreerd. 
(NED = No evidence of disease; AWD = Alive with disease; DOD = Dead of disease; DID = Dead of 
intercurrent disease (disease at the same time); DTC = Dead of treatment complications) 
(Richtlijn/literatuur: Input expert panel) 
2.1  .. waarbij het eerste residu, metastase of 2e primaire is opgetreden binnen 5 jaar na afronding van de in 
opzet curatieve behandeling. (Richtlijn/literatuur: Input expert panel) 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch 
Centrum (inclusief preferred partner) waarbij het eerste recidief is opgetreden binnen 5 jaar na de in opzet curatieve 
behandeling wordt het percentage patiënten bepaald….. 
2.2 .. waarbij het recidief residu, metastase of 2e primaire gespecificeerd is met betrekking tot 
a) de histologie; 
b) rTNM status;  
c) localisatie van het recidief  
d)     kenmerk a t/m c. 
(Richtlijn/literatuur: Input expert panel) 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch 
Centrum (inclusief preferred partner) wordt het percentage patiënten bepaald….. 
3.  .. waarbij een complicatie is opgetreden na behandeling met  
a)     radiotherapie (vroege complicaties) 
b)     radiotherapie (late complicaties) 
c)      chemotherapie  
d)     chirurgie 
(Richtlijn/literatuur: Input expert panel) 
Æ de complicaties voor radiotherapie en chemotherapie worden op een later moment meegenomen 
 
Kwaliteit van leven  
De kwaliteit van leven van patiënten met hoofd-halstumoren kan gemeten worden met drie instrumenten. Het 
voorstel is om de generieke kwaliteit van leven te meten met EuroQoL-5D en de specifieke kwaliteit van leven met 
de EORTC-QLQ-C30, aangevuld met de QLQ-hn35. Er wordt een baseline meting van de kwaliteit van leven gedaan 
voordat de patiënt start met de behandeling. Hierna wordt de vragenlijst 3, 6, 12 en 24 maanden na afronden van de 
laatste behandeling afgenomen. De laatste vragenlijst wordt afgenomen vijf jaar na het afronden van de laatste 
behandeling. 
 
 Indicatorenset Medisch specialist  
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Patiëntervaringen  
Voor het meten van de patiëntervaringen is het voorstel om een verkorte versie van de CQ-index ‘zorg voor 
patiënten met kanker’ te gebruiken en de eerste versie van CQ-index radiotherapie als pilot. De CQ-index 
radiotherapie wordt 6 maanden na diagnose afgenomen, de oncologische CQ-index ‘zorg voor patiënten met kanker’ 
wordt 12 maanden na diagnose afgenomen.  
 
 
Indicatoren Diagnostiek 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en een in opzet curatief behandeladvies heeft gekregen waarbij 
pathologie-onderzoek is uitgevoerd of gereviseerd op een biopt, resectiepreparaat of resectiepreparaat van de hals 
wordt het percentage patiënten bepaald… 
4  .. waarbij door de patholoog de onderstaande specifieke kenmerken zijn geregistreerd. 
(Richtlijn/literatuur: CCO/ NWHHT/ SIGN/ Hessel et al., 2010)  
- Specifieke kenmerken resectiepreparaat primaire tumor zijn: Tumor grootte in mm; Infiltratie diepte in mm; 
Marge status in mm; Patroon van infiltratie; Perineurale of vaso- invasieve groei; Speciaal type (bijv 
acontholytisch); HPV status bij OPC en Differentiatiegraad 
- Specifieke kenmerken resectiepreparaat hals zijn: Aantal lymfeklieren bekeken; Aantal positieve lymfeklieren; 
Level van betrokken lymfeklieren; Extracapsulaire uitbreiding van metastasen en Diameter grootste metastase 
- Specifieke kenmerken biopt zijn: HPV status bij OPC en Differentiatiegraad 
Æ deze indicator wordt door PALGA geregistreerd en niet door de centra/preferred partners zelf.  
 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en een in opzet curatief behandeladvies heeft gekregen wordt het 
percentage patiënten bepaald… 
5.   .. waarbij de patiënt voorafgaand aan de behandeling besproken is in het MDO van een Hoofd-Hals 
Oncologisch Centrum. (Richtlijn/literatuur: CCO/ HNTCSS/ IGZ / NICE/ SIGN/ Hessel et al., 2010) 
 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en een in opzet curatief behandeladvies heeft gekregen en 
besproken is in het MDO van een Hoofd-Hals Oncologisch Centrum voorafgaand aan de behandeling wordt het 
percentage patiënten bepaald… 
6.  .. waarbij de hoofdbehandelaar aanwezig was bij het MDO. (Richtlijn/literatuur: IGZ) 
Æ deze indicator wordt op een later moment meegenomen 
7.   .. waarbij de ondersteunende specialismen en ondersteunende disciplines A t/m F aanwezig waren. 
(Richtlijn/literatuur: IGZ) 
(Benodigde ondersteunende specialismen zijn: A. Twee erkende specialisten met ervaring in reconstructieve 
chirurgie in het hoofd-halsgebied; B. Twee erkende specialisten in de radiotherapie met ervaring in het hoofd-
halsgebied; C. Eén erkend patholoog met ervaring in de pathologie van het hoofd-halsgebied; D. Eén medisch 
oncoloog; E. Eén radioloog / nucleair geneeskundige; en F. Eén oncologieverpleegkundige of één casemanager).  
Æ deze indicator wordt op een later moment meegenomen 
8.  .. waarvoor een behandelplan is opgesteld. (Richtlijn/literatuur: IGZ) 
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Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner), die een in opzet curatief behandeladvies hebben gekregen, 
besproken zijn in het MDO van een Hoofd-Hals Oncologisch Centrum voorafgaand aan de behandeling en waarvoor 
een behandelplan is opgesteld wordt het percentage patiënten.. 
9.   .. waarbij onderstaande punten 1 & 2 zijn opgenomen in het behandelplan. (Richtlijn/literatuur: IGZ) 
(Punten behandelplan: 1. Is het een protocollaire behandeling? & 2. Zijn er overwegingen die leiden tot 
afwijkingen van het protocol (o.a. patiënt voorkeuren)? 
 
Indicatoren Behandeling 
Van de patiënten met een hoofd-halstumor dat in opzet curatief behandeld is in een Hoofd-Hals Oncologisch 
Centrum (inclusief preferred partner) zijn en een radiotherapeutische behandeling hebben ondergaan waarbij de 
mandibula en/of maxilla betrokken zijn in het radiotherapieveld (exclusie T1 glottis carcinomen) wordt het 
percentage patiënten bepaald…. 
10.  .. waarbij de patiënt gezien is door een tandheelkundig team voor start van behandeling met 
radiotherapie. (Richtlijn/literatuur: CCO/ HNTCSS/ NICE/ NWHHT/ SIGN) 
 
 
Indicatoren Nazorg & Follow-up  
Van de patiënten met een hoofd-halstumor dat in opzet curatief behandeld is in een Hoofd-Hals Oncologisch 
Centrum (inclusief preferred partner) zijn en een halsklierdissectie (level I t/m V) hebben ondergaan wordt het 
percentage patiënten bepaald… 
11. .. waarbij de patiënt is beoordeeld door de fysiotherapeut binnen zeven dagen na dissectie. 
(Richtlijn/literatuur: HNTCSS/ NWHHT) 
 
Van de patiënten met een hoofd-halstumor dat in opzet curatief behandeld is in een Hoofd-Hals Oncologisch 
Centrum (inclusief preferred partner) waarbij de schildklier geheel of gedeeltelijk in het bestralingsveld ligt wordt het 
percentage patiënten bepaald..   
12.  .. waarbij de schildklierfunctie is gecontroleerd na afronden van de bestraling op  
a.   6 maanden na laatste behandeling; 
a. 12 maanden na laatste behandeling; 
b. 24 maanden na laatste behandeling; 
c. 36 maanden na laatste behandeling; 
d. 48 maanden na laatste behandeling; 
e. 60 maanden na laatste behandeling; 
f.      6, 12, 24, 36, 48 & 60 maanden na laatste behandeling  
(Richtlijn/literatuur: NWHHT/ Hessel et al., 2010)  
Æ deze indicator wordt op een later moment meegenomen 
 
 
Indicatoren Coördinatie & Organisatie 
Van de patiënten die verwezen zijn naar een centrum door een huisarts of specialist met (verdenking op) een hoofd-
halstumor naar een Hoofd-Hals Oncologisch Centrum (inclusief preferred partner) waarbij diagnostiek is uitgevoerd 
of gereviseerd in een HHOC (inclusief preferred partner) en een in opzet curatief behandeladvies hebben gekregen 
wordt het percentage patiënten bepaald.. 
13.   .. waarbij de patiënt terecht kon op de poli van een Hoofd-Hals Oncologisch Centrum of preferred partner 
(van 1e lijn naar 2e lijn) binnen een ‘bepaald aantal dagen’. (Richtlijn/literatuur: Ouwens et al., 2007) 
 Indicatorenset Medisch specialist  
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Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen 
wordt het percentage patiënten bepaald.. 
14.     .. waarbij de diagnostiek na het eerste bezoek aan het Hoofd-Hals Oncologisch Centrum of preferred 
partner binnen een ‘bepaald aantal dagen’ is afgerond (afronden diagnostiek = het MDO). 
(Richtlijn/literatuur: Input expert panel) 
                       
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch 
Centrum (inclusief preferred partner) wordt het percentage patiënten bepaald…. 
15.   .. waarbij de behandeling binnen een ‘bepaald aantal dagen’ is gestart na eerste bezoek aan het Hoofd-
Hals Oncologisch Centrum of preferred partner (norm NWHHT is 80% behandeld binnen 30 dagen). 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een HHOC (inclusief preferred 
partner) wordt het percentage patiënten bepaald… 
16.   .. waarbij een volgende behandeling is gestart binnen een ‘bepaald aantal dagen’ na voltooiing van eerste 
behandeling. (Richtlijn/literatuur: Kelly et al., 2012)  
* tweede behandeling binnen het traject van de primaire behandeling. 
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Indicatorenset Kwaliteitsregistratie Hoofdhalsketen - Paramedici   
 
Uitkomstindicatoren  
Zie medisch specialisten 
 
 
Indicatoren Voedingszorg 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen 
wordt het percentage patiënten bepaald.. 
4.  .. waarbij door de verpleegkundige is gescreend op het risico op ondervoeding op: 
1. bij eerste polibezoek van een Hoofd-Hals Oncologisch Centrum of preferred partner & start 
chirurgische behandeling 
2. bij eerste polibezoek van een Hoofd-Hals Oncologisch Centrum of preferred partner & start 
(dag)behandeling (chemo)radiotherapie) 
(Richtlijn: Austr/ N&S/ Oncovoed) 
5. .. waarbij door de diëtist cq verpleegkundige is gemonitord op ondervoeding aan de hand van % gewichtsverlies 
op: 
a) indien radiotherapie en/of chemoradiatie: 
1. week 3 van de behandeling met radiotherapie en/of chemoradiatie (gelijktijdig toepassen 
chemotherapie en radiatie) 
2. laatste week van de radiotherapie en/of chemoradiatie behandeling 
3. twee weken tot een maand na de laatste behandeling (ongeachte welke behandeling; op moment 
van controle bij de arts) 
4. drie maanden na de laatste behandeling (ongeachte welke behandeling) 
b) indien chirurgie: 
1. twee weken tot een maand na de laatste behandeling (ongeachte welke behandeling; op moment 
van controle bij de arts) 
2. drie maanden na de laatste behandeling (ongeachte welke behandeling) 
(Richtlijn: Austr/ N&S/ Oncovoed) 
 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen 
waarbij de screeningsuitslag op ondervoeding ‘matig risico of ‘hoog risico’ is wordt het percentage patiënten 
bepaald.. 
6.  .. waarbij de patiënt is doorverwezen naar de diëtist én waarna een nutritional assessment is afgenomen (BMI 
classificatie en % gewichtsverlies). (Richtlijn: HHCvoed)  
 
  
Indicatoren Psychosociale zorg 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch  
Centrum (inclusief preferred partner) waarbij psychologische signalering plaats vindt met de Lastmeter of Oncoquest 
wordt het percentage patiënten bepaald.. 
7. ..waarbij psychologisch signalering plaats heeft gevonden op de momenten 1 t/m 4. (Richtlijn: Hypo/ 
Larynx/ Mond/ Oncopsy/ input expert panel) 
 Indicatorenset Paramedicus  
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1. Net na diagnose (vóór start behandeling); 
2. Net na behandeling; 
3. Zes weken na laatste behandeling;  
4. Elke drie maanden na laatste behandeling (op dit moment in het project is dat nog na drie maanden 
en na zes maanden); 
8. ..waarbij het resultaat van de Lastmeter of computersysteem OncoQuest is opgenomen in het 
(elektronisch) patiëntendossier. (Richtlijn: Oncopsy) 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch  
Centrum (inclusief preferred partner) met een ‘hoog risico’ volgens de Lastmeter of computersysteem Oncoquest 
wordt het percentage patiënten bepaald.. 
9.  . .. waarbij met de patiënt de noodzaak tot verwijzing naar een psycholoog, psychiatrisch verpleegkundige, 
maatschappelijk werkster, geestelijke verzorging of psychiater is besproken. (Richtlijn: HHCvoed/ Hypo/ 
Larynx/ Mond/ Oncopsy) 
 
 
Indicatoren Mondzorg 
Van dentate patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen 
wordt het percentage patiënten bepaald.. 
10.  .. waarbij ter preventie van radiatie cariës voorafgaand aan de radiotherapie fluoridekappen zijn 
aangemeten. (Richtlijn: Hypo/ Larynx/ Mond)  
 
Van dentate en edentate patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een 
Hoofd-Hals Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben 
gekregen wordt het percentage patiënten bepaald.. 
11. .. waarbij ter preventie van weefselbeschadiging, in de vorm van mucositis door verstrooiing van de straling, 
tijdens de radiotherapie de patiënt de mond frequent (8-10 maal daags) spoelt met een zout/soda oplossing  
(Richtlijn: Hypo/ Larynx/ Mond) 
Æ Deze indicator zal aan de patiëntenvragenlijst worden toegevoegd en zodoende door de patiënt worden ingevuld. 
 
Voor dentate en edentate patiënten, met kroon en/of brugwerk en/of amalgaam vullingen en/of implantaten, met 
een hoofdhalstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals Oncologisch Centrum 
(inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen wordt het percentage 
patiënten bepaald.. 
12.  .. waarbij voorafgaand aan de radiotherapie scatteringskappen zijn aangemeten ter preventie van 
mucositis. (Richtlijn Mondholte/ Oro). 
 
 
Indicatoren Lichamelijk functioneren  
Fysiotherapie 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen en 
een halsklierdissectie (level I t/m V) heeft ondergaan wordt het percentage patiënten bepaald.. 
13. .. waarbij een baseline meting en een postoperatieve (binnen 14 dagen na operatie) beoordeling plaats 
heeft gevonden door een fysiotherapeut op:  
a) Baseline beoordeling voor schouderfunctie en zenuwuitval (NXI); 
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b) Postoperatieve beoordeling voor schouderfunctie en zenuwuitval (NXI); 
c) Baseline beoordeling voor functie van de cervicale wervelkolom; 
d) Postoperatieve beoordeling voor functie van de cervicale wervelkolom; 
(Richtlijn: Behandelprogrev / Halskl) 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch  
Centrum (inclusief preferred partner) en een halsklierdissectie (level I t/m V) heeft ondergaan wanneer een patiënt 
een hoog risicoprofiel voor schouder disability heeft en de patiënt een behandelwens heeft wordt het percentage 
patiënten bepaald.. 
14.  .. waarbij een gestructureerde vervolgbehandeling plaatsvindt na ontslag door het centrum zelf of dat er 
een gestructureerde overdracht plaatsvindt. (Richtlijn: input expert panel) 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn een Hoofd-Hals Oncologisch  
Centrum (inclusief preferred partner) met onder andere een reconstructietechniek (fibulalap bij reconstructie van de 
kaak) wordt het percentage patiënten bepaald.. 
15. .. waarbij een fysiotherapeut in consult is geroepen door de behandelend arts. (Richtlijn: Behandelprogrev / 
Halskl/ input expert panel) 
 
 
Logopedie  
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn met een chirurgische behandeling 
bestaande uit onder andere een reconstructie of een totale larynxextirpatie in een Hoofd-Hals Oncologisch Centrum 
(inclusief preferred partner) wordt het percentage patiënten bepaald… 
16.  ..waarbij de patiënt pre-operatief is gezien door de logopedist ivm voorlichting, baseline meting of 
interventie (conform consensus in expertpanel). 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn met een chirurgische behandeling 
bestaande uit onder andere een reconstructie of een totale larynxextirpatie in een Hoofd-Hals Oncologisch Centrum 
(inclusief preferred partner) wordt het percentage patiënten bepaald… 
17.  ..waarbij de patiënt vóór ontslag is gezien door de logopedist voor diagnostiek en eerste advies/behandeling 
van de slik- en/of spraakstoornis of spraakrevalidatie na totale larynxextirpatie (conform consensus in 
expertpanel). 
 
 
Indicatoren Communicatie & Voorlichting 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn of waarbij diagnostiek is uitgevoerd 
of gereviseerd in een Hoofd-Hals Oncologisch Centrum (inclusief preferred partner) en een in opzet curatief 
behandeladvies heeft gekregen wordt het percentage patiënten bepaald.. 
18. … waarbij met de patiënt en diens familie de gevolgen van roken en alcohol op de ziekte en de noodzaak tot 
stoppen zijn besproken. (Richtlijn: input expert panel) 
Æ Deze indicator zal aan de patiëntenvragenlijst worden toegevoegd en zodoende door de patiënt worden ingevuld. 
 
 
 
 
 
 Indicatorenset Paramedicus  
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Indicatoren Coördinatie & Organisatie 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen 
waarbij een uitslaggesprek / slecht nieuwsgesprek plaats vindt wordt het percentage patiënten bepaald.. 
19.  .. waarbij de case manager/ oncologisch verpleegkundige aanwezig was. (Richtlijn: Input expert panel/ 
SlechtN) 
 
Van de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch  
Centrum (inclusief preferred partner) wordt het percentage patiënten bepaald.. 
20. .. waarbij een transmurale overdracht van patiënteninformatie is geweest vanuit klinische paramedici naar 
de eerste lijn. (Richtlijn: Oncovoed) 
 
Van de patiënten met een hoofd-halstumor waarbij diagnostiek is uitgevoerd of gereviseerd in een Hoofd-Hals 
Oncologisch Centrum (inclusief preferred partner) en die een in opzet curatief behandeladvies hebben gekregen 
wordt het percentage patiënten bepaald.. 
21. .. waarbij de case manager/oncologisch verpleegkundige aanwezig is bij het MDO van een Hoofd-Hals 
Oncologisch Centrum. (Richtlijn: IGZ) 
 
 
Indicatoren ziekenhuisniveau 
Bij de patiënten met een hoofd-halstumor die in opzet curatief behandeld zijn in een Hoofd-Hals Oncologisch  
Centrum (inclusief preferred partner) wordt het percentage centra bepaald.. 
22.  ..waarbij de score en het beloop van de Lastmeter/ OncoQuest goed toegankelijk zijn voor alle 
behandelaars. (Richtlijn: Oncopsy) 
23. ..waarbij een case manager/oncologisch verpleegkundige minimaal 4 dagen per week op de poli aanwezig 
is. (Richtlijn: Input expert panel/ IGZ) 
24. .. waarbij er op de poli 1 FTE verpleegkundige aanwezig is voor de opvang van 100 nieuwe HHO patiënten. 
(Richtlijn: Input expert panel, IKNL) 
Æ Indicatoren 22 t/m 24 zijn structuur indicatoren die één keer per centra/ziekenhuis geïnventariseerd word
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DANKWOORD 
Ik heb onwijs genoten van mijn promotietraject en onwijs veel geleerd. Ik heb zeker een paar 
keer symbolisch de computer uit het raam gegooid omdat het allemaal stom was maar vaker was 
mijn instelling: 'Oké, dan wassen we dit varkentje ook nog even'. Waarschijnlijk waren deze 
eigenschappen al deels aanwezig in mij maar….heel cliché.... ook ik wil graag mijn promotieteam 
bedanken. Hoe verder ik in mijn promotietraject kwam, hoe meer ik me realiseerde dat ik erg 
geboft heb. Ik heb menig persoon zien stoppen, maar ik heb nooit het idee gehad dat ik alleen 
stond. Rosella: iedere maandag stond ik trouw bij jouw deur te wachten met een lijstje met 
punten. Gewoon om even te sparren en te checken of ik op de goede weg zat. Ik besef nu dat ik 
best verwend ben! En hoe ik een stuk gecorrigeerd terug kreeg?! Vaak voor de helft rood, maar 
met allemaal goede punten waar niemand anders mee kwam en waarvan ik had gehoopt dat ik 
het zelf had gezien. Robert, jouw reactiesnelheid is er één om jaloers op te zijn. Ondanks dat je 
KNO arts bent, en keteneigenaar, en in allerlei commissies zit, en ga zo maar even door, kreeg ik 
altijd een snelle en concrete reactie. Als ik ’s avonds nog iets stuurde kreeg ik de volgende dag 
altijd het eerst van jou een reactie, zo rond 7.00u. Zeker niet te vergeten is Thijs, ik stond er altijd 
van te kijken hoe jij precies wist hoe de vork in de steel zat en welke issues er speelden. Politieke 
discussies wist je met mooie woorden altijd goed op te vangen en de angel eruit te halen. En 
Ludi, ik heb jou vaak telefonisch gesproken of via Skype gezien. Dank voor je verfrissende blik op 
stukken tekst en artikelen. Kort maar krachtig gaf je je mening en soms net even anders dan de 
anderen. Al met al, fijn dat jullie er voor mij waren! 
 
Voor mijn onderzoek heb ik verschillende ervaringsdeskundigen persoonlijk mogen spreken. Dit 
was voor mij van grote meerwaarde en dit heeft zeker het onderzoek en de audit naar een hoger 
niveau getild. Daarnaast heeft de stuurgroep, eerst onder leiding van Richard Grol en daarna 
onder leiding van Jetty Hoeksema, een enorme inzet getoond. Zonder jullie kritische feedback en 
motivatie hadden we nu niet gestaan waar we op dit moment staan. Tevens wil ik graag de 
deelnemende ziekenhuizen en de gemandateerde leden bedanken, ook jullie hebben soms 
hemel en aarde bewogen om dit project van de grond te krijgen. 
 
Daarnaast is er nog een legio aan mensen die ik wil bedanken en die mij de gelegenheid hebben 
gegeven om mijn eigen pad te gaan. Wytske: tijdens mijn hele promotietraject ben je mijn 
kamergenoot geweest, we hebben door de jaren heen veel gedeeld met elkaar: zowel leuke als 
minder leuke dingen. Andere kamergenootjes: Arna, Marijke, Myrna, Tessa, Dana, Anne, Tsjiske 
en Sander: dank voor alle lunches, etentjes, gesprekken, grappen etc! Eva: ik ken je al vanuit de 
studie, toen kwamen we elkaar weer tegen bij Epic en vervolgens weer bij IQ. Altijd in voor iets 
creatiefs of een ludieke actie (#paaseieren verstoppen met Wytske). Deze twee mede-paashazen: 
dank dat jullie mijn paranimfen willen zijn! En natuurlijk heb ik nog een heleboel fijne collega’s 
vanuit ‘de kelder’, hier hebben we vele uurtjes samen gezeten: jullie ook ontzettend bedankt 
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voor alle borrels, uitjes, intervisie en goede gesprekken! Niet alleen de kelder, maar natuurlijk 
ook een aantal personen ‘van boven’. Jozé; jij hebt veel bijgedragen aan het project en het onder 
de aandacht gebracht bij de NFU. Mariëlle; op verschillende nevenprojecten heb ik met jou 
mogen samenwerken en onder andere veel geleerd over standaardisering. Ik heb veel van jullie 
beide geleerd op verschillende vlakken en ik heb het altijd een prettige samenwerking gevonden!   
 
Omdat ik mezelf breder wilde verdiepen, heb ik op de valreep gesolliciteerd voor de UMC raad. 
Top plan! Toen ik eenmaal snapte waar het over ging kon ik meepraten en voelde ik me echt 
onderdeel van een heuse adviesraad voor het Radboudumc. Dank voor deze ervaring! 
 
Nu mijn vrienden in Nijmegen, ‘thuis’ of elders in het land: altijd mocht ik jullie updaten met de 
stand van zaken. Soms over leuke dingen en soms even mijn hart luchten en gewoon even 
zeuren. Maar bovenal hebben jullie mijn leven naast promoveren verrijkt.  
 
Mam, jij hebt de advertentie voor in de krant al 4 maanden klaarliggen. Na een paar keer 
uitleggen, wist je waar ik mee bezig was en wat zo’n traject precies inhoudt. Nu de verdediging 
zelf nog, en dan weet je alles! Pap, mama hield jou altijd goed op de hoogte en af en toe kreeg ik 
zelf een vraag over hoe het ging. Maar met name voor andere levensbeslissingen zoals verhuizen, 
nieuw laminaat, lamp ophangen etc. stapte jij zonder moeite in de auto om naar Nijmegen of ‘s-
Hertogenbosch te rijden. Jullie lieten me altijd mijn eigen weg gaan onder het thema ‘niks moet, 
alles mag’. Helaas moeten er soms toch een heleboel dingen, ook in een promotietraject, maar ik 
heb van kleins af aan voldoende ruimte gekregen om mijn eigen pad te gaan.  
 
Cynthia en Martin, ik gaf jullie zo nu en dan een update over de zussen-en-broer-app. Als we 
elkaar tegen kwamen ging het gesprek soms niet over het promoveren, en soms juist heel 
uitgebreid. Dank voor jullie interesse de afgelopen jaren! 
 
Thalia, jij hebt toch wel het meest meegekregen in de afgelopen jaren. Wekelijks hangen we aan 
de telefoon voor van alles en nog wat, maar zeker ook over promotiezaken. Sorry dat ik soms wat 
kortaf was omdat ik niet de tijd nam om een issue fatsoenlijk uit te leggen terwijl je soms als 
‘leek’ juist een goed idee had. Dank voor je luisterend oor, het relativeren en het meedenken! 
 
Last but not least, Jos. Jij kwam pas halverwege het traject binnen en soms met harde leer kwam 
jij er achter dat promoveren geen 9 tot 5 baan is. Toen we eenmaal samenwoonden stond toch 
menigmaal de wekker in het weekend al vroeg of liet ik tijdens het avondeten doorschemeren 
dat ik toch nog graag nog iets aan mijn promotie wilde doen die avond. Dit was met name het 
geval toen ik in Leiden bij mijn nieuwe baan begon. Maar altijd heb jij mij gesteund en mijn passie 
gewaardeerd. Op dat we nu even in rustiger vaarwater zitten, mijn nieuwe uitdaging nog even op 
zich laat wachten, en dat we samen 80 worden! 
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met de opleiding Biomedische Wetenschappen in Nijmegen. In haar studietijd heeft ze zich een 
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In november 2013 is Lydia begonnen aan haar promotietraject bij IQ healthcare waarin ze een 
kwaliteitsregistratie heeft opgezet voor patiënten met een hoofd-halstumor. Het eindresultaat is 
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